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THESIS SUMMARY  
This thesis aimed to evaluate the relevancy of different in vitro cell and culture 
models for osteoblastic-linage cells. Cell lines provide a convenient and accessible 
alternative to primary human osteoblast cells. However, the direct comparison  
of these cells demonstrated limited similarity of cell lines to the primary human 
osteoblasts indicating that their use should be limited to appropriate and specific 
research questions.  
To investigate the paracrine regulation of osteogenic development, the immature 
human osteoblasts and human bone-derived mesenchymal stem cells (MSCs)  
were co-cultured in monolayer or high density culture. Results from this part  
of the study suggested the presence of an active signalling pathway between MSCs  
and osteoblasts. What is more, the effect of cell-cell crosstalk depended on the type 
of culture system. Co-culture in a 3D micromass system stimulated the osteogenic 
differentiation of progenitor cells, while in monolayer this was not seen. While  
the stimulation of MSCs with inflammatory and chemotactic factors successfully 
regulated the cell gene expression and secretion profile, no effect of the secrotome  
on the osteogenic differentiation of unstimulated cells in monolayer  
was demonstrated. Altogether, these results indicated the importance of cell-to-
matrix interconnectivity.  
Therefore, the last part of this thesis focused on the assessment of osteogenic 
differentiation in 2D and 3D cell culture models, which are physiologically relevant. 
The progression in osteogenesis depends on the applied 3D culture model. While  
in both, micromass and type I collagen-hydroxyapatite gel, the differentiation  
is enhanced compared to monolayer, the regulation of this process is triggered  
in a different manner in these 3D culture models.  
Together these findings demonstrate how diverse outcomes can be obtained  
by the application of different models in in vitro research. Ultimately, the 3D in vitro 
models provide a better choice for a more in vivo-related osteogenic differentiation 
and its regulation.  
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THESIS BACKGROUND 
Within bone cells are embedded in a mineralised organic matrix composed of type  
I collagen, non-collagenous proteins and hydroxyapatite. In this milieu bone cells 
interact with ECM and each other through soluble factors or direct interactions which 
determine cell behaviour and phenotype, including proliferation, motility, 
metabolism, differentiation and survival. All these are important to maintain  
the specificity and homeostasis of the bone. Since the first attempt of isolation  
and in vitro culture of osteoblast cells from adult human bone by Bard et al (Bard et 
al., 1972), a great improvement in the knowledge of the biology of bone  
and, in particular, osteoblastic cells have been made. Nevertheless, the treatment  
of acute or chronic pathological conditions of bone is challenging. Within the last  
two decades, new tissue engineering strategies have been developed hoping  
for supporting the treatment these conditions and bone regeneration. Yet, the proper 
evaluation and understanding of the occurring processes in in vitro is fundamental 
when aiming for the best clinical outcome. Hence, it is crucial to apply  
the appropriate and reliable models for osteogenic differentiation of cells and its 
regulation in in vitro research. The research within this thesis responds for the need 
of reliable in vitro models by defining and evaluating their relevance  
to the physiological context.  
Various cell culture models and cell culture systems have been employed  
for tracking various aspects of osteprogenitor and osteoblast cell biology. The use  
of cell models allows overcoming the concern regarding the limited availability  
of primary cells. Stabilised osteoblastic cell lines have been developed as models  
for in vitro investigation of the regulation of cell differentiation, cytokine  
and hormonal regulation, synthesis and secretion of matrix proteins, molecular 
mechanisms of bone diseases, and drug pharmacokinetics. Nevertheless, in the case  
of osteoblast cells the existing differences, such as species-related, between primary 
human cells and various osteoblast cell models complicate the evaluation of results  
and comparisons with human situation. In chapter 3, this problem has been 
addressed. We aimed to characterise and compare commonly used osteoblast cell 
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models derived from different sources in order to determine the relevance  
of osteoblast cell models for bone-related studies. 
Taking into account the various cell types present in the bone and the complex ECM, 
the net of the interactions that occurs is very intricate which makes their in vitro 
investigations challenging. Nevertheless, direct and indirect in vitro co-culture 
models for the investigations aiming to elucidate the manner and importance of cells 
crosstalk have been developed. Although, models for both type of co-cultures  
are mainly based on monolayer in vitro culture systems, recently more attention  
has been directed towards a 3D co-culture, including the spheroids or scaffold 
systems. Regarding the communication of osteoblast cells and their progenitors, most  
of the evidences are based on the in vitro co-cultures of murine or rat cell models. 
Hence, in chapter 4, we aimed to elucidate the communication modes between cells 
derived from human bone. Specifically, the indirect communication between human 
bone forming cells in a monolayer and 3D co-cultures was investigated.  
The investigations regarding the paracrine communication were continued further.  
In chapter 5, the aim was to enhance the paracrine activity of cells and its functional 
evaluation regarding the stimulation of differentiation into an osteoblastic phenotype  
of MSCs. 
For decades, a monolayer culture system has been considered as a gold standard  
in vitro culture model. This simplified system ensures the controlled culture 
environment. However, it is clear that this system is not physiologically relevant. 
Results obtained in chapter 4 indicated the co-culture of MSC and osteoblast cells  
in a 3D micromass system promoted the osteogenic differentiation of MSCs. 
Encouraged by these results, we investigated the effect of the in vitro cell culture 
environment on the osteogenic differentiation of MSCs. For this, within chapter 6,  
two 3D culture models were used, including a standard high density micromass 
culture and a novel type I collagen-hydroxyapatite hydrogel. By employing the two 
different systems, the importance of the ECM for the osteogenic differentiation  
of bone derived MSCs was investigated. Additionally, the behaviour of MSCs 
in the 3D culture models was compared with the monolayer. Ultimately, we aimed  
to establish a 3D osteoblast cell model resembling a more natural milieu allowing  
 Thesis background 
3 
 
for better understanding of the osteoblastic cell development and application for cell-
cell communication research.  
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INTRODUCTION 
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Czekanska E.M., Stoddart M.J., Richards R.G., Hayes J.S. In search of an osteoblast 
cell model for in vitro research. Eur Cell Mater 2012 9;24:1-17. 
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1.1. Bone biology 
1.1.1. Bone function 
The skeletal system of the human body is comprised of bones, cartilage, muscles, 
ligaments and tendons. Bone is a complex and dynamic vascular mineralized 
connective tissue with various mechanical, synthetic and metabolic functions.  
The skeleton acts as a frame for the body giving it support and keeping its shape.  
In particular, bones provide physical protection and support for internal organs,  
such as the skull protecting the brain, or ribs protecting the lungs and heart. Bone 
serves as an attachment site for tendons and muscles which together form  
a movement apparatus. Moreover, the presence of bone is essential for the sense 
 of hearing. The auditory ossicles (malleus-hammer, incus-anvil, stapes-stirrup) 
present in the middle ear space transmit sounds waves from the air to the cochlea 
(Gray, 1973). In addition, within the medullar cavity of long bones and the interstices 
of cancellous bone marrow is found, which is the source of multipotent cells  
and the centre of haematopoiesis. Finally, by having a direct effect on energy 
metabolism, bone acts as an endocrine organ whose action influence the whole body 
(Schwetz et al., 2012). 
1.1.2. Bone microstructure 
Regarding their macroscopic appearance, two forms of bone in the skeleton  
are distinguishable, namely compact (dense) bone and spongy (cancellous) bone 
(Fig.1.1A). Most bones contain both of these forms. 
Compact bone is dense, stiff and always located externally to the spongy bone 
(Fig.1.1A). It consists of a number of irregular cylindrical units named osteons 
(Harvesian systems) which are predominantly oriented in longitudinal direction. 
Each osteon comprises of a Harvesian (central) canal surrounded by concentric 
lamellae of bony tissue varying from 5 to 7μm in thickness. Osteocytes, located  
in lacunae, make contact with other cells via transverse canaliculi canals. These 
canals connect with the central (Harvesian) canal (Fig.1.1B&C). The central canal 
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encloses a neurovascular bundle, which connects through Volkmann's canals located 
perpendicularly to central canals. Usually the central canal is 50μm in diameter and 
contains one or two capillaries and mainly non-myelinated nerve fibres, together 
with Schwann cells. The network formed by canaliculi canals and Harvesian canal 
facilitates the exchange of nutrients and metabolic waste. 
Compared to compact bone, cancellous bone has a less dense and more porous 
matrix which results in a higher surface area to mass ratio and weaker mechanical 
properties. These properties enable cancellous bone to be suitable for metabolic 
functions. To fulfil all its metabolic functions, cancellous bone is highly 
vascularised. Here, the large diameter nutrient vessels and arteries, passing from 
episphysis towards subchondral bone, form intreaosseous anastomoses. The primary 
structural and functional unit of spongy bone is a honeycomb like trabecular 
structure. In long bones, cancellous bone is located proximal to joints, whereas in flat 
bones it is between cortical bone.  
 
Figure 1.1. Schematic diagram of the microstructure of mature bone seen in transverse  
and longitudinal section. Taken from: http://classes.midlandstech.edu 
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1.1.3. Bone matrix 
1.1.3.1. Inorganic compartment  
The main inorganic bone matrix component, which gives bone its hardness  
and rigidity, is an analogue of naturally occurring hydroxyapatite (Ca10(PO4)6(OH)2). 
In hard tissues, such as bone and dentine, the OH group can be substituted with 
CO3
2
, Mg
2+
, F
-
 or H2PO4
-
 (Boskey, 2008). In general, apatite crystals deposited  
in bone have a needle-shape measuring 20-40nm in length and 3-6nm in breadth 
(Gray, 1973). The deposition of the apatite crystals is oriented in relation  
to the collagen fibrils. Specifically, in bone, crystals are located within the individual 
fibers and along the fibril surfaces in the extrafibrillar space between the fibers 
(Orgel et al., 2011;Veis and Dorvee, 2013). The process of biomineralisation  
is initiated and coordinated by the bone-related proteins. Biomineralisation  
is biphasic, comprising mineral formation within matrix vesicles (MV) and mineral 
propagation into the extracellular matrix (ECM), which is regulated by enzymes, 
proteins and phospholipids (Anderson, 2003). The specific role of the main 
regulators of biomineralisation is discussed in the following paragraphs. 
1.1.3.2. Organic compartment 
1.1.3.2.1. Collagen matrix  
Type I collagen is the most abundant protein in bone comprising about 90% of bone's 
organic material. It is also abundantly present in the extracellular matrix of tendons, 
ligaments and skin. In bone it provides tensile strength and torsional stiffness, 
especially after calcification. Type I collagen belongs to the group of fibrillar 
collagens, which consist of long triple helical molecules self-assembling into highly 
organised fibres (Kadler et al., 1996). Each molecule of type I collagen, called 
tropocollagen, is usually composed of two α1 and one α2 chains. In humans, genes 
coding these chains have distinct locations. Specifically, the gene coding the α1 chain 
is located at chromosome 17 (17q21.3-q22), whereas the gene coding the α2 chain  
is located at chromosome 7 (7q21.3-q22) (Chu et al., 1984;de Wet et al., 1987;Rosset 
and de Crombrugghe, 2002). Both of these genes are similar in structure, having  
52 exons. The difference between the genes for both chains is the location  
of the coding sequence for the triple helical domain and N-propeptide. The triple 
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helical domain of the α1 chain is coded by 3 exons, whereas it is coded by 2 exons  
for the α2 chain. Moreover, the N-propeptide is coded by 3 exons for α1 and 6  
for α2 chain.  In both cases, the main triple helix and C-peptide are coded by 41 and 4 
exons, respectively. After transcription, the pre-mRNA undergoes exon splicing, 
capping and addition of poly(A) tail. This mature mRNA is translated in polysomes 
and the resulting protein is transported to the endoplasmic reticulum where  
it is subjected to posttranslational modifications. Upon entering the rough 
endoplasmic reticulum (RER), signal peptides from the N-terminal ends are cleaved, 
followed by the hydroxylation and glycosylation of both α1 and α2 chains  
at the X and the Y position of the Gly-X-Y triplets. As a result of hydroxylation, 
approximately 100 proline residues at the Y position, few at the X position and about 
10 lysines at Y position undergo hydroxylation by prolyl-4-hydroxylase, prolyl-3-
hydroxylase and lysyl-hydroxylase, respectively. Importantly, the hydroxylation 
process is essential for stable folding into a triple helix at a later time.  
The hydroxylation process can only progress in the presence of cofactors, such  
as Fe
2+
, O2, α-ketoglutarate and ascorbic acid. In the next process, glucosyl  
and galactosyl residues are added to the ε-OH group of the hydroxylated-lysines  
by hydroxyllysyl glactosyltransferase and galactosylhydroxyl-glucosylotransferase, 
respectively. Next, each pro-α chain of C-peptide undergoes the addition  
of mannose-rich oligosaccharides. Following this process, C-propeptides of both  
α1 and α2 propeptides associate, with the formation of inter and intrachain disulfide 
bonds. Subsequently, the triple helix is formed progressing from the C-terminal end 
towards the N-terminal end. The final step in the rough endoplasmic reticulum  
is directed by HSP47 protein, the collagen specific molecular chaperone, which 
stabilises the triple helical structure of the procollagen molecule. From the RER, 
procollagen proceeds into the Golgi complex via ERGICs (Endoplasmic Reticulum 
to Golgi Intermediate Compartments) or VTCs (Vesicular Tubular Clusters)  
in a COPII-dependent process (Coat Protein Complex II). Subsequently, it is secreted 
in the extracellular matrix where specific amino- and carboxypeptidases cleave  
the N- and C-propeptides, respectively (Rosset and de Crombrugghe, 2002). Mature 
collagen molecules naturally assemble into quarter-staggered/cross-striated fibrils  
in an entropy-driven process due to the loss of solubility properties resulting from  
the cleavage of terminal propeptides (Kadler et al., 1996). In the type I collagen 
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fibril, molecules are parallel to each other. Moreover, they overlap each other  
by multiples of 67nm (distance D). Each molecule is 4.4D (300nm) long and spaced 
from another one by 0.6D gap. The final step of collagen biosynthesis  
is the introduction of covalent cross-links in order to stabilise the supramolecular 
assembly. In the case of fibrillar collagens, including type I collagen, cross-linking  
is initiated and driven by lysil oxidases, which are copper-dependent amine oxidases 
(Hulmes, 2008;Molnar et al., 2003). These enzymes convert lysine or hydroxylysine 
in the C- and N-terminal telopeptides to respective peptidyl aldehydes. As a result  
of this reaction, aldehydes on one molecule condense with aldehydes of other lysines 
and hydroxylysines on adjacent molecules, forming interchain and intrachain 
covalent cross-links which significantly increase the tensile strength of the fibrils. 
The role of collagen synthesis and its proper alignment is essential for osteoblast 
noncollagenous protein expression, synthesis and differentiation of bone cells. 
Moreover, in the ECM milieu, collagen, together with the non-collagenous proteins, 
including bone sialoprotein (BSP), osteonectin, osteopontin and osteocalcin regulate 
mineral propagation. 
1.1.3.2.2. Non-collagenous proteins and their role in matrix 
mineralisation 
The expression and localisation of specified non-collagenous proteins expressed  
at the mineralisation stage have been studied in detail using human, rat and chicken 
in vitro and in vivo.  
Alkaline phosphatase (ALP) has an important role in the mineralisation and its 
expression coincides with the synthesis of the type I collagen (Whyte, 2002).  
The tissue non-specific isoform of ALP present in bone is bound to the matrix 
vesicles (MV) within the cell membrane that bud from osteoblasts via 
phosphatidylinositol-glycan (Moss, 1997;Hoshi et al., 1997). ALP acts locally  
to increase the phosphate (Pi) concentration via hydrolysis of monophosphate esters 
(inorganic phyrophophate) at high pH (Harris, 1990), which together with calcium 
ions form the substrate for hydroxyapatite formation. During the first phase  
of mineral formation, liberated Pi is transported to the MV via type III Na/Pi co-
transporter, whereas calcium accumulation is facilitated by calcium binding  
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proteins and phospholipids, such as annexin II, annexin V, calbindin D9K  
and phosphatydiloserine, respectively (Orimo, 2010). The saturation of  
the microenvironment of MV with calcium and PO4 ions leads to the precipitation  
of calcium phosphate that is subsequently released from the MV.  
Bone sialoprotein (BSP) and osteonectin belong to the SIBLING (Small Integrin-
binding Ligand N-linked Glycoprotein) gene family which contain RGD (Arg-Gly-
Asp) motifs in their structure that can bind to various matrix constituents and cell 
types (Roach, 1994). Studies using a steady-state agarose gel system showed that 
BSP acts as a nucleation factor for hydroxyapatite formation and deposition (Hunter 
and Goldberg, 1993), whereas osteonectin is a promoter of hydroxyapatite crystal 
formation. The detailed analysis of this process revealed that osteonectin acts  
as a promoter only when connected to the collagen by binding to its discrete fibrillar 
sites. It reacts with calcium from hydroxyapatite providing the appropriate alignment 
and organisation of hydroxyapatite with respect to the collagen axis (Lane and Sage, 
1994;Termine et al., 1981). 
Osteopontin is another glycoprotein with a RGD sequence, that is secreted  
in mineralising and non-mineralising tissues, and in both normal and pathological 
states (McKee and Nanci, 1996). Conversely to BSP and osteonectin, osteopontin  
is believed to act as an inhibitor of mineralisation as it hinders hydroxyapatite 
nucleation de novo in gelatine and agarose gel systems (Hunter et al., 1996),  
by preventing premature precipitation of calcium phosphate crystals (Roach, 1994). 
Osteopontin is first expressed in the proliferation phase, where it reaches the level  
of 25% of maximum that occurs during mineralisation (Sodek et al., 2000). 
Additionally, owing to a RGD sequence in peptide structure osteopontin serves as  
a cell-matrix/matrix-mineral mediator (McKee and Nanci, 1996;Hunter et al., 1996).  
Another non-collagenous protein, osteocalcin contains three gamma-
carboxyglutamic acid residues formed by a posttranslational carboxylation  
of glutamic acid residues (Romberg et al., 1986). These residues interact with 
calcium and hydroxyapatite (Poser and Price, 1979) by regulating the process  
of mineralisation and bone remodelling (Roach, 1994). At the gene expression level, 
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no osteocalcin mRNA was detected in tissues, such as the liver, heart, lung and skin 
(Fraser and Price, 1988;Hauschka et al., 1989). Instead, the presence and 
accumulation of osteocalcin is restricted to the osseous culture systems (Auf'mkolk 
et al., 1985;Auf'mkolk and Schwartz, 1985;Aarden et al., 1996).   
The radioimmunoassay analysis of mineralising tissues from different species timed 
the accumulation of osteocalcin in extracellular matrix of the bone only after  
the initiation of the mineral deposition (Price et al., 1981). Thus, the osteocalcin  
is considered as a marker of late osteoblast differentiation (Owen et al., 1990).  
1.2.  Biology of bone forming cells 
1.2.1. The principles of osteoblastic lineage cell development 
Osteoblast lineage cells originate from multipotent mesenchymal stem cells, which 
can also give rise to bone marrow stromal cells, chondrocytes, muscle cells,  
and adipocytes (Aubin and Triffit, 2002). 
The generally accepted model of osteoblast cell differentiation encompasses  
the progression from osteoprogenitor cells to preosteoblast, osteoblasts, and then 
bone lining cells or osteocytes. In vitro osteoblast cell differentiation has been 
studied using various cell models in monolayer culture system. One of the most 
widely accepted and referenced models of osteoblast differentiation were derived 
from observations of rat bone-derived cells, which synthesized mineralised matrix 
(Lian and Stein, 1995). 
Based on the results from in vitro investigation of progressive establishment  
of the osteoblast cell phenotype, it is accepted that osteoblast cells differentiate 
through a characterised temporal sequence of expression osteoblast markers (Lian 
and Stein, 1992). Specifically, three phases were identified, namely proliferation, 
matrix synthesis, matrix maturation and mineralisation, with each phase delineated  
by characteristic changes in protein and gene expression (Fig.1.2).  
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Figure 1.2. Temporal changes in expression of osteoblast cell genes associated with rat 
calvarial osteoblast cell phenotype. These changes are illustrated as arrows representing 
changes in cell cycle-regulated genes (green) and genes associated with the osteoblast 
phenotype differentiation (blue). ALP-alkaline phosphatase, BSP-bone sialoprotein, c-fos-
proto-oncogen, Cfba-1 (Runx2) - core-binding factor α1, CollαI-type I collagen, OC-
osteocalcin, ON-osteonectin, OP-osteopontin, Osx-Osterix. Adapted from (Lian and Stein, 
1992).  
The genes associated with the first phase of the cell cycle are histones, cyclines and 
protooncogenes (c-fos, c-myc, c-jun), which are responsible for modulating cell 
proliferation. They are up-regulated together with the transcription factors core 
binding factor alpha 1 (Cbfa1/Runx2) and osterix (Osx/SP7) (Lian and Stein, 1992). 
Runx2 is a runt-domain gene widely considered as earliest osteoblastic marker.  
It binds to the osteoblast-specific element (OSE-2), which activates the promoter  
of the major osteoblast genes expressed, such as osteocalcin, alkaline phosphatase 
(ALP), bone sialoprotein (BSP), osteopontin and α1 type I collagen genes (Ducy, 
2000;Ducy et al., 1997). Gene expression analysis and in situ hybridisation have 
demonstrated Runx2 expression early in lateral plate mesoderm before the existence 
of actual osteoblast cells (Ducy et al., 1997). Furthermore, studies using Runx2 
deficient mice demonstrated a lack of adequate calcification of the skull, humerus 
and femur resulting in death straight after birth (Komori et al., 1997). Interestingly, 
maintained expression of Runx2 produces a reduction in cortical bone mass  
and increased trabecular bone mass mineralisation (Maruyama et al., 2007) 
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indicating that while this factor is essential for osteoblast lineage specificity, its 
prolonged expression actually hinders subsequent osteoblast differentiation.  
Downstream of Runx2 is the zinc-finger transcription factor Osterix. Similar  
to Runx2, osterix is essential for osteoblast differentiation and subsequent bone 
formation. In osterix knockout animals, preosteoblast cells are prevented from 
differentiating into mature osteoblasts resulting in an inhibition of both 
intramembranous and endochondral ossification (Komori et al., 1997). Additionally 
during proliferation, adhesion proteins, type I collagen and growth factors, such  
as transforming growth factor β (TGFβ) and fibroblast growth factor (FGF), are 
actively synthesized (Aubin and Triffit, 2002).  
Other than providing a scaffold for mineral deposition, type I collagen is essential for 
osteoblast cell functionality based on the fact that dysfunctional fibril formation 
impair subsequent stages of osteoblast phenotypic development (Wenstrup et al., 
1996). Moreover, through interaction with α2β1 integrin, collagen influences 
activation of the osteocalcin promoter within the nucleus (Xiao et al., 1998). 
Additionally, the α2β1 integrin-collagen interaction activates mitogen-activated 
protein kinase (MAPK) signalling pathway, leading to phosphorylation of Runx2 
(Wenstrup et al., 1996). In cells expressing truncated pro-collagen α1 and secreting 
shortened fibrils, cells had higher and longer proliferation and decreased ALP 
activity. On the other hand, osteocalcin secretion was elevated 5-fold when compared 
to cells expressing normal collagen (Wenstrup et al., 1996). 
Active osteoblasts are cuboidal cells enriched with endoplasmic reticulum as they 
synthesise large quantities of proteins (Gay et al., 2000). These include proteins, such 
as osteopontin, osteonectin, osteocalcin,  and bone sialoprotein (detailed description 
in paragraph 1.1.3.2.2), whose expression by osteoblasts reaches maximal levels 
during mineralisation (Lian and Stein, 1992). Osteoblasts are asymmetric cells 
meaning that they secrete collagen and non-collagenous proteins in the form  
of osteoid on one side, whereas their contralateral side is sensitive to regulatory 
signals (Robey, 2002). Importantly, osteoblast cells also secrete autocrine  
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and paracrine factors. The latter strongly acts on  osteocytes and osteoclast cells 
regulating their function (Gay et al., 2000).  
With the end of the bone formation phase, osteoblast cells can become osteocytes, 
transform into inactive osteoblasts and become bone lining cells or undergo 
programmed cell death (apoptosis).  
In humans, depending on the bone type and age, between 10-30% of osteoblasts 
differentiate into osteocyte cells, while the majority of cells undergo apoptosis 
(Parfitt, 1990;Aubin and Triffit, 2002). When differentiating into osteocytes, 
osteoblasts become embedded in the osteoid. At this stage, the osteoblast enlarges  
in size and has a well-developed Golgi apparatus for collagen storage. When fully 
embedded in the matrix, cells cease their activity and become smaller in size due  
to reduced Golgi apparatus and endoplasmic reticulum. The bone type, size and  
the activity of committed osteoblasts influence the shape and the size of newly 
formed osteocyte. Specifically, in rapidly formed woven bone with randomly 
oriented collagen fibres, osteocytes are isodiametric. In lamellar bone they  
are elongated along the longitudinal axis and round or triangular in the transverse 
plane (Holtrop, 1990).  
Currently, five transitional stages from osteoblast to mature osteocyte  
are distinguished based on the heterogenity in the cell morphology, molecular  
and secretory characteristics. These include, osteoblast, osteoblastic-osteocyte (type  
I osteocyte), osteoid-osteocyte (type II osteocyte), type III osteocyte, young 
osteocyte, old osteocyte (Palumbo, 1986;Holtrop, 1990;Franz-Odendaal et al., 2006). 
Importantly, based on research evidence the Bonewald's group suggested that  
the osteoid-osteocyte regulates and controls the mineralisation process of bone rather 
than osteoblasts themselves (Dallas and Bonewald, 2010). 
As previously stated, gene and protein expression is significantly different between 
the osteoblast and developing osteocyte cells. In general, osteocytes synthesise  
a number of proteins important for cytoskeletal function, including CapG, cdc42  
and E11/podoplanin (Dallas and Bonewald, 2010). Although, the latter is not 
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exclusive for bone-lineage cells; it is believed to be the earliest marker  
for osteocytes. In fact, E11 is highly expressed in osteoid-osteocytes, but not in old 
osteocytes (Zhang et al., 2006). This protein is associated with the formation and 
elongation of dendrites, through which osteocytes interact with each other and with 
cells on the bone surface. The expression of E11 and dendrites is regulated in bone 
by mechanical load and shear stress (Zhang et al., 2006). In response to the shear 
stress, osteocytes release nitric oxide (NO), ATP and prostaglandin, all influencing 
the activity of osteoblasts and osteoclasts, which results in new bone formation 
(Bonewald, 2010). Instead of E11, more mature osteocytes express high levels  
of sclerostin, a negative regulator of bone formation that inhibits canonical Wnt/β-
catenin signalling pathway (Dallas and Bonewald, 2010). By the expression  
of phosphate-regulating neutral endopeptidase X-linked (PHEX), dentin matrix 
acidic metalloproteinase (DMP-1), matrix extracellular phosphoglycoprotein 
(MEPE) and fibroblast growth factor 23 (FGF23), osteocytes regulate phosphate and 
biomineralisation. Upon apoptosis, osteocytes release apoptotic bodies and homing 
factors for osteoclasts, such as RANKL, responsible for the bone resorption 
(Bonewald, 2010). 
Other osteoblast descendants in the adult bones are the bone-lining cells covering  
the bone surface. These cells are flat and elongated, without proliferative capacities 
(Aubin, 1998). Bone-lining cells can be reactivated to active osteoblast cells  
in response to a specific stimulus, such as parathyroid hormone (PTH) (Dobnig and 
Turner, 1995). Additionally, they take part in the bone remodelling process  
by secreting collagenase to remove the unmineralised collagenous layer of matrix, 
enabling osteoclasts to attach to the mineralised matrix (Manolagas, 2000).  
1.2.2. Osteoclast cells 
Osteoclast cells differentiate from the granulocyte-macrophage progenitors (myeloid 
cells) of the hematopoietic origin. Two hematopoietic factors secreted  
by osteoblasts and stromal cells, RANKL and M-CSF are prerequisite  
for osteoclastogenesis and the subsequent activation of RANK on the surface  
of the precursor cells.  These factors induce expression of the specific osteoclast 
lineage genes, such as tatrate-resistant acid phosphatase (TRAP), cathepsin K, 
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calcitonin receptor and β3-integrin (Boyle et al., 2003). Mature osteoclasts  
are polykarions arising from multiple (10-20) individual cells with abundant 
mitochondria and have high number of vesicles and vacuoles. The most 
characteristic feature of the active osteoclast cell is the ruffled border of their cell 
membrane which increases surface area interface at the bone resorption site.  
In the human skeleton, bone remodelling is entirely dependent on the bone resorption 
conducted by osteoclast cells (Manolagas, 2000). At the resorption site, before 
formation of ruffled border, osteoclasts attach to the bone through a membrane 
domain, called the sealing zone. Ruffled border is the resorption area originating 
from fusion of the cell membrane and intracellular acidic vesicles. On the opposite 
site of the osteoclast the functional secretory domain is formed (Vaananen et al., 
2000). For the dissolution of HAP, osteoclast cells secrete H
+
 protons through proton 
pumps and Cl
-
 though the chloride channels (Hall and Chambers, 1989). Organic 
matrix is degraded by proteolytic enzymes belonging to the lysosomal cysteine 
proteinases and matrix metalloproteinases. Especially, high levels of MMP9, 
MMP13, cathepsin K and collagenases are secreted into the resorption lacuna 
(Vaananen et al., 2000). Bone resorption products are eliminated through  
a transcytosolic vesicular pathway from the ruffled border to the functional secretory 
domain on the apical side of cells into the extracellular space (Salo et al., 
1997;Vaananen et al., 2000). During osteoclastic degradation of the type I collagen 
network, matrix bound factors, such as IGFs are released and induce new bone 
formation through the stimulation of osteoblasts in a paracrine manner (Gelse et al., 
2003). After fulfilling its resorption task, the osteoclast may repeat it once more  
or undergo apoptosis (Vaananen and Zhao, 2002). 
1.3. Osteoblast cell models in in vitro research 
Since the first attempt of isolation and in vitro culture of osteoblast cells from  
the adult human bone (Bard et al., 1972), a great improvement in the knowledge  
of bone biology and, in particular, osteoblastic cells has been made. Immortalised 
osteoblastic cell lines have been developed as models for the in vitro investigation  
of the regulation of cell differentiation, cytokine, hormone regulation, synthesis  
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and secretion of matrix proteins, molecular mechanisms of bone diseases and drug 
pharmacokinetics. In more recent years, osteoblast cell culture has also evolved  
to include cytocompatibility and osteogenicity evaluation of the novel biomaterials.  
Various cell culture models have been employed for studying osteoblast cell biology, 
including primary cells from different species, induced osteoblasts from pluripotent 
stem cells, immortalised and malignant cell lines. The use of these osteoblast models, 
as well as any in vitro cell model, presents advantages and disadvantages which  
need to be considered before embarking on any notable evaluation (Tab.1.1).  
In the following paragraphs, factors that influence the phenotype of osteoblast cells 
derived from different sources are presented and discussed. The advantages  
and disadvantages of these cell types will also be highlighted.  
1.3.1. Human primary osteoblast cells 
The main advantage of using primary human primary osteoblast cells (HOb's) is the 
lack of interspecies differences and they retain their differentiated phenotype in vitro. 
On the other hand, primary human cells represent a heterogeneous population of cells 
and, therefore, exhibit phenotypic differences relating to the skeletal location from 
which they were isolated (Kasperk et al., 1995;Martinez et al., 1999). 
To date, several primary human osteoblast isolation methods have been developed, 
including enzymatic digestion and spontaneous outgrowth cultures (Gallagher, 
2003;Gotoh et al., 1990). Several studies have identified an effect of the isolation 
technique on subsequent in vitro performance of cells (Voegele et al., 2000;Jonsson 
et al., 1999). Specifically, cells obtained through the enzymatic isolation proliferate 
faster than cells from outgrowth cultures, but alkaline phosphatase (ALP) activity  
is comparable in cells from both isolation types (Voegele et al., 2000). Contradictory 
results in terms of ALP activity were found in another study where the enzyme level 
was higher in cells obtained from outgrowth culture (Jonsson et al., 1999). This can 
be further influenced by the donor age. Indeed, cells from donors younger than  
65 years-old were shown to have shorter population doubling times, than osteoblast 
cells from older donors (Voegele et al., 2000). In agreement with this, a decreased 
rate of proliferation in trabecular bone cell cultures of donors over 60 years of has 
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been reported elsewhere (Evans et al., 1990), with the most significant decline being 
attributed to the first three decades of life (Fedarko et al., 1992;Shigeno and Ashton, 
1995). Moreover, in cells isolated via outgrowth cultures, mineral deposition was 
more pronounced 4 weeks after osteogenic induction than in cells obtained from 
enzymatically digested bone specimens (Jonsson et al., 1997). 
In correlation with the proliferation potential of cells, the expression of genes and 
protein synthesis associated with the osteoblast phenotype is also influenced by the 
donor age. Synthesis of type I collagen and osteonectin were at the highest level in 
cells isolated from foetal bones, up to 20 year-old donors. A decrease of approx.  
65% in collagen levels were observed in cells obtained from donors above the age  
of 20 years old (Fedarko et al., 1992). Additionally, after the induction with 
1,25(OH)2D3 the level of osteocalcin secreted by cells isolated from the foetal 
cortical femoral bone was less than cells from postnatal (age 4-12 years) and adult 
donors (20-30 years) (Morike et al., 1993;Morike et al., 1995). In cells from donors 
in the third decade of life, the protein level was 10-fold higher than in the foetal bone 
cells (Morike et al., 1995). Furthermore, osteocalcin expression became higher  
in foetal cells after 10 days of culture with osteogenic supplements and 1,25(OH)2D3 
(Montjovent et al., 2004).  
Considering the changes in the osteoblast phenotype relating to donor age, it is 
important to emphasize that bone aging, determined as changes in the degree  
and distribution of mineralisation occurs differently in cortical and cancellous bone 
(Bergot et al., 2009;Bonjour et al., 1991). This is reflected in osteoblast physiology 
with slower proliferation and increased secretion of ALP and OC in cells derived 
from the femoral head compared to the upper tibia and the lower femur (Martinez et 
al., 1999). Results from our laboratory also indicate higher proliferation  
and mineralisation potential of cells derived from knee than from femoral head bone 
(unpublished observation). Kaperk and colleagues (1995) conducted within-patient 
comparisons and demonstrated that the mandibular derived osteoblast cells had  
a higher proliferative rate associated with decreased ALP activity than cells isolated 
from the iliac crest. Furthermore, decreased expression of the FGFβ and IGFII genes 
was also observed in the mandibular-derived osteoblast cells (Kasperk et al., 1995). 
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With inclusion of the age defined differences, it was shown that cells from the knee 
had higher ALP activity in patients over 70 years-old than in those between 50  
and 70. The opposite was seen in osteoblasts derived from the femoral head 
(Martinez et al., 1999). However, as stated above, the major differences in cellular 
behaviour are the most pronounced at earlier stages of life. 
The age changes occurring in the bone composition affect mostly bones  
in the lumbar and hip regions in postmenopausal women due to the decline  
of oestrogen  (Davis et al., 1994). Indeed, Zhang and colleagues (2004) reported that 
the expression of ALP, BSP and type I collagen was significantly increased in cells 
isolated from female patients below 15 years-old, which was observed  
to subsequently decline with  increasing  age. Furthermore, a 3.8-fold difference  
in ALP activity was noted between young and postmenopausal women while  
the osteocalcin level was shown to be higher in cells from the premenopausal women 
below 50 years-old (Zhang et al., 2004). In contrast, osteoblasts derived from the 
male femoral head and long bones did not show the age related differences in terms 
of ALP and osteocalcin level (Katzburg et al., 1999). Conversely, Battmann and co-
workers (1997) reported that osteocalcin production by cells from the femoral head 
and iliac crest changed markedly with the age of donors, but were not correlated with 
gender differences (Battmann et al., 1997).  
As presented above, many factors influence primary human osteoblast cell 
behaviour; age, site of isolation and gender differences are the most notable. Thus, 
the time frames for phenotypic changes in vitro differ for cells isolated from different 
origins. Some studies indicate that nodule formation in the mineralisation of human 
bone cell cultures may not occur (Siggelkow et al., 1999). Furthermore, the question 
arises, which factors are of utmost importance and should be included for screening 
cells (or donors) before applying them for research purposes? The answer is not 
simple and the selection of cells should be controlled and judged on the perspective  
of the addressed subject and the aim of study.  
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1.3.2. Animal primary osteoblasts 
Due to limited accessibility of human osteoblast cells and their phenotypic 
heterogeneity, cells isolated from other species can provide an alternative in vitro 
research model. A distinct advantage is their ease of attainability compared to the 
human cell sources. For humans, the location of bone specimens for cell isolation are 
limited mainly to long bones, mandible and the iliac crest, whereas they can be 
obtained more easily from additional sites from animals, such as the calvaria.  
The selection of donor animals can be more controlled in relation to age, weight and 
sex. Unlike human donors, isolation from animals is not restricted to only 
pathological subjects. On the other hand, the distinct disadvantage of animal cells is 
the interspecies differences making extrapolation difficult. Furthermore, the biology 
and structure of bone is different among animals. Here, the sizes of the animal  
and weight influence bone composition, quality, remodelling method, healing  
and signalling pathways driving these processes (Pearce et al., 2007).  
1.3.2.1. Rat cells 
Rat osteoblast cells serve as a model in various in vivo and in vitro researches.  
In 1994, the Food and Drug Administration presented guidelines for preclinical and 
clinical evaluation of agents used in the treatment or prevention of postmenopausal 
osteoporosis, with the recommendation of using two animal models, rat and sheep, 
for this evaluation (Thompson et al., 1995). Due to the wide availability of bone 
samples and known genome, rat osteoblast cells are an attractive model for research 
focused on hormonal regulation of the cell phenotype (Abe et al., 2000;Aronow et 
al., 1990), as well as the osteoinductivity and cytotoxicity of polymer or implant 
biomaterials (Hayes et al., 2010;Liao et al., 2003;Washington et al., 2011;Wirth et 
al., 2008).  
Rat osteoblast cells isolated from foetal, neonatal/adult calvaria or long bones retain 
their osteoblastic phenotype during in vitro culture (Manduca et al., 1997;Yamamoto 
et al., 2002). Osteoblast isolation from rat tissue is performed mainly through 
repeated enzymatic digestion and less often through the spontaneous migration from 
explant specimens. The use of enzymatic treatment has been shown to be an effective 
isolation method of cells from calvarial bones of foetal or neonatal animals (Declercq 
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et al., 2004). However, in this case the phenotype of the cells is influenced by many 
factors. As a result of enzymatic isolation, cells derived from individual fractions  
of digestion exhibit different osteoblastic differentiation ability and response  
to hormones (Lian and Stein, 1992). When comparing calvarial cells from five 
fractions obtained from rat foetuses, the first 3 fractions responded positively  
to dexamethasone administration with increased ALP activity and calcium 
deposition, whereas cells from last two fractions did not show this response. 
Moreover, based on the number of nodules formed and the assumption that nodule 
formation is correlated to the number of osteoprogenitor cells, fraction three 
contained the highest number of osteoprogenitor cells (Yamamoto et al., 2002). 
Despite the fact that the rat 'donor' selection can be more controlled than for humans, 
the cell phenotype is similarly affected by age and sex of the animals, as well  
as the tissue origin. A comparative study by Declercq and colleagues (2004), 
evaluating osteoblastic cells derived from adult and foetal rat, via explant culture  
or enzymatic digestion, showed that the osteogenic differentiation was enhanced  
in cells isolated by proteolytic treatment, as determined by matrix mineralisation  
and nodule formation. Additionally, for cells originating from explant cultures, both 
calvarial and long bone (tibia) samples had lower ALP activity and more diffuse 
mineralisation pattern compared to foetal cells from enzymatically digested tissue. 
Moreover, the temporal pattern of mineralisation differed between different types  
of bone (Declercq et al., 2004). Other studies have shown that cells from  
the mandible of a rat foetus (20 day-old) demonstrated β-glycerophosphate (βGP)-
independent matrix mineralisation, whereas βGP was required for nodule formation 
and mineralisation of calvarial cells obtained from the same animals (Abe et al., 
2000;Bellows et al., 1987;Bellows et al., 1992).  
Mineralisation was also noted to be influenced by donor age differences.  
For instance, cells isolated from 7 day-old rat tibia formed mineralised nodules after 
41 days in culture compared to positive osteocalcin detection after just 21 days for 
foetal mandibular cells (Stringa et al., 1995). A more recent study has also revealed 
gender differences in osteoblast cells isolated from calvaria. Specifically, ALP 
activity in osteoblasts cells from both genders was positively regulated  
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by 1,25(OH)2D3  in similar manner, but cells derived from 6 week-old male rats had 
higher initial ALP activity compared to aged matched female counterparts. The dose-
dependent response to 1,25(OH)2D3 was evident for cell proliferation and osteocalcin 
production, with decreased cell number and increased protein synthesis in osteoblast 
cells isolated from male donors (Olivares-Navarrete et al., 2010). 
1.3.2.2. Bovine cells 
Bovine and ovine derived osteoblast cells are less often used as osteoblast cell 
models compared to rodents. This is surprising considering that these animals are 
frequently used as large animal in vivo models, and other skeletal cells from these 
animals serve as established in vitro models. For instance, chondrocytes  
or intervertebral disc cells from bovine specimens are widely used in tissue 
engineering research and for investigating basic biological  mechanisms (Collin et 
al., 2011;Peroglio et al., 2011;Sakai et al., 2009;Hoshiba et al., 2011;Dowthwaite et 
al., 2004). However, studies focused on bovine osteoblast cells are limited. The first 
attempts to explore in vitro bovine osteoblast culture  system involved cells isolated 
from hind-limbs of 3 to 6 month-old foetal calves (Whitson et al., 1992). This 
resulted in the identification of functional osteoblast cells that secrete ALP, type  
I collagen, BSP, osteonectin and bone proteoglycans. Moreover, investigations 
showed 4.5-6 month-old foetus to be optimal for osteoblast cell isolation.  
The enzymatic extraction of osteoblast cells from foetus at this stage resulted  
in higher number of viable cells and superior proliferation compared to older 
foetuses. Additionally, cells from younger foetuses had slower mineralisation 
potential when compared to 4.5-6 months-old foetuses. In bovine cell cultures after 
stimulation, ALP activity increased in cultures by day 6, which was followed by  
an increase in mRNA expression of type I collagen, osteonectin and osteopontin 
(Whitson et al., 1992). In this system, the deposition of minerals and nodule 
formation were initiated 6 days after osteogenic induction with β-glycerophosphate 
and ascorbic acid (Ibaraki et al., 1992). The centres of mineralisation first appeared 
in the matrix located between the single cell layer adhering to the surface and multi-
cellular layer located above (Whitson et al., 1984). Interestingly, these cells also 
formed independent and interconnected mineralised trabecular structures (Whitson et 
al., 1992). Interestingly, we have observed that the explant cultured cells isolated 
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from 6 month-old bovine specimens do not have the ability to form nodules  
or mineralise matrix. Furthermore, ALP activity remained at basal levels over a 21 
day period but then increased rapidly by day 28.  
1.3.2.3. Ovine cells 
In the majority of orthopaedic research studies, the sheep is considered an established 
large animal in vivo model for the testing of novel implant systems in fracture 
healing. This is due to the advantage of adult sheep having a similar body weight  
to humans and the long bone dimensions of long bones being appropriate for  
the implantation of human implants and prostheses (Newman et al., 1995). Thus,  
the inclusion of ovine osteoblast cells as an in vitro model holds several clear 
advantages. Unfortunately, there are few in vitro studies using ovine osteoblast cells. 
The main reason for this is the lack of a fully sequenced genome, which limits  
the application of many molecular biology methods. Currently, institutions such as 
the International Sheep Genomic Consortium are attempting to address this issue  
by applying genome mapping research to sheep.  
The available literature focusing on osteoblastic activities of ovine cells in vitro 
indicate that these cells are capable of mineralisation (Collignon et al., 1997). Foetal 
ovine osteoblast cells stimulated post-proliferatively with ascorbic acid,  
β-glycerophosphate and CaCl2 exhibited highest ALP activity after 6 days  
of culturing and formation of the mineralisation centres from day 12. Culture 
medium analysis demonstrated rapid increase in ALP concomitant with initiation  
of mineralisation. Furthermore, ovine osteoblast cells produced osteocalcin in a time-
dependent manner from day 6 (Collignon et al., 1997). Interestingly, a more recent 
study has shown that  trabecular bone from ovine specimens classed as middle-aged 
(3-5 year-old) behaved similarly to human cells isolated from the femoral condyle 
(donor age not known). Ovine cells responded to 1,25(OH)2D3  stimulation similarly 
to human osteoblast cells, which resulted in an increase in ALP, osteocalcin   
and TGFβ1 (Torricelli et al., 2003). However, ovine osteoblast cells isolated from 
trabecular bone from 2 year-old animals, used in our laboratory failed to mineralise. 
It is not known how common this phenomenon is, since to our knowledge, we are  
the only group to demonstrate the lack of mineralisation in ovine and bovine cells  
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of this age under a variety of established culture conditions (unpublished 
observation). 
1.3.2.4. Rabbit cells 
Rabbits are a widely used in vivo model in various biomedical research applications, 
such as musculoskeletal research (Neyt et al., 1998), including implant biomaterials 
testing, infection or gene therapy studies. Differences in bone structure, composition 
and remodelling between rabbit bone and human bone has been discussed  
and reviewed recently (Pearce et al., 2007) yet, not much is known about the biology 
of rabbit osteoblastic cells in vitro. Similarly to bovine and ovine osteoblast cells,  
the available literature is limited and gives poor insight regarding phenotype  
and behaviour. Early reports established an isolation protocol of enzymatically 
digesting rabbit bones with 0.1% crude collagenase (Yee, 1983;Shaw et al., 1989). 
Later, explant cultures from cervical vertebrae were used for isolating cells.  
The morphological and functional evaluation of cells isolated from the cortical 
endosteal bone surface of adult rabbits identified that almost all populations of cells 
had typical osteoblastic polygonal shape, whereas cells migrating out from  
the cervical bone had more spindle or triangle shape (Cao et al., 2006). The former 
were positive for ALP activity and were capable of mineralisation. Stimulation with 
parathyroid hormone (PTH) positively influenced cAMP production  (Shaw et al., 
1989). Extracellular matrix mineralisation and nodule formation was reported after 3 
weeks of culturing rabbit osteoblast cells with ascorbic acid, dexamethasone  
and ΒGP (Cao et al., 2006). However, current knowledge regarding rabbit osteoblast 
cells is lacking and further studies are needed to evaluate rabbit osteoblast 
physiology and its relation to human osteoblast cells. Recently, it has been shown 
that the rabbit bone marrow stromal cells can undergo spontaneous immortalisation 
after prolonged culture and lose their potential to differentiate into chondrocytes  
and adipocytes (Ahmadbeigi et al., 2011).  
1.3.3. Cell lines 
The list of advantages of immortalised cell lines is long, including ease  
of maintenance, unlimited number of cells without the need of isolation and relative 
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phenotypic stability. On the other hand, some reports present evidence of progressing 
phenotypic heterogeneity among cell lines, which is correlated with prolonged 
passaging of cells (Leis et al., 1997;Wang et al., 1999;Grigoriadis et al., 1985). 
Additionally, both transformed and non-transformed cell lines, as they are stage 
arrested, do not reflect the whole range of phenotypic features of the normal 
osteoblast cells. Specifically, in the case of malignant cell lines, proliferation is non-
physiological since the mechanism of contact inhibition is disturbed. Despite these 
disadvantages, the use of osteoblast cell lines is prevalent. The most commonly used 
cell lines are MC3T3E1(Quarles et al., 1992), hFOB (Harris et al., 1995), MG63 
(Billiau et al., 1977), SaOs2 (Rodan et al., 1987) and U2OS (Ponten and Saksela, 
1967). The reader is directed to the excellent review of Kartsogiannis and Ng (2004) 
which discusses the aforementioned cell lines in addition to many not covered here.  
1.3.3.1. Human Cell Lines 
Rodan and colleagues (Rodan et al., 1987) characterized the osteoblastic properties 
of the human osteosarcoma cell line SaOs2, which were isolated from an 11 year-old 
Caucasian female in 1975. These cells have a mature osteoblast phenotype with high 
levels of ALP activity. This marker was reported at a much higher level than in other 
osteosarcoma cell lines, such as MG63 and SaOs1 (Murray et al., 1987). 
Additionally, when comparing to primary human osteoblast cells, the ALP activity 
was similar at the early time points, but it increased 120-fold after 14 days  
of culturing cells under the same conditions (Saldana et al., 2011). In our laboratory, 
we observed enzyme activity in SaOs2 cells to increase rapidly from day 1 to 7  
and subsequently decrease until day 28. Moreover, these cells had twice the activity 
levels of primary human osteoblast cells at day 7, which even at this early time point, 
was higher than maximum activity of primary human osteoblast cells at day 21. Even 
though the differences at different time points occurred, the time sequential pattern  
of the enzyme activity was similar in both primary and SaOs2 cells (unpublished 
observations). Interestingly, SaOs2 cells have been reported to form calcified  matrix 
in diffusion chambers akin of woven bone (Rodan et al., 1987). Detailed analysis  
of the collagen structure synthesised by SaOs2 revealed that it is similar  
to collagen formed by primary human osteoblast cells but with a higher level of lysyl 
hydroxylation in SaOs2 cells (Fernandes et al., 2007). 
Chapter 1: General Introduction 
26 
 
ALP in SaOs-2 cells can be further stimulated by dexamethasone (Rao et al., 1996) 
and phosphate substrates (Muller et al., 2011). Continuous culturing in medium with 
dexamethasone has been reported to increase ALP activity and produce a more 
differentiated phenotype (Rao et al., 1996).  Due to the much higher ALP activity 
level in SaOs2 cells, compared to primary cells in basal conditions, the necessity  
of the additional administration with dexamethasone should be balanced. Moreover, 
the supplementation of culture medium with phosphate substrates should  
be introduced at a much lower level compared to other cell types and specifically at 
the post-proliferative stage when a layer of matrix is produced to avoid deleterious 
effects on viability (Figure 3). Finally, cytokine and growth factor expression  
of SaOs-2 cells have been  shown to be similar to primary normal human osteoblast 
cells (Bilbe et al., 1996).  For instance, SaOs2 cells express surface parathyroid 
hormone (PTH) and 1,25(OH)2D3 receptors found in osteoblasts in vitro and in vivo. 
Dexamethasone administration of SaOs2 cells increases their sensitivity to PTH, 
1,25(OH)2D3 and 17-b estradiol (Rao et al., 1996).  
The MG-63 cell line derives from juxtacortical osteosarcoma diagnosed in the distal 
diaphysis of the left femur of a 14 year-old male (Billiau et al., 1977). These cells 
display rapid cell growth without exhibiting contact inhibition, resulting in  
the formation of aggregates (Heremans et al., 1978). This cell type attracted much 
attention as it produces high yields of interferon (Billiau et al., 1977). Further 
research identified the responsiveness of MG63 cells to 1,25(OH)2D3 as affecting 
cellular morphology and phenotype by increasing ALP activity (Franceschi et al., 
1985). MG63 cells represent an immature osteoblast phenotype and undergo 
temporal development in long term culture. However, inconsistencies exist in  
the literature regarding the mineralisation capabilities of MG63 cells in monolayer. 
Kumarasuriyar and colleagues (2009) reported changes in MG63 phenotype that 
replicate the differentiation model proposed by Lian and Stein (Lian and Stein, 
1992). Briefly, ALP activity increased by day 15 and then declined to basal levels, 
whereas type I collagen expression increased during the second week  
of the culture. Osteocalcin and osteonectin expression were observed at day 15  
and 29, whereas Runx2, BSP and osteopontin were not detected while calcium 
accumulation was initiated after day 28 (Kumarasuriyar et al., 2009). In our 
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laboratory, we observed 14-fold lower ALP activity in MG63 cells than in primary 
human cells and no calcium deposition in the matrix (unpublished observations). 
Moreover, other reports showed that MG63 cells have low ALP enzyme activity  
and did not mineralise (Saldana et al., 2011;Pierschbacher et al., 1988). Attempts  
to successfully select fibronectin positive cells from MG63 cells resulted  
in the identification of a clone (MG-63.3A) which has been shown to deposit calcium 
phosphate in culture without the need for phosphate substrate addition to the culture 
medium (Pierschbacher et al., 1988). 
The response of MG63 cells to 1,25(OH)2D3 administration has been shown to be 
similar to normal human osteoblast cells (Clover and Gowen, 1994). Additionally, 
only after 1,25(OH)2D3 treatment, osteocalcin was detected in the supernatants  
of the cells, and increased 9- to 20- fold (Clover et al., 1992;Franceschi et al., 1988). 
The time and dose dependent stimulation of protein secretion by 1,25(OH)2D3  was 
reported in both freshly isolated and MG-63 cells. The 1,25(OH)2D3 stimulates  
the synthesis of a1(I) and a2(I) chains of type I  collagen together with type III 
collagen and fibronectin synthesis (Franceschi et al., 1988). Additionally, both 
human and MG63 cells produce cAMP in response to PTH treatment (Lajeunesse et 
al., 1990). Johansen and colleagues (Johansen et al., 1992) showed differences  
in matrix protein secretion by MG-63 cells and normal human osteoblast cells 
isolated from foetal and adult femoral head. Osteosarcoma cells secreted gelatinase, 
YKL-40 protein, tissue inhibitor of metalloproteinase 1 (TIMP-1) and 2 (TIMP-2) 
and β-microglobulin but no C-terminal propeptides of the α1 and α2 chains of type  
I collagen. Moreover, normal human osteoblasts from the foetal trabecular bone 
secrete primarily matrix constituent proteins such as C-terminal propeptides  
of α1 and α2 chains of type I collagen together with osteonectin. In addition to this, 
cells from adult donors secrete gelatinase, TIMP-1 and β-microglobulin 
(Pierschbacher et al., 1988).  
Collectively these results indicate the similarity of MG63 and normal osteoblasts  
in their response to 1,25(OH)2D3 and PTH administration which makes them 
attractive model for hormonal regulation of phenotypic changes investigations. 
However, the inconsistency in the expression of matrix proteins resulting from their 
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clonal heterogeneity limits their use as a model for osteoblast phenotype develop-
ment and matrix mineralisation.  
1.3.3.2. Mouse cell lines 
MC3T3E1 represents a popular osteoblast cell line representative of a pre-
osteoblastic phenotype. Several subclones have been established from this newborn 
mouse calvaria clonal cell line. Five of them, subclones 4, 8, 11, 14, 26 demonstrate 
mineralisation with the addition of ascorbic acid and inorganic phosphate (Wang et 
al., 1999). Mineralising subclones express high levels of mRNA for BSP, OCN,  
and the PTH/PTHrP receptor. From these clones, only subclone 4 and 14 have been 
shown to mineralise the collagenous extracellular matrix. Subclone 4 was shown  
to undergo temporal changes from proliferation to nodule formation and 
mineralisation in similar manner as in intramembranous osteogenesis in vivo (Sudo et 
al., 1983). Cells proliferated actively in vitro and synthesised type I collagen from 
day 3 in culture. Simultaneously, ALP enzyme activity increased from day 3 to day 
21 and the mineral deposition was reported early at day 14 (Quarles et al., 1992).  
Ascorbic acid and βGP supplementation is a prerequisite for matrix mineralisation in 
MC3T3-E1 cells.  In the absence of these stimulators, ALP activity remains low and 
fails to result in mineralisation (Hong et al., 2010). Differentiation of MC3T3E1 cells 
is also influenced by the type of serum used in culture medium, and serum derived 
cytokines and growth factors (Yohay et al., 1994). With the addition of complete 
foetal bovine serum, cells have increased proliferative capabilities during early 
differentiation. Furthermore, ALP activity, protein and mRNA expression  
is increased in the post-proliferative stage compared to cells maintained in medium 
with resin/charcoal-stripped serum (Yohay et al., 1994). Although being a cell line, 
MC3T3E1 at high passages (above 36) have reportedly decreased proliferation   
and at very high passages (above 60) exhibit inconsistent cell cycling indicative  
of replicative senescence (Grigoriadis et al., 1985) similar to human cells, which 
makes them an attractive tool for in vitro investigations relating to bone remodelling 
and formation.  
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Table 1.1. Cell models and their culture conditions required. The mature phenotype states 
for the capability of cells to deposit calcium in matrix. Dex – dexamethasone, βGP-glycerol-
2-phosphate, Ca- calcium, a.a. – ascorbic acid, ITS - insulin, transferrin, selenium. 
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1.4. In vitro cell-cell communication models of osteoblast lineage cells 
Skeletal development, remodelling and repair require a tightly orchestrated interplay 
among bone cells at all stages of their phenotypic differentiation. Within bone, these 
cells can communicate through three mechanisms; direct cell-cell contact through 
cell membrane molecules (tight and adherence junctions), gap junction 
communication forming cytoplasmic connections between cells and complex 
paracrine interaction through cell- or matrix-derived secretion factors (Grellier et al., 
2009). Taking into account the complex structure of bone, the web of interactions 
appears highly intricate. Currently, analysis of these interactions in vitro is possible 
to a certain extent, while more complex analysis that includes more variables remains 
challenging. Nevertheless, established co-culture models enable the investigations  
of cell-cell communication in both directly and indirectly. Based on the number  
of scientific reports, there is a high interest in the communication between osteogenic 
and endothelial lineage cells as a result of  the needs of tissue engineering (reviewed 
by (Grellier et al., 2009)), while less focus is directed towards the interactions among 
osteoblast cells and their progenitors. The next paragraphs will outline the current 
knowledge regarding the influence of the in vitro communication between 
osteoblastic lineage cells on their phenotype development. 
1.4.1. Direct cell-cell communication 
The mode of the crosstalk among cells in vitro strictly depends on the type of co-
culture. Direct communication can be easily achieved in a 2D or 3D environment,  
by plating different cell types together. Upon direct cell-cell contact, interactions 
between cells are mediated by adherence junctions formed by cadherins, and gap 
junctions formed by connexions (Civitelli, 2008;Stains and Civitelli, 2005). 
Interestingly, this co-culture model is not very often used for analysis of osteoblast-
MSCs interactions. Conversely, to the ease of establishing the direct culture model, 
the later discrimination between the two cell types and subsequent analysis  
is difficult. Yet, a number of research groups have employed this co-culture model  
to evaluate the influence of direct cell-cell communication on osteogenic 
differentiation (Tsai et al., 2012;Csaki et al., 2009;Wang et al., 2007;Kim et al., 
2003). Initial studies suggested limited synergistic interactions between MSCs and 
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osteoblast cells during in vitro osteogenesis when cells were plated at a 1:1 ratio 
(Kim et al., 2003). Although, there was no influence of co-culture on ALP activity  
in cells, the calcium deposition was decreased in co-cultured cells compared to single 
cell type cultures. This, however, could be due to co-culture of cells from two 
different species, rabbit MSCs with rat osteoblasts, and potential antagonistic 
influence of factors secreted by these cells (Kim et al., 2003). Additionally,  
the evidence from further research reports disagrees with those reported by Kim and 
co-workers. In fact, stimulation of osteogenic differentiation was reported  
in monolayer and monolayer-3D co-culture of osteoblasts with pluripotent stem cells 
(Ahn et al., 2006;Tsai et al., 2012). What is more, ALP activity and mineralisation  
of nodules was higher in co-cultures with increased proportion of osteoblast cells up 
to 50% in co-cultures compared to single cell type cultures and co-cultures in which 
lower number of osteoblasts (Tsai et al., 2012;Csaki et al., 2009). On the other hand, 
it was not evaluated which cell type, MSC or osteoblasts, directs mineralisation  
of ECM.  
The results from Ahn suggest that not only the number of each cell type, but also  
the phenotypic maturity of the cells influences the differentiation of the other (Ahn et 
al., 2006). Specifically, the mineralisation of human embryonic stem cells was higher 
in co-cultures with primary human bone derived cells than with SaOs2 (Ahn et al., 
2006). Considering the phenotypic maturity of cells further, Wang and co-workers 
demonstrated that the direct co-culture of osteoblasts with MSCs had a profound 
effect on MSCs, but not on osteoblast cells (Wang et al., 2007). This indicated  
the primary role of the osteoblasts in directing the differentiation of MSCs. Further 
evidence revealed that proteins involved in the Wnt signalling pathway  
are implicated in the osteoblast-directed stimulation of MSC osteogenic 
differentiation (Wang et al., 2007).    
1.4.2. Indirect cell-cell communication 
Indirect co-culture, based on the action of secreted diffusible factors only, overcomes 
the limitation of direct co-culture models regarding the separation of two cell 
populations. Additionally, it allows for the analysis of one-way communication  
or two-way communication. The former, is achieved when one cell type is cultured 
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in medium conditioned by other cell type. Two-way communication, in which 
paracrine factors are secreted by both cell types and affect both cell types, can be 
investigated using porous membranes separating different populations of cells. 
Importantly, by applying the indirect co-culture the determination of the importance 
and necessity of direct cell-cell contact on the secretion of trophic factors  
and differentiation can be revealed (Grellier et al., 2009). The indirect cell crosstalk 
between MSCs and osteoblast cells has been extensively studied using human  
and murine cell models.  
Significant influence of one way communication between cells on osteogenic 
differentiation has been reported. Specifically, ALP activity and ECM calcification 
were stimulated in MSC cultures in the presence of medium conditioned by human, 
murine and rat osteoblast cells (Ilmer et al., 2009;Buttery et al., 2001;Ueno et al., 
2001;Maxson and Burg, 2008). Importantly, the magnitude of response of co-
cultured cells depends on the quality of CM. The CM collected every 3 days  
up to day 9 after plating of osteoblast cells was the most effective in inducing rat 
MSC differentiation compared to CM collected from cells at later time in culture 
(Ueno et al., 2001). Similarly, effects on human MSC differentiation, marked  
by the up-regulation of ALP, osteocalcin and bone sialoprotein (BSP), was exerted  
by osteoblast growth medium conditioned by human osteoblast cells for 5 days 
(Ilmer et al., 2009). 
The early osteogenic marker, Runx2, mRNA expression was at similar level in 
cultures with and without the conditioned medium (Ilmer et al., 2009). Interestingly, 
serum-free DMEM supplemented with antibiotics conditioned for 48 hours after 
confluence by less differentiated human MSCs, induced proliferation, Runx2 and 
osteocalcin gene expression in rat MSCs (Osugi et al., 2012). Moreover, medium 
collected specifically between day 3 and 6, was the most effective and supported  
a significant increase of ALP activity, osteocalcin gene expression and mineralisation 
at specific time points during the culture period (Ueno et al., 2001). The factors 
secreted by cells after confluence in vitro, seem to be the most important  
for supporting the differentiation of cells in both, paracrine and, potentially, 
autocrine manner. Indeed, the secretion profile depends on the differentiation state  
of cells (Hoch et al., 2012;Li and Niyibizi Ch, 2012).  
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In the indirect co-culture of both cell types, the secretion of paracrine factors from 
one cell type can be further regulated by the factors released by the other cell type. 
Most of the reports focused on the analysis of MSCs and only some on osteoblast 
cells. Results regarding the effect of indirect co-culture demonstrated no effect of co-
culture on murine osteoblast cells phenotype (Wang et al., 2007). Conversely, 
indirect co-culture has a positive effect on osteogenic differentiation of MSCs.  
In monolayer co-culture with osteoblasts, a 5-fold increase in nodule formation  
and mineralisation was reported for murine embryonic cells (Buttery et al., 2001).  
On the gene expression level, the co-culture with osteoblasts significantly stimulated 
the expression of Runx2, type I collagen, osteopontin and BSP in MSCs when cells 
were plated in 1:1 ratio (Wang et al., 2007). Similarly for direct co-culture,  
the osteogenic differentiation of MSCs positively correlated with the number  
of osteoblast cells. Higher levels of ALP, BSP and OC mRNA expression was 
reported when MSCs were co-cultured with osteoblasts in 1:2 ratio than in 1:1 ratio 
(Ilmer et al., 2009). In addition to increasing cell number, MSC differentiation into 
osteoblasts in co-culture can being stimulated to a greater extent by encapsulating 
cells in 3D environment. Seto and co-workers demonstrated that MSCs encapsulated 
in heparin gel and co-cultured with osteoblasts in monolayer had 10-fold higher  
ALP activity and calcium accumulation than MSCs from single cell type cultures 
(Seto et al., 2012).   
Up to date, only one study has undertaken the interesting aim to compare  
the osteogenic differentiation of MSCs in direct and indirect co-culture system  
to evaluate how the contact mode influences the mechanisms directing  
the differentiation process (Wang, 2007). In both co-culture types, the differentiation 
of murine MSCs is regulated by Wnt signalling pathways. While upon direct cell-cell 
contact the cadherin pathway was up-regulated, which resulted in the suppression  
of Wnt signalling, in indirect co-culture the suppression of cadherin and stimulation 
of the Wnt pathway was demonstrated. This was further reflected in the higher extent 
of osteogenic differentiation being reported for cells in indirect co-culture (Wang et 
al., 2007). Interestingly, in indirect co-culture, the influence on only ALP, but not 
later osteogenic markers, in human MSCs by osteoblast-induced Wnt pathway was 
reported (Ilmer et al., 2009). 
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1.5. Bone regeneration  
Upon fracture, the cortical bone and periosteal tissue, together with surrounding soft 
tissues are ruptured. The process of fracture healing is initiated immediately and is  
a series of molecular and cellular events leading to the restoration of the tissue. Bone 
fracture healing is a specific process of wound healing because unlike soft tissue 
wound healing it does not lead to scar formation. This results in the anatomical re-
alignment and restoration of the physiological function of the bone and complete 
return to the physiological function. Intensive studies in this area indicate that  
the bone healing process is regulated by multiple parameters such as pH, oxygen 
tension, growth factors and cytokines present at the site of the injured tissue,  
and mechanical stability of the fracture bone fragments (Sfeir et al., 2005). 
Depending on the nature and the treatment, fracture healing can be divided into 
primary (direct) and secondary (indirect). Secondary fracture healing differs in  
the formation of callus compared to the primary healing. Both of these processes are 
very complex and require stabilization, either absolute or relative. Stabilization can 
be obtained by external or internal fixation devices.  
1.5.1. Primary fracture healing  
Primary healing of a fracture involves a direct attempt by the cortex to re-establish 
itself. To restore mechanical continuity, bone fragments at one side of the cortex 
must unite with bone in the other side of the cortex. This process occurs when there 
is anatomical restoration of the fracture fragments, which is achieved by rigid 
fixation, and when the stability of fracture reduction is ensured by a substantial 
decrease in interfragmentary strain (McKibbin, 1978;Einhorn, 1998). The process  
of direct healing is based on the osteonal bone remodelling, which is also observed  
in normal physiological bone turnover. 
As stated above, mechanical stability is crucial in the type of the bone fracture 
healing observed. The absolute stability of the fracture is at the utmost importance 
for direct bone healing as it restores and maintains anatomical reduction of fracture 
fragments by avoiding interfragmentary motion, which results in resorption of the 
contact surfaces of bone fragments (McKibbin, 1978). Perren proposed the 
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‘infragmentary strain hypothesis’ to explain the effect of the interfragmentary strain 
and fracture immobilization on the tissue response in the fracture healing process 
(Perren, 1979). According to his theory, fracture healing will occur when rigid 
internal fixation is ensured and when the interfragmentary movement divided  
by the fracture gap width is lower than 2% (the fracture strain of bone). 
Depending on gap width, primary healing can be further divided into gap healing  
and contact healing. The first occurs when the interfragmentary space is less than 
0.1mm and is mediated by marrow derived vessels and vessel-associated 
osteoprogenitor cells differentiating into osteoblasts (Shapiro, 2008). Primarily,  
the gap is filled directly by woven bone which is followed by the formation  
of lamellar bone having perpendicular orientation to the long axis of bone. From  
the mechanical point of view this union of bone ends is weak and further undergoes 
secondary osteonal remodelling, restoring stable biomechanical properties  
of the healed bone. In this process, longitudinal oriented cavities are formed across 
the fracture plane/line by osteoclasts in cutting cones. This provides pathways  
for the penetration of blood vessels and capillaries. Later osteoblast cells residing  
at the end of the cutting cone produce bone which fills the cavity and restores  
the Harvesian system in the original longitudinal orientation (Sfeir et al., 
2005;Shapiro, 2008).  
Contact healing occurs only when the gap between the bone ends is less than 
0.01mm and it interfragmentary strain is less than 2% (Shapiro, 1988;Marsell and 
Einhorn, 2011). Under these conditions, the lamellar bone of original axial direction 
is formed during primary osteonal reconstruction. This process is directed 
exclusively by the intraosseous Harvesian system osteoblasts and osteoclasts. 
Initially, the cutting cones are formed at the ends of the osteons closest  
to the fracture site. These cutting cones generate cavities through the fracture line  
at a rate 50-100 µm/day (Griffon, 2007). The developing Harvesian system (osteon) 
is filled with lamellar bone aligned parallel to the long axis of the bone.  
1.5.2. Secondary fracture healing 
Secondary (indirect, endochondral) fracture healing occurs under the relative 
stability. As primary bone repair is akin to bone remodelling, secondary fracture 
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healing is very similar to the process of embryological development, which includes 
two distinct and interactive responses, intramembranous and endochondral bone 
formation. While both these processes result in bone formation, their mechanisms  
are significantly different. In intramembranous bone formation, bone synthesis  
is direct and proceeds without cartilage participation. In case of endochondral bone 
formation, bone synthesis is preceded by cartilage formation that further undergoes 
mineralization and acts as a scaffold for bone formation. Relative stability allows for 
motion at the site of injury, which promotes the formation of a cartilaginous fracture 
callus providing intermediate stabilization of the fracture (Probst and Spiegel, 1997). 
If the local strain (deformation) is higher than the forming woven bone can tolerate, 
bone bridging and callus will not occur which will result in a reactive non-union 
(Kessler et al., 1986). The process of secondary fracture healing is a continuous 
process that can be divided into consecutive but overlapping stages: inflammation, 
reparative (including soft and hard callus formation) and remodelling phase (Fig.1.3).  
1.5.2.1. Inflammatory phase 
Initially, the bone fracture results in the disruption of the blood vessels within  
the marrow, periosteum, osteons and tissues adjacent to the fracture site (Fig.1.3A). 
Due to low oxygen and nutrient supply, cells at the margins of the bone fragments 
undergo necrosis (Sfeir et al., 2005;McKibbin, 1978). Consequently, a hypoxic state 
forms and initiates inflammatory response (Taguchi et al., 2005). In the rat fracture 
model, the acute inflammatory response occurs within the first 7 days after  
the fracture. The immune cells produce a wide spectrum of factors and cytokines 
within that time, including Interleukin 1 (IL1), IL6, IL8, IL12, platelet-derived 
growth factor (PDGF), tumour necrosis factor α (TNFα), IL8, vascular endothelial 
growth factor (VEGF), CXC Receptor 4 (CXCR4) and osteopontin/secreted 
phosphoprotein 1 (SPP1), which are essential for mobilisation and chemotaxis  
of other cells, angiogenesis and osteogenesis (Kolar et al., 2011;Park and Barbul, 
2004). Moreover, the extravasation forms a hematoma which encloses the fracture 
area and is a source of signalling molecules to initiate the activation  
of the complement cascade, platelet aggregation and the release of platelet contents 
(Bolander, 1992).   
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Polymorphonuclear neutrophils (PMNs) are the first cells recruited to the fracture 
site by dead cells, debris and platelet degranulation within 24 hours after fracture. 
They secrete several chemokines, such as Chemokine CC-motif ligand 2 (CCL2)  
and IL6, attracting macrophages from the two distinct locations which emerge within 
48-96 hours post-fracture and are the principle cell types during inflammatory phase. 
The first type are macrophages residing on the endosteal and periosteal surface of the 
bone close to the bone lining cells, which are crucial for intramembranous bone 
formation during healing, The second type are inflammatory macrophages derived 
from recruited and divided monocytes from the blood, which affect the endochondral 
ossification. These cells provide a barrier against bacterial invasion and are essential 
in wound debridement and at the hypoxic milieu initiate angiogenesis (Leibovich and 
Ross, 1975). Lastly, lymphocytes are recruited and initiate the adaptive immune 
response.  
Emerging at the fracture site, platelets adhere to the exposed vascular collagens, type 
IV and V. This interaction initiates the activation and aggregation of the platelets that 
degranulate releasing their d-granule contents, such as fibronectin, platelet-derived 
growth factor (PDGF), platelet-activating factor (PAF), thromboxane A2 (TXA2)  
and TGFβ (transforming growth factor β) that are essential for the further stages  
of blood coagulation process. As a result, a fibrous blood clot is formed around  
the fracture and the periosteum, providing pathways for the cellular migration  
of phagocytes, neutrophils and fibroblasts (Fig.1.3A) (Probst and Spiegel, 
1997;Shapiro, 2008).  
As mentioned above, macrophages are essential for initiating angiogenesis under 
hypoxic conditions through secretion of factors essential for this process, such  
as fibroblast growth factor β (βFGF), VEGF and insulin-like growth factor 1 (IGF-1) 
(Knighton and Fiegel, 1989). These factors induce the formation of capillaries within 
the clot and the loose aggregate of fibroblasts which forms the granulation tissue. In 
addition, macrophages produce cytokines and growth factors, such as IL1, IL6, IL8, 
IL12, platelet-derived growth factor, TNFα, attracting migration of other cells 
towards the injury site, stimulating proliferation and/or differentiation of these cells 
and the collagen synthesis (Park and Barbul, 2004).   
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In endochondral bone healing, the main source of progenitor cells differentiating into 
osteoblasts is provided by inner osteogenic layer of periosteum and by bone marrow. 
These cells are recruited to the fracture site by the chemotactic factors. Recently,  
it has been shown that stromal-derived factor (SDF1) and its receptor, CXCR4,  
are crucial for recruiting and homing of osteoprogenitor cells to the site  
of the fracture (Kitaori et al., 2009). 
Hematoma, and the inflammatory reaction, initiates the repair of bone by attracting 
and promoting differentiation of MSCs, initiating angiogenesis and enhancing ECM 
synthesis. The local increased levels of mRNA expression of IL8, VEGF together 
with IL6, CXCR4 and SPP1 in fracture hematoma indicate its importance  
for chemotaxis, angiogenesis and osteogenesis (Kolar et al., 2011). Combating 
inflammation and removal of the hematoma can negatively affect the bone healing 
process in various ways. Indeed, the removal of the hematoma, together with  
the cells contained within, prolonged the time of fracture healing compared  
to fracture with hematoma (Kolar et al., 2011). One of the reasons is the lack  
of ability to adapt to the hypoxic conditions, which in physiological scenario  
is regulated by hypoxia-inducible factor (HIF-1). The expression of HIF-1, which 
regulates the cellular adaptation to low oxygen by switching the cellular metabolism 
from oxidative phosphorylation toward glycolysis (Semenza, 1998) and inducing 
angiogenesis via VEGF and IL8, upregulates in the fracture hematoma. 
Furthermore, in the absence of macrophages, the increased levels of tumour necrosis 
factor-alpha (TNFα) together with reduced levels of transforming growth factor-β1 
(TGFβ1) and vascular endothelial growth factor (VEGF) in the wound, resulted  
in decreased collagen synthesis and impaired vascularization (Mirza et al., 2009). 
Furthermore, treatment with non-steroidal anti-inflammatory drugs, such as 
cyclooxygenase-2 inhibitors (COX-2) can result in prolonged fracture healing.  
COX-2 is an enzyme implicated in inflammation by converting arachidonic acid  
to prostaglandin H2. It is abundant in activated macrophages and, in addition,  
it promotes differentiation of MSC into osteoblasts and angiogenesis during  
the fracture healing (Gerstenfeld et al., 2003). Finally, the depletion of all  
T-lymphocyte cells negatively affects the wound healing (Efron et al., 1990).  
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1.5.2.2. Soft callus formation  
The reparative phase of secondary starts after inflammation and lasts for few weeks. 
Initially, it begins with soft callus formation (Fig.1.3B). The progenitor cells residing 
in the cambial layer of periosteum and endosteum differentiate into osteoblast cells, 
which subsequently deposit woven bone via intramembranous ossification.  
At the same time, the granulation tissue formed after the fracture is replaced  
by fibrocartilagenous tissue formed by fibroblasts and chondrocytes. This process  
is initiated by the growth factors stimulating the cell proliferation and differentiation. 
In detail, the bone matrix and broken bone cortex are the source of many growth 
factors, including BMPs (Bostrom et al., 1995). The members of BMP family 
together with IGF1, platelet-derived growth factor (PDGF), transforming growth 
factor β (TGFβ) and fibroblast growth factor 1 (FGF-1) stimulate fibroblast  
and chondrocyte proliferation, and chondrocyte differentiation. In addition,  
the expression of BMP family members was demonstrated in various cells  
at different stages of the fracture repair, including chondrocytes in soft callus. 
Moreover, in these cells the distribution of BMPs depended on the cellular 
differentiation stage and the location within the fracture callus, which may contribute 
to BMP-mediated response to the injury (Yu et al., 2010).  
Initially, the cartilage tissue is formed from the outer sides of the fracture gap  
and ingress into the centre region where the fibrocartilagenous tissue is formed. This 
fibrocartilage callus has increased stiffness and, thus, it bridges and stabilizes  
the fracture sites by resisting the compression and tension (except angular tension). 
In addition, it acts as a template for the superceding bony callus (Rahn, 2002). 
Initially, the avascular soft callus is invaded by vascular endothelial cells.  
1.5.2.3. Hard callus formation         
About one week after the formation of soft callus, the next stage, leading to hard 
callus formation starts and lasts until the fragments are united by a new bone  
(3-4 months). With ongoing intramembranous bone formation at the periosteal site  
of the fracture gap and vascularisation within the soft callus, the chondrocytes from 
proximal to distal parts of the fracture undergo calcification followed  
by endochondral ossification forming woven bone (Fig.1.3C) (McKibbin, 1978).  
The hypertrophic chondrocytes enlarge and vascular buds invade the soft callus. 
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Then, the osteoprogenitor cells differentiate into osteoblasts which resorb  
the calcified cartilage and the woven bone replacing them further with mature bone 
trabelculae (Probst and Spiegel, 1997). The process starts from the fracture periphery 
towards the fracture gap and results in the final joining of the original cortex 
(Einhorn, 1998;Ito, 2007).  
1.5.2.4. Remodelling    
The remodelling phase of fracture healing leads to an optimal stability of the healed 
bone similar to the bone structure before the fracture occurred. This phase begins 
with the activation of osteoclasts forming cutting cones in the immature woven bone, 
where the blood vessels enter bringing osteoblasts that deposit bone matrix, resulting 
in the formation of the lamellar bone along the longitudinal axis of the bone 
(Fig.1.3D). This type of bone withstands physiological mechanical load. In addition, 
the osteoclast activity decreases the size of the callus (Perren, 1979;Probst and 
Spiegel, 1997). The remodelling process takes from months to years and depends  
on both the type of bone and fracture. Trabecular bone (cancellous) fractures  
are more stable and have a better blood supply, therefore, heal faster than cortical 
bone fractures (Sfeir et al., 2005). 
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Figure 1.3. Schematic and histological representation of secondary fracture healing stages.  
A) The inflammatory phase with haematoma formation. Schematic presentation of cells  
in fibrous clot. B) The soft callus stage. The replacement of granulation tissue by the fibrous 
tissue and cartilage. Intramembranous ossification starts at the distal parts of fracture 
fragments followed by capillaries ingrowth into the calcified callus. C) The hard callus stage. 
At this stage callus is completely calcified. During endochondral ossification the woven bone 
is formed. D) The remodelling stage. The woven bone is replaced by lamellar bone that 
withstands physiological mechanical load. Adapted from (Ito, 2007) and Schindeler (2010). 
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1.5.3. Vascularisation  
A bone is a well vascularised tissue and when a bone is fractured, the blood  
vessel system is severely disrupted. The vascular restoration is extremely important 
in the bone fracture healing process, as damaged blood circulation leads to hypoxia 
and acute necrosis of the adjacent bone and marrow (Probst and Spiegel, 1997). After 
fracture, the disrupted circulation cannot provide the proper and adequate reaction  
to the injury. Hence, immediately after fracture an additional external blood supply 
develops from adjacent soft tissues and is referred to as the extraosseous supply. 
Initially, the extraosseous vascular capillaries supply blood to the soft periosteal 
callus. 
In relation to blood supply in the healing bone, three types of osseous callus are 
distinguished – periosteal, medullary and intercortical (Fig.1.4). The periosteal callus 
is situated externally to the bone and during the early stages of healing it is supplied 
by the extraosseous vasculature. However, with time it receives more blood from  
the medullary arterial supply which also constitutes vascularisation for the medullary 
callus confined to medullary cavity. Between the fracture fragments at the opposite 
sites of cortex the intercortical callus forms and acts as a scaffold for  
the reconstructing bone. Blood circulation to the intercortical callus is provided  
by the medulla, when the medullary arterial supply is not damaged. Otherwise,  
the vascularity comes from extraosseous blood supply, until the medullary blood 
supply is fully regenerated (Carano and Filvaroff, 2003). 
 
 
Figure 1.4. Schematic model of the three types of osseous callus encountered at sites of bone 
repair. Adapted from Sunner-Smith and Fleckerman Bone in Clinical Orthopedics 2
nd
 
Edition, 2002. 
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1.6. Objectives and Hypotheses 
The ultimate goal of this thesis was to deliver a reliable in vitro cell culture model for 
ostoblast-lineage cells. The specific hypotheses and objectives are outlined below. 
 
Hypothesis I (chapter 3):  
Osteoblast cell lines are not relevant models as an alternative to the primary human 
osteoblasts for investigating osteoblast cell phenotype    
Objectives:  
1) Characterise the phenotype of primary human osteoblast cells and osteoblast cell 
lines (SaOs2, MG63 and MC3T3E1) 
2) Compare the osteoblastic phenotype of cell lines with primary human cells 
Goal: Determine the relevance of osteoblast cell models for bone-related studies 
 
Hypothesis II (chapter 4):   
Paracrine communication regulates the osteogenic phenotype of bone forming cells 
Objectives:   
1) Assess the effect of paracrine communication between osteoblasts and MSC cells 
in monolayer indirect co-culture 
2) Assess the effect of paracrine communication between osteoblasts and MSC cells 
in micromass indirect co-culture 
3) Establish an osteoblast cell model allowing the analysis of the influence of direct 
cell-cell communication on osteoblastic phenotype development 
Goal: Determine the influence of 2D and 3D environment on paracrine cell crosstalk 
 
Chapter 1: General Introduction 
44 
 
Hypothesis III (chapter 5):   
Short-term stimulation of human MSCs with inflammatory and chemotactic factors 
results in functional regulation of the cells paracrine activity  
Objectives:   
1) Assess the direct effects of stimulation on cytokine gene expression profile  
2) Assess the direct effects of stimulation on cytokine protein secretion profile  
3) Characterise the secondary effects of stimulation on osteogenic differentiation  
of unstimulated human MSCs 
Goal: Determine the potential influence of the regulation of paracrine activity  
of MSCs on the processes involved in bone healing processes 
 
Hypothesis IV (chapter 6):  
Culturing human bone-derived mesenchymal stem cells (MSCs) in a 3D in vitro 
microenvironment promotes their phenotypic development  
Objectives:   
1) Formulate and establish a physiologically relevant culture system based on type I 
collagen gel  
2) Investigate the effect of 2D and 3D cell culture models on osteoblast cell 
development 
3) Investigate the importance of the extracellular matrix proteins for osteogenic 
differentiation  
Goal: Develop a 3D osteoblast culture model resembling more natural milieu  
and allowing the better understanding of osteoblastic cell development  
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CHAPTER 2  
 
 
 
 
 
MATERIALS AND METHODS 
 
 
 
 
 
 
 
Sections of this chapter have been previously published: 
E. M. Czekanska: Assessment of cell proliferation with resazurin-based fluorescent 
dye Methods in Molecular Biology 740: 27-32 (2011). 
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2.1. Materials 
 100x Insulin-Transferrin-Selenium+1 (Sigma, I2521) 
 1-Bromo-3-chloropropane for molecular biology (BCP; Sigma B9673) 
 2-Amino-2-methylpropanol (Sigma, A9199) 
 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; Clonetics, CC-
5024)  
 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; Invitrogen, 
15630) 
 45Ca, Calcium chloride in aqueous solution (Perkin Elmer, NEZ013) 
 4-nitrophenyl phosphate disodium salt hexahydrate (20 mg tablets; Sigma, 
N2765) 
 Alizarin Red S (Sigma-Aldrich, A5533) 
 Alkaline buffer solution (Sigma, A9199) 
 Alpha Minimal Essential Medium (αMEM; Gibco, 12000-063) 
 Assays on Demand (Applied Biosystems) 
 B4-78 antibody (26 µg/ml, produced on 28.01.2010; DSHB) 
 Basic FGF, human recombinant (Fitzgerald, RDZ-118B-218) 
 Calcein AM (Fluka, 17783; stock solution: 1mg/ml in DMSO) 
 Calf thymus DNA (Invitrogen, 15633-019) 
 Cell Titer-Blue® Cell Viability Assay (Promega, G8080) 
 Collagen type I from rat tail (Gibco, A10483-01)  
 DeoxyNTPs mixture, 0.5 mM each dNTP (Applied Biosystems, N8080260) 
 Dexamethasone (water soluble; Sigma, D2915) 
 Diethanolamine (Sigma, D0681) 
 Dimethyl sulfoxide (DMSO; Fluka, 41640) 
 dNTP Mix (Applied Biosystems, 362275) 
 Dulbecco's Modified Eagle Medium, high glucose (DMEM, powder; Gibco, 
41965-02) 
 Dulbecco's Modified Eagle Medium, low glucose (DMEM, powder; Gibco, 
31600-083) 
 Ethanol (for molecular biology; Fluka, 51976) 
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 Ethidium homodimer-1 (Fluka, 46043; sock solution: 1 mg/ml in 20% DMSO 
in H2O) 
 Ethylenediaminetetraacetic acid (EDTA; Sigma, E5134) 
 Eukitt® (Fluka, 03989) 
 FBS Superior (Biochrom, S0165, lot# 0306A) 
 Ficoll (Histopaque, 1077) 
 Foetal bovine serum, heat inactivated (Gibco, 10500) 
 Formic acid 70% (Fluka, 06460) 
 Granulocyte colony stimulating factor, human recombinant (PromoKine, C-
60437) 
 GenElute HP Plasmid Mini Prep (Sigma, NA0160) 
 Glycerol-2-phosphate (Sigma, G62511) 
 Hoechst 33258 (Polysciences, Inc., 09460) 
 Horse serum (Vector Laboratories, S2000) 
 Human basic FGF (PeproTech Inc., AF-100-18B) 
 Human Cytokine Antibody Array G-series 2000 (RayBiotech Inc., AAH-
CYT-G2000-8) 
 Human qualified foetal calf serum (Gibco, 12662) 
 Hydrogen peroxide (H2O2; Fluka, 95313) 
 Hydroxyapatite 'fast flow' (Fluka, 55497) 
 Interleukin 1β, Human recombinant (PromoKine, C-61120) 
 ImmPACT DAB (Vector Laboratories, SK-4105) 
 L-Ascorbic acid-2-phosphate seqimagnesium salt hydrate (Sigma, A5533) 
 Magnesium chloride hexhydrate (Fluka, 63064) 
 Magnesium chloride solution (25mM; Applied Biosystems, N8080010) 
 MultiScribe Reverse Transcriptase 50 U/μl (Applied Biosystems, 1108105) 
 OCT4-30 antibody (Abcam; AB13418) 
 OGM Differentiation SingleQuots (Lonza, CC-4194) 
 OptiPhase ‘Hi Safe’ Scintillation Liquid (Perkin Elmer, 1200-437) 
 Osteoblast basal medium (Lonza, CC-3208) 
 Osteogenesis assay kit (Millipore, ECM815) 
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 PCR Buffer II 10 x (500 mM KCl, 100 mM Tris/HCL, pH 8.3 ;Applied 
Biosystems, 4376212) 
 PCRArray PAHS-021C-12 (SABiosciences, 330231) 
 Penicillin-Streptomycin (10 kIU/ml; Gibco, 15140) 
 Phosphatase substrate: 4-Nitrophenyl phosphate disodium salt hexahydrate 
(20mg tablets; Sigma, N-2765) 
 Phosphate buffered saline, tablets (PBS; Sigma, P4417) 
 Phosphate-buffered saline (PBS; Sigma, P4417 tablets) 
 Platinium Retrovirus Expression System, pantropic (Cell Biolabs, Inc.,  
VPK-302) 
 Platinum-GP Retroviral Packaging cell line, pantropic (Cell Biolabs, Inc.,  
RV-103) 
 p-Nitrophenol (10umol/mL; Sigma, 104-1) 
 p-Nitrophenol solution 10 mM (Sigma, V7660) 
 P-Nitrophenyl standard solution 10mM (Sigma, N7660) 
 Polyacryl carrier (Molecular Research Center; PC152) 
 Polybrene, 10 mg/ml (Millipore, TR-1003-G) 
 Potassium chloride (Fluka Chemica, 60130) 
 Potassium phosphate monobasic (Fluka Chemica, 60230) 
 Power Sybr Green PCR Master Mix (Applied Biosystems, 4367659) 
 Proteinase K (Roche, 1000144) 
 QuickStart Bovine Serum Albumin, 2mg/ml (Bio-Rad, 500-0206) 
 QuickStart Bradtford Dye Reagent 1x (Bio-Rad, 500-0205) 
 Random Hexamer 50 μM (Applied Biosystems, 8080127) 
 RNase Inhibitor 20 U/μl (Applied Biosystems, N8080119) 
 RNaseZap® (Sigma, R2020) 
 RNeasy mini kit (Qiagen, 74106) 
 RQ1 RNase-Free DNase (Promega, M6101) 
 RT2 First Strand Kit (Qiagen, 330401) 
 RT2 SYBR Green ROX qPCR Mastermix (Qiagen, 220522) 
 S.O.C medium (Invitrogen, 15544-034) 
 Stem Cell Factor, human recombinant (PromoKine, C-63120) 
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 Stromal cell-derived factor-1α, human recombinant (PromoKine, C-67220) 
 Self-designed primers and probes (Microsynth, CH) 
 Sodium bicarbonate (Sigma, 63100) 
 Sodium Chloride  (Fluka Chemica, 71380) 
 Sodium hydroxide (Fluka Chemica, 71690) 
 Sodium phosphate dibasic (Fluka Chemica, 71645) 
 Superior foetal bovine serum (Biochrom, S0615) 
 TaqMan Gene Expression Master Mix (Appied Biosystems, 4370074) 
 TNS (Lonza, CC-5012) 
 TRI Reagent® (Molecular Research Center, Inc., TR118) 
 Tris-EDTA buffer solution (for molecular biology; Sigma, 9285) 
 Triton-X-100 SigmaUltra (Sigma, T9284) 
 Trypan Blue (Sigma, TB154) 
 Trypsin-ethylenediaminetetraacetic acid (10x; 5g/L trypsin, 2g/L EDTA,  
8g/L NaCl; Gibco, 15400-054) 
 Tween20 (Sigma, P1379) 
 Vectastatin ABC Elite kit (Vector Laboratories, PK-6102) 
2.2. Methods 
2.2.1. Culture and propagation of cells 
In this study, 6 types of osteoblast cells from different origins and human bone 
marrow-derived mesenchymal stem cells (MSCs) were used (Tab.2.1).  
The summary list of differentiation medium supplements, used for the induction  
of mineralisation, is presented in Table 2.2. All cell types were maintained in  
the same conditions at 37˚C with an atmosphere of 5% CO2 and 95% humidity. 
Unless otherwise stated, the medium was changed every 2 or 3 days. 
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 Cell name Type Animal Origin  Source 
 MSC Primary Human  
Bone Marrow aspirates 
from iliac crest  
and vertebral body 
Isolated 
 Human 
 osteoblasts 
 (HOb) 
Primary Human  
Human osteoblast cells  
of a 6-year old female  
(long bone) 
Lonza, USA  
 MG63 Osteosarcoma Human  
Primary osteosarcoma  
of a 14-year old 
Caucasian male 
ECACC, 
UK  
 SaOs2 Osteosarcoma Human  
Primary osteosarcoma  
of an 11-year old Cauca-
sian female 
DSMZ, DE 
 MC3T3E1 Cell line Mouse  Newborn mouse calvariae DSMZ, DE  
Table 2.1. Origin of osteoblast and MSC cells used in this study.  
2.2.1.1. Human bone marrow derived stromal cells (MSC) isolation  
and propagation 
Human bone marrow aspirates were obtained with the ethical approval and written 
consent of donors undergoing total hip replacement, vertebral body isolation  
or spinal fusion. Bone marrow aspirates were provided by Dr. Lorin Benneker,  
Dr. Sven Hoppe (Interspital Bern, Bern, Switzerland), Dr. Markus Loibl 
(Universitatsklinikum Regensburg, Regenesburg, Germany) and Dr. Gian Salzmann 
(Universitatsklinikum Freiburg, Freiburg, Germany). Before proceeding with  
the isolation protocol, undiluted bone marrow aspirate was pipetted up and down  
to dislodge any clumps. Next, marrow was mixed with PBS (1:3) and passed through 
a 70µm cell strainer into a 50ml Falcon tube. One additional volume of PBS was 
used to rinse the cell strainer. The diluted marrow was transferred into a new tube 
containing 2.6ml Ficoll per 1ml of undiluted marrow and centrifuged at 800xG  
for 20 min at room temperature. The mononuclear cells from the interphase were 
transferred into a new tube and 5ml αMEM with 10% FCS medium was added  
to each ml of the collected interphase (Fig.2.1). Cells were mixed gently with 
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medium and centrifuged at 400xG for 15 minutes at room temperature. Supernatant 
was aspirated and pelleted cells were washed again. After washing, cells were re-
suspended in the medium and counted with a Scepter 2.0 Handheld Automated Cell 
Counter (Millipore, US) using 40µm sensor. Isolated mononuclear cells were plated 
at a density of 50,000 cells per cm
2
 in αMEM medium with 10% MSC qualified 
serum, 1% Penicillin-Streptomycin and 5ng/ml basic FGF. Medium was changed 
 4 days after plating and every 2-3 days thereafter. After reaching 80% confluence, 
cells were harvested and frozen down to -196°C.   
 
Figure 2.1. Phase-separation of bone marrow using Ficoll (Histopaque, 1077). Adapted from 
standard operating procedure document PRBT 002-04 (AO Research institute Davos, Davos, 
CH). 
2.2.1.2. Primary Human Osteoblast (HOb) cells 
Proliferating cells were maintained in Osteoblast Growth Medium (OGM) composed 
of Osteoblast Basal Medium supplemented with 10% FBS, 1% Penicillin-
Streptomycin and 50μg/ml L-ascorbic acid 2-phosphate sesquimagnesium salt 
hydrate. For mineralisation experiments OGM was supplemented with 7.5mM β-gly-
cerophosphate and 200nM hydrocortisone. 
2.2.1.3. MC3T3E1 cells 
Proliferating cells were maintained in standard growth medium composed of high 
glucose DMEM supplemented with 10% FBS and 1% Penicillin-Streptomycin. Cells 
from passage 7 were used for the osteogenic assays. Differentiation was induced  
by addition of 50μg/ml L-ascorbic acid 2-phosphate sesqimagnesium salt hydrate, 
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10nM final concentration dexamethasone and 5mM final concentration β-glycerol 
phosphate to standard growth medium.  
2.2.1.4. MG63 cells 
The MG-63, human cells from an osteosarcoma of 14-year-old male were purchased 
from ECACC (European Collection of Cultured Cells, UK). Proliferating cells were 
maintained in DMEM supplemented with 10% FBS and 1% Penicillin-Streptomycin. 
To induce mineralisation the growth medium was supplemented with 50μg/ml L-
ascorbic acid 2-phosphate sesquimagnesium salt hydrate, 10nM final concentration 
of dexamethasone and 5mM final concentration of β-glycerol phosphate. Cells from 
passage 5-8 were used for experiments. 
2.2.1.5. SaOs2 cells 
Cells were purchased from DSMZ (Deutsche Sammlung von Mikroorganismen und 
Zellkulturen GmbH, DE) and received as an active culture in McCoy medium 
supplemented with 15-20% of FBS. Proliferating cells were maintained in DMEM 
supplemented with 10% FBS and 1% Penicillin-Streptomycin. Cells from passage 7 
were used for osteogenic assays and from passage 8 for cell growth experiment. 
Proliferating cells were maintained in DMEM supplemented with 10% FBS  
and 1% Penicillin-Streptomycin. Differentiation was induced by the addition  
of 50μg/ml L-ascorbic acid 2-phosphate sesquimagnesium salt hydrate.  
Cell type Differentiation medium supplements 
MSC 50 µg/ml AA, 10 nM dex, 5 mM βGP 
HOb 50 µg/ml AA, 7.5 mM βGP, 200 nM hydrocortisone  
MC3T3E1 50 µg/ml AA, 10 nM dex, 5 mM βGP 
MG63 50 µg/ml AA, 10 nM dex, 5 mM βGP  
SaOs2 50 µg/ml AA 
Table 2.2. List of supplements used for osteogenic differentiation of MSC, HOb, MC3T3E1, 
MG63 and SaOs2 cells; AA - L-ascorbic acid 2-phosphate sesquimagnesium salt hydrate, 
βGP - β-glycerol phosphate, dex - dexamethasone. 
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2.2.2. Cell passaging 
Cell subculture was performed using 0.05% Trypsin-EDTA solution in PBS  
at 70-80% confluence of the monolayer cell cultures. The protease, trypsin, breaks 
down the proteins responsible for cell-cell and cell-matrix adherence by cleaving 
peptide bonds at lysine and arginine residues. The presence of divalent cations, such 
as calcium, which inhibits trypsin properties, is reduced by chelating it with EDTA. 
Before exposing cells to trypsin-EDTA solution, monolayer was washed twice with 
sterile PBS to ensure a total removal of medium and cell debris. Small volume  
of pre-warmed 0.05% Trypsin-EDTA in PBS (0.03ml per cm
2
) was applied into cell 
culture flasks containing cells. Depending on the cell type, cells were incubated with 
trypsin solution for 3-10 minutes at 37°C, followed by assessing of the cell 
detachment using an Axiovert 25 microscope (Carl Zeiss AG, Oberkochen, 
Germany) and the trypsin inactivation with growth medium containing 10% FBS. 
Cell suspension was transferred to the Falcon tube and centrifuged at 250xG  
for 10 minutes. Then, the supernatant was aspirated and cells were re-suspended  
in medium prior to manual cell counting of viable cells. After counting the desired 
concentration of cells per cm
2
 was platted in a flask filled with respective volume  
of medium.  
2.2.3. Cell freezing  
For cryopreservation of cells, freezing medium containing 10% DMSO (dimethyl 
sulphoxide) in FBS was used. DMSO is commonly used cryoprotectant to prevent 
cells from rupture by the formation of ice crystals. Furthermore, for successful 
cryopreservation and viability of cells after reconstitution, cells were frozen at a rate 
1°C per minute by -80°C using 5100 Cryo 1°C Freezing Container (Nalagene, USA).  
After trypsinisation and counting procedure, cells were centrifuged again at 250xG 
for 10 minutes and re-suspended in freezing medium to obtain 1-2 million cells per 
ml. Then, 1ml aliquots of cells were distributed into cryotubes (Nunc, Rochester, 
NY) which were placed in freezing container. For initial freezing cells were placed at  
-80°C overnight and then cryotubes with frozen cells were stored in liquid nitrogen. 
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2.2.4. Cell reconstitution 
Frozen cells were transferred into the sterile cell culture room on ice  
and reconstituted by quick thawing in water bath. The cryotube containing cells was 
cleaned with 70% ethanol before transferring into sterile laminar flow. Reconstituted 
cells were slowly transferred into 50ml tube containing 10ml pre-warmed growth 
medium. Cells were centrifuged at 250xG for 10 minutes. After resuspension in fresh 
growth medium, cells were counted manually and plated into a cell culture flask  
at the density 3000-6000 cells per cm
2
, depending on cell type. 
2.2.5. Generating osteoblast cell line with stable GFP expression 
2.2.5.1. Propagation of pMX-GFP and pCM-VSV-G retroviral vectors 
pMX-GFP and pCM-VSV-G retroviral vectors (Fig.2.2) were propagated  
in chemical competent TOP10 E. coli bacteria. After thawing on ice, 2µl of both 
vectors were added to bacteria, mixed gently and incubated on ice for 5 minutes. 
Next, bacteria underwent heat-shock for 30 seconds in the 42°C water bath. After 
adding 250µl S.O.C medium, bacteria was incubated for 1 hour in 37° C water bath 
under agitation (SWB25 Haake, Thermo Fisher Scientific Inc., US). Following this, 
50µl bacteria were distributed evenly on pre-warmed ampicillin selective agar plates. 
Plates were incubated overnight in a 37°C. Next, two colonies were transferred from 
agar plate to 50ml Falcon tube containing 10ml LB medium supplemented with 
100µg/ml ampicillin. Liquid cultures were grown for 16 hours under agitation (260 
rpm) in a shaking incubator at 37°C. 
 
Figure 2.2. Schematic representation of pMX-GFP retroviral vector (A) and pCMV-VSV-G 
envelope vector (B). Figure adapted from the Product Manual provided by Cell Biolabs, Inc.  
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Isolation of pMX-GFP and pCM-VSV-G DNA was performed using Gene Elute 
Plasmid Miniprep Kit (Invitrogen). Briefly, liquid cultures were transferred to 15ml 
falcon tubes at 5ml per tube and bacteria were pelleted by centrifugation at 3000xG  
for 10 minutes (5810R, Eppendorf, DE). After removing supernatant, pellet  
was mixed with 200µl resuspension buffer. Then, 200µl cell-buffer mixture  
was transferred to the supplied tubes and mixed with 200µl lysis buffer  
by inverting the tubes gently 8 times. Lysis was stopped after 3.5 minutes by adding 
350µl neutralization buffer into the each tube. The neutralization buffer was mixed 
with the lysate by inverting columns 8 times. Next, tubes were centrifuged at 
12000xG for 10 minutes (Micro22, Hettich, DE). In the meantime, 500µl column 
preparation buffer was added to each column supplied by manufacturer and 
centrifuged at 12000xG for 1 minute. The flow-through was discarded and approx.  
600µl supernatant from the lysed bacteria was added to the column and centrifuged 
at 12000xG for 1 minute. After discarding flow-through, 500µl of 'first washing 
buffer' was added and centrifuged as before. When finished, 750µl 'second washing 
buffer' was added to the columns and again, centrifuged at 12000xG for 1 minute. 
Additional centrifugation was performed at 12000xG for 4 minutes after discarding 
flow-through. Any leftovers of the buffers were removed from column using a 10µl 
pipette. Columns were air dried and transferred into the new collection tubes. Then, 
50µl elution buffer was added to the membrane of the columns and incubated  
for 2 minutes. To ensure better binding of the DNA, elution buffer was pre-warmed 
before adding to the column. DNA was collected by centrifugation at 12000xG  
for 1 minute. The purity and amount of the DNA was assessed using 260/280  
and 260/230 ratio using the NanoDrop system (Witec Gmbh, DE) and associated 
software. Samples were then stored at -80°C until required.  
2.2.5.2. Transfection of PlatGP cells with pMX-GFP and pCM-VSV-G 
vectors 
The packaging PlatGP cell line cells were transfected with pMX-GFP and pCM-
VSV-G vector using FuGENE
®
 HD Transfection Reagent carrier. This carrier  
is composed of lipids and other components which form a complex with DNA. It has 
high transfection efficiency and very low cytotoxicity. Before transfection  
all reagents and DNA were adjusted to the room temperature. First, 6µg pMX-GFP 
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DNA and 3µg pCMV-VSV-G was diluted with 300µl high glucose DMEM (without 
serum, antibiotics and fungicides). The transfection complex was formed  
by adding 27µl FuGene® to the diluted DNA followed by incubation for 15 minutes 
at room temperature. After that time, PlatGP cells at 80% confluence were 
transfected. The transfection complex was added to the cell culture medium drop-
wise. Flasks were swirled to ensure the even distribution of the transfection complex 
in the flasks. After 48 hours the supernatant from the flask was collected and 
centrifuged at 500xG for 10 minutes to eliminate any cell debris. Collected 
supernatant was snap frozen in liquid nitrogen and stored at -80°C until required. 
2.2.5.3. MG63-GFP cell line 
For generating an osteoblast cell line with stable expression of green fluorescent 
protein (GFP), MG63 cells were transduced with retroviral vector containing GFP 
insert. MG63 cells were thawed, plated in 75cm
2
 flask and cultured in standard 
conditions for 48 hours before proceeding with retroviral transduction. On the day of 
transduction, cell morphology and confluence were assessed using an Axiovert 25 
microscope. Retroviral vectors and 'Polybrene' were thawn on ice. After aspiration  
of the cell culture medium, 900µl supernatant was mixed with 7.2µl Polybrene and 
added to flask with MG63 cells. Transduction was conducted under standard 
conditions for 2 hours. To ensure even distribution of transduction  mix, the flask 
was gently rocked every 15 minutes. After transduction, 15ml complete medium was 
added to the flask and changed after 24 hours. In addition, mock-treated control 
group was included where retroviral supernatant was substituted with  
900µl of serum free DMEM. Transduced and non-transduced cells were trypsinised 
at 70% confluence as described in paragraph 2.2.2. Before counting cells were 
passed through 40µm cell strainer. Subsequently, cells were sorted with  
FACS Aria III (BD Biosciences, Franklin Lakes, USA). For acquisition and analysis 
manufacturer software BD FACSDiva version 6.1.3 was used followed by histogram 
analysis using non-commercial software Cyflogic version 1.2.1 (CyFlo Ltd., FI). 
After analysis, single cell cultures from a positive cell population were seeded  
in 96-well plates to obtain pure MG63 colonies expressing GFP. For proliferation  
or osteogenic differentiation cells were maintained in the same conditions as MG63 
(paragraph 2.2.1.4). 
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2.2.6. Monolayer cell culture of cells from different origins 
For the study comparing the osteoblast cells from different origins, cells from 
human, bovine and ovine bone, SaOs2, MG63 and MC3T3E1 cells were cultured  
in 6 or 24 well plates on the Thermanox® discs (Nunc, Rochester, NY). To assess 
matrix mineralisation, alkaline phosphatase activity and mRNA expression  
of osteoblast specific genes cells were plated at a density of 5000 cells per cm
2
  
in 6-well plates on 25 mm Thermanox discs and cultured in cell differentiation 
medium specific for the each cell type (Tab.2.2) by 21 days. Samples for analysis 
were collected at day 1, 7, 14 and 21. Cells for the growth assay ('CellTiter Blue') 
were seeded at a density of 10000 cells per cm
2
 in 24 well plates on 13mm diameter 
Thermanox
®
 discs and cultured in growth medium specific for each cell type  
as described above (Tab.2.2).   
In the study comparing cells differentiation in different cell culture models, 
monolayer cultures of MSC or MG63 cells were made by plating 20000 cells per cm
2
 
in 24-well plates. Subsequently, 500µl differentiation or growth medium was added 
to each well. At day 2, 7, 14 and 21 of cell culture samples were collected for ALP 
activity, DNA content quantification and mRNA expression analysis of genes 
specific for differentiation. 
2.2.7. High density culture (micromass) of MSC 
The high density culture was used for a single cell type culture and co-culture 
experiments. In single cell type culture, micromass was produced by suspending 
200000 cells in 10μl of growth medium consisting of low glucose DMEM, 10% FBS 
and 1% Penicillin-Streptomycin. This volume was placed in the middle of 24-well 
plate. Then, approximately 50μl of medium was placed around the well edge  
and samples were incubated for 3 hours in incubator to let micromass attach. After 
that time, additional 500μl of differentiation or growth medium was added. At day  
14 of the cell culture, samples were collected for ALP activity, DNA content 
quantification and mRNA expression analysis of genes specific for differentiation.  
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2.2.8. Cell culture in type I collagen-hydroxyapatite gel 
All solutions used for the gel preparation were at 4°C and the preparation was carried 
out on ice. To prepare 1ml type I collagen gel, 320µl DMEM and 50µl 10xPBS were 
mixed in 50ml tube. Then, 833µl type I collagen gel was added and mixed with other 
constituents by slow pipetting. Subsequently, the pH was elevated by adding  
30µl 1N NaOH and mixed. The final concentration of prepared gel was 2.5mg type  
I collagen per ml and pH ~7. In order to stabilise gel when culturing with cells  
and prevent shrinkage as well as cell dropping through the gel, the hydroxyapatite 
(HAP) was added before gelation. Several HAP concentrations (0.2-1.25mg HAP per 
1 ml type I collagen gel) were tested. As a result, 1mg HAP per 2.5 mg type  
I collagen (CHAP) per ml was used.  
Collagen type I-hydroxyapatite (CHAP) gel was applied for the cell culture.  
The expanded and harvested cells were centrifuged and counted. Then, the desired 
amount of cells was re-suspended in small volume of DMEM containing 
hydroxyapatite particles. Type I collagen gel was prepared as described above.  
The volume of DMEM used in gel preparation was subtracted by the volume used 
for the cell re-suspension to ensure that the final concentration of type I collagen gel 
is 2.5mg/ml. This mixture containing cells was transferred to the tube containing 
type I collagen and mixed by slow pipetting. After ensuring uniform distribution 
within the CHAP, 250μl CHAP with cells were transferred into a well of 24-well 
plate. One million of cells were used per ml of CHAP. Thus, one sample contained 
250000 cells in 250μl CHAP. Samples were incubated for an hour at 37°C  
for gelation to occur, before adding 500μl medium.  
2.2.9. Stimulation of MSC cells with different factors 
Expanded MSC were harvested, counted and plated at a density of 15000 cells  
per cm
2
 in cell culture polystyrene flasks and cultured in DMEM supplemented with 
10% FCS and 1% Penicillin-Streptomycin overnight at 37˚C with an atmosphere of 
5% CO2 and 95% humidity. Two experimental designs for cell stimulation were 
applied. The schematic presentation is presented on figure 2.3. 
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On the day of stimulation, medium was aspirated and fresh medium containing 
10ng/ml IL1β, 100ng/ml SCF, 100ng/ml GCSF or 1μg/ml SDF1 was added.  
For negative controls, cells were kept in medium without any factor. After 2 hours, 
medium was aspirated and cells were washed with PBS to ensure complete removal 
of the factors. For the following 48 or 72 hours, cells were cultured in fresh DMEM 
supplemented with 1% pen/strep (Fig.2.3B) and, in part of the experiments,  
10% FBS (Fig.2.3A). 
 
Figure 2.3. Outline of stimulation experiments and analysis. A: 24 hours after plating MSC 
cells were stimulated with 10 ng/ml IL1β, 100 ng/ml SCF, 100 ng/ml GCSF or 1 μg/ml 
SDF1 for 2 hours. After that time fresh medium with 10% FBS and 1% Penicillin-
Streptomycin was added to cells. Gene expression analysis was performed 72 hours later. B: 
24 hours after plating MSC cells were stimulated with 10 ng/ml IL1β or 100 ng/ml SCF. 
After stimulation, cells were maintained in DMEM with 1% Penicillin-Streptomycin for 48 
hours before conditioned medium collection.  
2.2.10. Conditioned medium collection 
Medium conditioned for 48 hours by stimulated or unstimulated cells was collected 
and centrifuged at 1000g at 4°C for 20 minutes to remove any cell debris. 
Subsequently, supernatant was transferred into fresh tubes and stored until required 
at -20°C.   
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2.2.11. Indirect co-culture of cells 
2.2.11.1. Monolayer co-culture of cells  
Indirect co-culture of cells in ML was set up in 24-well plates (BD Falcon, Belgium) 
and inserts (tissue culture treated polyethylene tetphthalate-PET membrane  
with 0.4µm pore size) and MM in 24-well plates (TPP, Switzerland). The expanded 
and harvested MSC and MG63 cells were centrifuged and counted. Twenty thousand 
cells per cm
2
 were seeded onto the insert membrane and companion tissue culture 
plate according to the design presented in table 2.3. Five hundred microliter  
of differentiation (DMEM DM) or growth (control; DMEM GM) medium was added 
to each well, whereas 300μl of media were applied into each insert. Medium  
was changed every 2-3 days. Samples were harvested at day 14 for ALP activity  
and DNA quantification assays; and at day 21 for the gene expression analysis. 
 
Table 2.3. Experimental groups and configuration of cells used in monolayer co-culture 
study. MSC – bone derived mesenchymal stem cells; MG – MG63 cells; DM – 
differentiation medium; GM – growth medium. 
2.2.11.2. Micromass co-culture of cells 
The procedure of micromass cultures preparation was similar as described  
in paragraph 2.2.7 with the exception of cell number used. Table 2.4 summarises  
the subdivision of the experimental groups. Cultures were prepared in 24 well plates 
(TPP, Switzerland). Briefly, micromass’ made of 100000 cells of MSC or MG63 
cells per 5μl were prepared. To each well 500μl of differentiation (DMEM DM)  
or growth (control; DMEM GM) medium was added. Medium was changed every  
2-3 days. Samples were harvested at day 14 for ALP activity, DNA content assay 
and at day 21 for gene expression, 
45
Ca incorporation and DNA content analysis. 
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Table 2.4. Experimental groups and configuration of cells used in micromass co-culture 
study. MSC – bone deriver mesenchymal stem cells; MG – MG63 cells; MG+MSC – co-
culture of MG63 and MSC; DM – differentiation medium; GM – growth medium 
2.2.11.3. Co-culture with conditioned medium 
Human bone marrow MSC were expanded and plated in monolayer on Thermanox® 
discs at a density of 20000 cells per cm
2
 for differentiation and 5000 cells per cm
2
 for 
proliferation analysis. For differentiation, cells were maintained in medium 
consisting of conditioned medium collected from MSC cells stimulated with IL1β, 
SCF or unstimulated cells mixed with control or osteogenic medium in 1:1 ratio. 
Control medium contained DMEM low-glucose supplemented with 1% FBS  
and 1% Penicillin-Streptomycin. Osteogenic medium was composed of the control 
medium supplemented with 100µg/ml ascorbic acid salt, 20nM dexamethasone  
and 10mM glycerol-2-phosphate. Medium was changed twice per week.  
For the analysis of cell proliferation cell samples were harvested at day 2, 4, 7  
and 10. Osteogenic differentiation was assessed at day 7 and 14 by gene expression 
and ALP activity, and at day 28 by Alizarin Red S staining and quantitation.  
2.2.12. Determination of cell number and proliferation 
2.2.12.1. Manual cell counting 
In order to determine cell number and distinguish between viable and nonviable cells 
the Trypan Blue exclusion method for cell counting was used. This method is based 
on the principle that live cells having intact cell membrane exclude this diazo-dye, 
whereas the dye transverses the membrane of dead cells. As a result, viable cells 
have clear cytoplasm and nonviable cell is as a distinctive blue colour under  
a microscope. Manual cell count was performed during passaging of cells, freezing 
of cells or cell seeding for an experiment. For cell counting, 20µl cell suspension was 
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mixed with 20µl of Trypan Blue before filled into the chamber of a Neubauer 
haemocytometer. Using a bright field microscope (Carl Zeiss AG, Oberkochen, 
Germany) cell count was performed. Unstained cells were counted within each  
of the four corner squares. Cells located on the top and left-hand lines of each square, 
whereas those on the bottom or right-hand lines were included in the counting.  
Cell number was calculated using the following formula: 
                             , 
where n - average number of cells per square, d – dilution factor, v – total volume  
of cell suspension. 
2.2.12.2. Hoechst assay 
The method is based on the enhancement of fluorescence seen when bisbenzimide 
(Hoechst 33258) binds to the minor groove of DNA. Crude homogenates in which 
chromatin has been dissociated with high salt buffer can be assayed directly in a few 
minutes. The dissociation of chromatin is critical to accurate determination  
of DNA in biological materials. The fluorescence of Hoechst 33258 is related  
to the AT content of a DNA sample, so it is very important to use a standard similar 
to the sample under investigation. The calf thymus DNA standard is double-stranded, 
highly polymerized, and it has an approximate content of 60% AT (40% GC). 
The DNA was assessed in samples digested in Proteinase K solution, which consists 
of 0.5mg proteinase K per ml of PBS containing 3.36g/L disodium-EDTA with 
pH6.5. Before overnight incubation of samples with proteinase K solution, samples 
were washed with PBS. Plates sealed with parafilm and wrapped in aluminium foil 
were incubated overnight at 56°C. Then, samples were transferred into a 1.5ml tubes 
and stored at -20°C until further analysis. The determination of DNA content  
for all samples from one experiment was performed at the same time.  
Calf thymus DNA was used as a standard to determine DNA content in samples.  
For this, 2-fold dilutions of the DNA ranging from 0.39 to 12.5μg/ml were made  
in PBS containing 2M NaCl (DPBS). Forty microliters of each sample, standard  
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and blank were pipetted in duplicates into a white opaque 96 well plate (Falcon® 
Becton Dickinson Labware, France). Then, 160μl of assay solution containing 
0.1µg/ml Hoechst 33258 in DPBS were added into each well. Plate was wrapped  
in aluminium foil and incubated for exactly 20 minutes at room temperature.  
The fluorescence values were measured (excitation/emission: 360/465 nm) using  
a Multilabel Counter Wallac 1420 (Perkin Elmer). The results were calculated  
by averaging fluorescent values of the samples and subtracting average value  
of blank. The amount of DNA was calculated from the equation defined by a linear 
standard curve vs DNA amount (μg/ml).   
2.2.12.3. Cell Titer-Blue®  assay 
The assessment of cell accumulation was performed using the Cell Titer-Blue
®  
Assay. This method is based on the ability of viable cells to metabolically reduce 
resazurin (indicator dye) into highly fluorescent resorufin (Czekanska, 2011). Cells 
were seeded at the density 5000 cells per cm
2
 in 24 well plates. Cell number  
was evaluated every 24 hours up to 10 days. At each time point, the media  
was aspirated from 4 wells and the samples were subsequently washed with  
0.1M phosphate buffered saline (PBS) solution. After rinsing, 350µl of fresh medium 
containing a 10% solution of Cell Titer-Blue
®  
were added to the wells. Three no cell 
control wells were included. Culture plates were wrapped in aluminium foil  
and incubated at 37˚C with an atmosphere of 5% CO2 and 95% humidity.  
The incubation time was 4 hours for MC3T3E1, bovine and ovine osteoblast cells 
and 2 hours for HOb cells. For the optimisation of incubation time see Appendix 1. 
After incubation, 150µl aliquot of each sample and media with dye alone, were 
transferred to a white opaque 96 well-plate (Falcon® Becton Dickinson Labware, 
France) in duplicate. Subsequently, the fluorescence values of samples were 
measured (excitation/emission: 560/590 nm) using a Multilabel Counter Wallac 1420 
(Perkin Elmer, US). The results were calculated by averaging fluorescent values  
of the samples and subtracting average value of samples without cells. Cell number 
at each time point was calculated using the equation defined by a standard curve 
generated from fluorescence values obtained from known number of cells. 
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2.2.13. Determination of cell viability 
Viability of cells cultured in type I collagen-hydroxyapatite gel was assessed with 
fluorescent dyes, calcein AM and ethidium homodimer-1 which allow  
to discriminate between live and dead cells. Calcein AM, acetomethoxy derivate  
of calcein, is an indicator of live cells. After the transport through the cellular 
membrane into live cells, intracellular esterases remove the acetomethoxy ester 
group from dye molecule. Liberated calcein gives strong green fluorescence  
at excitation and emission wavelengths of 495/515nm. Ethidium homodimer  
is a membrane-impermeable fluorescent dye with excitation/emission maxima  
at 528/617nm. It has a high nucleic acid binding affinity and upon binding to DNA 
emits strong red fluorescence. 
Before staining with fluorescent dyes, CHAP gels were washed twice with PBS. 
Second washing was performed for 5 minutes. During that time dyes were mixed 
with DMEM in light shield tube to obtain working solution containing  
10ng/ml calcein and 1ng/ml ethidium homodimer-1. Gel was incubated with working 
solution for 20 minutes at room temperature followed by 10 minutes incubation  
at 37°C. For the incubation, plate containing gel was covered with aluminium foil  
to avoid exposure to light. After incubation, working solution was aspirated and fresh 
medium was added to the samples. Labelled cells within the gel were visualised with 
Axiovert 200 M microscope (Carl Zeiss AG, Oberkochen, Germany).  
2.2.14. Alkaline phosphatase activity 
2.2.14.1. Staining 
Qualitative alkaline phosphatase activity measurement was performed using 
Leukocyte Alkaline Phosphate Kit. It consists of naphthol AS-MX phosphate  
and fast violet B salt (4-Amino-5-methoxy-2-methylbenzanilide diazotated zinc 
double salt). By the action of Alkaline Phosphatase (ALP) the phosphate group  
is hydrolysed and liberated naphthol AS-MX and reacts with a diazonium salt 
forming an insoluble blue pigment at sites of phosphatase activity. The concentration 
and intensity of this pigment reflect the activity of the enzyme. 
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The Fast blue dye solution (dissolved fast blue salt from one tablet in 48ml deionised 
water and 2 ml Naphthol AS-MX) was prepared according to the manufacturer 
protocol. Prior to fixation, samples (n=4) were washed three times with 0.1M PBS 
solution and then fixed in 90% ice cold ethanol for 4 minutes. Then, samples were 
washed three times with deionised water. Fast Blue dye solution was added 
subsequently to three dishes. At each time point one sample was included  
as a negative control that was incubated with the dye and 10mM tetramisole 
hydrochloride (Sigma, UK). All samples were wrapped in aluminium foil and 
incubated for 1 hour at room temperature. After incubation, samples were washed 
three times with deionised water and visualised with Axiovert 200 M microscope 
(Carl Zeiss AG, Oberkochen, Germany). 
2.2.14.2. Quantification 
Samples (n=4 per time point) were washed three times with PBS and cell layers were 
extracted with 0.1%Triton-X in 10mM Tris-HCl pH 7.4 for 1 hour at 4˚C  
on a gyratory shaker. Then samples were transferred into tubes and frozen until 
required.  
Prior to analysis, samples were thawed and stored at 4˚C for 30 minutes. Then,  
250µl 1.5M alkaline buffer pH 10.3 (2-amino-2-methylpropano), 50µl phosphate 
substrate solution (4-nitrophenyl phosphate disodium salt hexahydrate) were added 
into the tube. For part of this study (chapter 3), 100µl deionised water followed by 
100µl sample were added into the reaction mixture. Otherwise, 200µl cell lysate 
were pipetted into each tube. The mixture was mixed and incubated  
for 30 minutes at 37˚C in a heated block. The reaction was stopped by adding  
500µl 0.1M NaOH. The standard curve was prepared by using serial dilutions  
of 1mM p-nitrophenol in 0.1%Triton-X in 10mM Tris-HCl added to the mixture 
instead of the unknown sample and incubating for 15 minutes at 37˚C. The absor-
bance of 250µl standard and samples were measured at 405nm in duplicates  
on a Multilabel Counter Wallac 1420 (Perkin Elmer, US). The standard curve was 
prepared and sample values were calculated as nM p-Np per minute per µg of protein 
or nM p-Np in 30 minutes per µg DNA. 
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2.2.15. Determination of calcification 
2.2.15.1. Alizarin Red S  
2.2.15.1.1. Staining 
Qualitative mineralisation was performed using 40mM Alizarin Red S dye at pH4.1-
4.3. Prior staining cell cultures were washed twice with PBS followed by fixation 
with 4% paraformaldehyde for 15 minutes. After that time, samples were washed 
with deionised water for 5 minutes and this step was repeated two times. 
Subsequently, 250μl per cm2 of 40mM Alizarin Red S solution was added into each 
sample. Samples were covered with aluminium foil and incubated for 1 hour at room 
temperature on a rotating plate. After incubation, samples were washed five times 
with deionised water and stored at 4˚C for until required for image analysis 
performed on Axiovert 200 M microscope (Carl Zeiss AG, Oberkochen, Germany). 
2.2.15.1.2. Quantification 
After staining, calcium-bounded Alizarin Red S dye was quantified. As a standard 
Alizarin Red S dye in concentration range from 0.47μM to 30μM. Serial dilutions 
were prepared from 40μM stock solution used for staining of samples. Alizarin Red 
S was diluted with 'standard solution' composed of 10% ammonium hydroxide  
and 10% acetic acid (1:4).  
 For this, stained samples were incubated for 30 minutes at room temperature with 
10% acetic acid. Subsequently, the loosely attached monolayer with acetic acid  
was transferred into 1.5ml Eppendorf tube which was later sealed with parafilm. 
After incubating at 85˚C for 10 minutes, samples were placed on ice for 5 minutes. 
Next, samples were centrifuged at 20000g for 15 minutes. The supernatant  
was transferred into a new tube and 120µl 'standard solution' was added to each 
sample to neutralize the acetic pH to 4.1-4.5. One hundred and fifty microliters  
of 'standard solution' used as blank, standard and samples were transferred into 
transparent 96-well plate in duplicates. The absorbance was read at 405nm  
on a Multilabel Counter Wallac 1420 (Perkin Elmer, US). The concentration  
of bounded-Alizarin Red S in samples was determined using the equation defined  
by standard curve. 
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2.2.15.2. Radioactive calcium incorporation 
Biosafety procedures level II was followed at all the times during the procedures. 
Medium from samples was aspirated and samples were washed with PBS. Three 
hundred microliter  medium containing 1.25µCi 45Ca per ml was pipetted per each 
sample in 24-well plate. Then, plates were carefully wrapped in aluminium foil  
and incubated overnight at 37°C in cell culture incubator. The following day, 
samples were transferred in the radioactivity hood (cabinet) and medium  
was removed. After rinsing with PBS, 500μl 70% formic acid were added into each 
well. The plate was wrapped in parafilm and aluminium foil and incubated at 65°C 
for 60 minutes. The plate was then stored at room temperature within the laminar 
flow. After 2 days of incubation, the whole volume of formic acid from each well 
was transferred into a scintillation tube and 3.5 ml of scintillation fluid was added. 
Samples were mixed and placed into the scintillation counter rack. Scintillation  
was measured with WinSpectral 1414 Liquide Scintilation Counter (Perkin Elmer, 
US). The amount of incorporated calcium was expressed in counts per minute  
and made relative to total DNA amount. 
2.2.16. Molecular biology 
2.2.16.1. RNA extraction 
The RNA isolation was performed by combination of the traditional single step 
method based on TRI reagent and RNeasy Mini-Kit. Since its introduction  
by Chomczyński and Sacchi the TRI-reagent is the most effective method  
of extraction a whole spectrum of RNA molecules (Chomczynski and Sacchi, 1987). 
The TRI reagent solution consists of combination of phenol and guanidine 
thiocyanate in a mono-phase solution that inhibits RNase activity. Using the spin 
column with silica-based membrane as an additional step allow to obtain a high 
quality of RNA (>200 bases).  
At specific time points, the RNA isolation started with the removal of the culture 
medium from the cells. One millilitre of TRI reagent was added to each well  
to perform lysis of cell monolayer. Samples were incubated with the reagent  
for 2 minutes at room temperature (20-23°C) and cell lysis was completed  
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by repetitive pipetting. Then, the cell lysate was transferred to an RNase-free 
Eppendorf tube containing 5µl of Polyacryl Carrier, which consists of acryl polymer 
facilitating the isolation of small amounts of RNA. The cell lysate was mixed with 
Polyacryl Carrier by repetitive pipetting and subsequent shaking on Vortex-2 Genie 
Shaker. Next, the 100µl 1-bromo-3-chloro-propane was added to the samples  
and they were immediately shacked vigorously for approximately 30 seconds  
and incubated for 15 minutes at room temperature to achieve phase separation.  
To complete this process the incubation was followed by centrifugation at 12000xG 
for 15 minutes at 4˚C (5417R Eppendorf, DE). In phase separation process  
the homogenate separates into three phases: aqueous containing RNA, interphase 
with DNA and organic phase were proteins are present. After centrifugation,  
the tubes were collected very carefully and about 270µl of aqueous phase of each 
sample were transferred into new 1.5ml RNase-free Eppendorf tube and an equal 
volume of 75% ethanol was added to the aqueous phase. Then the RNA precipitate 
was transferred to RNA binding column and centrifuged for 25 seconds at 8000xG. 
The collected ethanol was discarded. Subsequently, the Qiagen protocol for RNeasy 
Mini-Kit was followed. The 700µl RW1 buffer contained within the Qiagen kit was 
applied to the column and it was centrifuged for 25 seconds at 8000g. The flow 
through was discarded and 500µl RPE wash buffer containing ethanol was applied to 
the column and centrifuged as previously. Once completed, the flow through  
was discarded and again, 500µl RPE wash buffer was added to the column.  
To ensure complete buffer penetration of the membrane, samples were stored  
at room temperature for 2 minutes. This was followed by the centrifugation  
for 2 minutes at 8000xG. Then, to prevent the ethanol carryover, the column  
was transferred to a new 2 ml collection tube and centrifuged for 1 minute  
at 12000xG. Finally, the column was transferred to a 1.5ml collection tube and  
30µl RNA-free water was applied directly to the membrane and column was 
centrifuged for 1 minute at 8000xG. Upon completion, the eluted RNA was 
transferred to RNase free 1.5ml tubes. Samples were then stored at -80°C until 
required.  
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The purity and amount of the RNA was assessed using 260/280 ratio and 260/230 
ratio using the NanoDrop system (Witec Gmbh, Germany) and associated software. 
Samples were then stored at -80°C until required. While the first ratio determines  
the amount of nucleic acids versus protein in the sample, the second one describes 
the amount of nucleic acids versus salts in the sample. For pure RNA both ratios  
are expected to be about 2.0. 
2.2.16.2. DNase digestion and clean-up. 
Samples designated for analysis with RT
2 
PCRArray were treated with RQ1 (RNA-
Qualified) RNase-Free DNase to ensure very high quality of RNA samples. DNase I 
RQ1 RNase-Free DNase is an endonuclease enzyme that degrades both double-
stranded and single-stranded DNA, producing 3´-OH oligonucleotides.  
The protocol of DNase digestion reaction for 1µg RNA encompassed 1μl RQ1 
RNase-Free DNase 10X Reaction Buffer, 1U/μg RNA RQ1 RNase-Free DNase and 
1μg RNA. At the end, the reaction mix was completed with nuclease-free water to a 
final volume of 10μl. The reaction was performed at 37°C for 30 minutes. After the 
incubation, the reaction was terminated by adding 1μl RQ1 DNase Stop Solution and 
subsequent inactivation of DNase at 65°C for 10 minutes. Then, the enzyme  
and buffer components were removed with on-column RNA Clean-Up protocol. 
Briefly, samples were diluted with RNase-free water to 100μl and then, 350μl RLT 
Buffer was added. Diluted samples were mixed with 250μl ethanol (100%).  
The mixture was transferred to RNA binding column and centrifuged for 30 seconds 
at 8000xG using 5415R centrifuge (Eppendorf, Germany). The collected flow-
through was discarded and 500µl RPE wash buffer containing ethanol was applied  
to the column and centrifuged. From this point, the protocol described in previous 
paragraph 2.2.16.1 was followed.  
2.2.16.3. Reverse transcription 
Two protocols of reverse transcription were applied within this study. The reverse 
transcription for most of the samples was performed using "Multiscribe™ Reverse 
transcriptase", which is a recombinant Moloney murine leukemia virus (rMoMuLV) 
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reverse transcriptase that uses single-stranded RNA as a template in the presence  
of a primer to synthesize a complementary DNA (cDNA) strand.  
For each reaction, between 0.5 and 1μg of isolated RNA was used in 20μl reaction. 
First, the non-enzymatic components were mixed in RNase free tube. This included 
2.0µl 10x TaqMan RT Buffer (PCR Buffer II), 4.4µl 25mM Magnesium chloride, 
4.0µl deoxy nucleotide triphosphates mixture (dATP, dCTP, dGTP, dTTP; each 
25mM), and 1.0µl Random Hexamers (50µM). The mixture was briefly vortexed 
before adding 0.4μl RNase inhibitor (20U/µl) and 0.5μl Multiscribe Reverse 
Transcriptase (50U/µl). The mixture was carefully mixed by inverting the tube. 
Then, the appropriate volume of total RNA sample was added. Lastly, the reaction 
mixture was made up to 20μl by adding RNase free water. The reaction was 
performed in a GeneAmp 5700 SDS instrument (Applied Biosystems, US)  
at 10 minutes at 25°C for primer incubation, 30 minutes at 48°C for reverse 
transcription, and 5 minutes at 95°C for reverse transcriptase inactivation. When 
reaction was completed, 20-60μl Tris-EDTA buffer was added to stabilise the pH of 
the cDNA in thawed samples. Samples were then stored at -20C until required. 
A different protocol for reverse transcription was used for samples undergoing gene 
expression analysis with RT² Profiler™ PCR Array. For these samples, cDNA was 
prepared using RT
2
 First Strand Kit containing genomic DNA elimination  
and reverse transcription reagents. Before the reactions, RNA concentration and 
purity was checked using NanoDrop spectrophotometer. To eliminate genomic DNA 
0.5μg RNA sample was mixed with GE Buffer and supplemented with RNase-free 
water up to 10μl. Then the reaction was performed at 42°C for 5 minutes  
and followed by immediate termination at 4°C for 5 minutes. Samples were then 
placed on ice for subsequent steps. Ten microliters of the reverse transcription mix 
used for one reaction contained 4μl 5x buffer BC3, 1μl control P2, 2μl RE3 Reverse 
transcriptase mix and 3μl RNase-free water. This RT mixture was added to tube 
containing 10μl genomic DNA elimination – RNA mix. The reverse transcription 
was performed in a GeneAmp 5700 SDS instrument at 42°C for 15 minutes and then 
immediately stopped by the incubation at 95°C for 5 minutes. After the competition, 
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the obtained cDNA was diluted with 91μl RNase-free water and stored at -20°C until 
required.  
2.2.16.4. Real-Time PCR 
For the gene expression analysis two systems of cDNA amplification were applied; 
DNA-binding agent (Sybr Green) and hydrolysis probes (TaqMan© probes). 
Sybr Green is a fluorescent intercalating agent which upon binding to double 
stranded DNA emits a strong fluorescent signal that is proportional to the amount  
of double stranded DNA present. This method was used in the study comparing 
different cell models. The primers for alkaline phosphatase (ALP), Osteocalcin (OC), 
Runx2/Cbfa1, collagen type I (COLI), Sp7 and housekeeping gene 18S rRNA were 
purchased from Mycrosynth (Tab.2.5). The procedure optimising primer 
concentration was carried out to determine the minimum primer concentrations 
giving the lowest threshold cycle (CT; the cycle in which there is a significant 
increase in reporter signal above the threshold) and the maximum ΔRn  
(the magnitude of the signal generated by the given set of PCR conditions) while 
minimising nonspecific amplification. For each gene, reactions with different 
concentrations of forward and reverse primer were performed. Nine conditions were 
tested with mixed concentration (200, 400 and 800nM) of primers. Based  
on the results the concentration of 400nM was chosen as optimal for both primers. 
In addition, the primer concentration was tested for the amplification efficiency using 
a diluted template from a positive control of osteoblast cells cultured  
in differentiation medium. This point is important for the direct comparison  
of CT values between the target gene and the reference gene (relative quantification). 
The amplification efficiency of both, the target and reference gene, should be close  
to 100% and not different than ±10%. The efficiency was calculated from the linear 
regression curve of concentrations against the logarithm of dilution (Appendix 2). 
The Real-Time PCR reactions were performed in AB 7500 thermocycler (Applied 
Biosystems, US). Duplicate reactions were performed for each sample. The reaction 
mixture for one 20μl reaction contained 10μl Power SybrGreen PCR Master Mix, 
Chapter 2: Materials and methods 
72 
 
0.4μl forward and reverse primer (final concentration of 400nM), 7.2μl RNasy free 
water and 2μl cDNA template. Reaction mixture was transferred into flat deck 
thermo-fast 96 detection plates (Thermo Scientific, UK) and sealed with optical clear 
adhesive seal sheets (Thermo Scientific, UK). As a negative control one sample with 
all reagents but without template was included for each primer set. Plate was 
centrifuged for 2 minutes in a Rotanta 46 plate centrifuge (Hettich, CH) to ensure  
all reaction mixture was at the bottom of each well. After transferring to an Applied 
Biosystems 7500 thermocycler the plate was incubated for 10 minutes at 95°C  
for AmpliTaq Gold polymerase activation and then 40 cycles of PCR reaction were 
run at 95°C  for 15 seconds and 60°C for 1 minute. To confirm the absence  
of nonspecific amplification a dissociation curve was generated (60-95°C for 20 
minutes). 
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Table 2.5. Primer sequences used for real-time PCR with SybrGreen method. 
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In chapter 4, 5 and 6 gene expression was analysed with TaqMan probes method.  
In addition to primers, additional oligonucleotide-probe is included in the reaction. 
This probe contains both a reporter and a quencher dye attached. During real time 
PCR reaction probe is cleaved by the 5´ nuclease activity of the Taq DNA 
polymerase which generates a fluorescent signal that increases with each binds to the 
amplicon during each annealing step of the PCR.  
Primers and probe for Runx2, OC, type I collagen, Sp7 were purchased from 
Mycrosynth, CH (Tab.2.6). Primers and probes for 18S rRNA (4310893E),  
RPL13a (Hs_01926559_g1), ALP (Hs00758162_m1), Sox9 (Hs00165814_m1), 
interleukin-6 (IL6; Hs00985639_m1), interleukin-8 (IL8; Hs00174103_m1), 
interleukin 10 (IL10; Hs00961622_m1), TNFα (Hs01113624_g1),  
Wnt3a (Hs00263977_m1), Wnt4 (Hs00229142_m1), Wnt5a (Hs00998537_m1), 
Wnt7b (Hs00536497_m1), βcatenin (Hs00170025_m1), Sox9 (Hs00165814_m1) 
were bought from Applied Biosystems as 'Assay On Demand' (no sequences 
provided). The optimal concentration for primers and probe (Tab.2.6) and primer 
efficiency were assessed previously by the other members of AO Research Institute 
Davos. Plates for the Real-Time PCR were prepared as described above.  
The 20μl reaction mixture included 10 μl of TaqMan Universal Master Mix,  
0.4μl forward and reverse primer (final concentration 900nM), 0.4μl probe (final 
concentration 250nM), 6.8μl RNasy free water and 2μl cDNA template. The PCR 
was run at standard conditions with 2 minutes at 56°C, 10 minutes at 95°C, followed 
by 40 cycles of 15 seconds at 95°C and 1 minute at 60°C. 
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Table 2.6. Primer and probe sequences used for real-time PCR with TaqMan method. 
2.2.16.5. Gene expression analysis with RT² Profiler™ PCR Array 
RT² Profiler™ PCR Array system was applied to analyse the expression of human 
cytokine genes. Each 96-well plate contains primer assays for 84 genes of interest 
(Tab.2.7), 5 housekeeping genes, genomic DNA control, 3 reverse transcription 
controls and 3 positive PCR controls.  
Diluted with RNase-free water cDNA samples (102μl) were thawed and mixed with 
1350μl 2xRT2 SybrGreen mastermix and 1248μl RNase-free water. Then,  
25μl reaction mix was added to each well of RT² Profiler™ PCR plate. Plate was 
sealed with the Optical Adhesive Film and centrifuged for 1 minute at 1000g  
to remove any air bubbles. The reaction was performed on StepOne Plus cycler 
(Applied Biosystems, US). Plate was incubated for 10 minutes at 95°C for HotStart 
DNA Taq polymerase activation and then 40 cycles of PCR reaction were run  
at 95°C for 15 seconds and 60°C for 1 minute. To confirm the absence of nonspecific 
amplification a dissociation curve was generated (60-95°C for 20 minutes). After  
all reactions, the same threshold was set across all PCR array runs according  
to the Qiagen's guidelines; i.e. threshold value was set above the background  
but within the lower one-third to lower one-half of the linear phase  
of the amplification plot and the CT was 20±2 for PCR positive controls  
for all arrays).  The CT values for all genes were exported to a blank Excel spread 
Chapter 2: Materials and methods 
76 
 
sheet and analysed with the SABiosciences PCR Array Analysis Web-based 
software. Average of two housekeeping genes, β-2-microglobulin and RPL13A,  
were used for calculating ΔCT. Gene expression was calculated using 2
-ΔΔC
T method. 
All genes which were ±1.5-fold different than control were considered as responsive 
to the treatment.  
 
Functional Gene Grouping 
Interferons IFNA1, IFNA2, IFNA4, IFNA5, IFNB1, IFNG 
 Interleukins 
IL10, IL11, IL12A, IL12B, IL13, IL15, IL16, IL17A, IL17B, IL17C, 
IL18, IL19, IL1A, IL1B, IL1RN, IL2, IL20, IL21, IL22, IL23A, IL24, 
IL25 (IL17E), IL27, IL3, IL4, IL5, IL6, IL7, IL8, IL9, TXLNA (IL14) 
Growth 
Factors 
CNTF, CSF1 (MCSF), CSF2 (GM-CSF), CSF3 (GCSF), FIGF 
(VEGFD), LEFTY2 (EBAF), LIF, NODAL, OSM, PDGFA, TGFA, 
THPO, VEGFA 
TGFbeta 
family 
BMP1, BMP2, BMP3, BMP4, BMP5, BMP6, BMP7, BMP8B, GDF2 
(BMP9), GDF5 (CDMP-1), GDF9, INHA, INHBA, MSTN (GDF8), 
TGFB1, TGFB2, TGFB3 
TNF 
Superfamily 
CD40LG (TNFSF5), CD70 (TNFRSF7), FASLG (TNFSF6), LTA 
(TNFB), LTB, TNF, TNFRSF11B, TNFSF10 (TRAIL), TNFSF11, 
TNFSF12, TNFSF13, TNFSF13B, TNFSF14, TNFSF4 (OX40L), 
TNFSF8 
Other 
cytokines 
ADIPOQ, FAM3B, SPP1 (Osteopontin) 
Table 2.7. Functional grouping of genes included in Human Common Cytokines RT² 
Profiler™ PCR array plate. 
2.2.17. Proteomic analysis 
2.2.17.1. Determination of protein content  
The protein content was assessed with colorimetric 'Bradford assay' based  
on the proportional binding Coomassie Brilliant blue G-250 dye to proteins. The dye 
reacts primarily with arginine residues and less with histidine, lysine, tyrosine, 
tryptophan, and phenylalanine residues. Coomassie Brilliant blue G-250 dye exists  
in three different forms: doubly-protonated (red), neutral (green) and unprotonated 
(blue) which absorbs UV at different wavelengths. Upon binding to protein the dye  
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is stable in doubly-unprotonated blue form (Amax=595nm). The concentration  
of solubilised protein in the sample is measured with a spectrophotometry  
and assessed relatively to the standard curve.  
For the assay, 4 µl sample, which was extracted with 0.1%Triton-X in 10mM Tris-
HCl pH 7.4 for 1 hour at 4˚C on a gyratory shaker, was applied in duplicates into  
a 96-flat bottom transparent well-plate. Subsequently, 196µl Bradford reagent  
was added and the plate with samples and the dye was incubated for 5 minutes  
at the room temperature. After the incubation time, the absorbance was read  
at 595nm on a Multilabel Counter Wallac 1420 (Perkin Elmer, US). The protein 
concentration in samples was determined using the equation defined by standard 
curve that was prepared with different concentrations of bovine serum albumin  
in range 0-25µg/ml. 
2.2.17.2. RayBio® human cytokine antibody array G-series 
The analysis of proteomic profile of cytokines secreted by cells was performed using 
RayBio
®
 Human Cytokine Antibody Array G-series 2000, which enables detection 
and semi quantitative evaluation of multiple cytokines present in the conditioned 
media. Specifically, 174 antibodies for various cytokines are divided within 3 glass 
slides:  RayBio
®
 Human Cytokine Antibody Array G6, G7 and G8. The overview  
of the antibody array map is presented in Appendix 3. Detection of proteins  
by RayBio
®
 Human Cytokine Antibody Array is semiquantitive and based  
on indirect Enzyme-linked immunosorbent assay (ELISA; Fig 2.4.). 
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Figure 2.4. Schematic principle of RayBio
®
 Human Cytokine Antibody Array protocol. 
Glass slide is pre-coated with different primary antibodies against specific cytokines. After 
adding samples, specific cytokines within samples binds to its antibody. After adding 
mixture of biotinylated secondary antibodies, they bind specifically to using a different 
epitope to their respective cytokine. In the following step, added Streptavidin labeled with 
HiLyte Plus Fluor 532 binds to the biotin on secondary antibody. The signal intensity can  
be obtained by a laser scanner using the Cy3 channel. Figure adapted from the User Manual 
(revised July 2, 2012) provided by RayBiotech, Inc.  
All reagents were prepared according to the supplied instructions; Wash buffers I  
and II 20X stocks were diluted with deionised water, Biotin-conjugated anti-
cytokines were mixed with 300µl 1X Blocking Buffer and Streptavidin-Fluor reagent 
was diluted with 1X Blocking Buffer to a final volume of 1500µl.  
All reagents were prepared prior to use and kept on ice while proceeding with  
the protocol.  
First, glass slides were let to equilibrate to room temperature and subsequently air-
dried for 2 hours. Next, 100µl 1X Blocking Buffer was added into each well  
and incubated at room temperature for 30 minutes to block slides. After decanting  
the blocking buffer, 100 µl conditioned media samples were added to each sub-array 
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on all three glass slides. Chambers were covered with adhesive films and arrays were 
incubated with sample at 4°C overnight with gentle shaking. Then, samples were 
aspirated from sub-arrays and washed for 2 minutes with 150µl 1X Wash Buffer I at 
room temperature. This washing procedure was repeated additional two times. Glass 
slides in the assemblies were placed in a plastic container which was then filled with 
approx. 50ml Wash Buffer I ensuring that all glass slides with chamber assemblies 
are submerged. Washing was performed for 10 minutes at room temperature with 
gentle rocking. After that time, Wash Buffer I was decanted and the washing step 
was repeated once with Wash Buffer I and 2 times with Wash Buffer II. To ensure 
the complete removal, all leftovers of the Wash Buffers were carefully aspirated with 
pipette. Then, 70µl 1X Biotin-conjugated Anti-Cytokines was added to each  
sub-array. Chambers were covered with adhesive film and incubated for 2 hours at 
room temperature with gentle rocking. After aspirating Biotin-conjugated Anti-
Cytokine reagent, each sub-array was washed 3 times for 2 minutes with Wash 
Buffer I and then with Wash Buffer II making sure to completely remove buffer 
between washes and after final wash. Next, 70µl 1X Streptavidin-Fluor was added  
to each sub-array. Chambers were covered with adhesive film and entire chamber 
assemblies were covered with aluminium foil to avoid exposure to light during  
2 hour incubation at room temperature with gentle rocking. Following careful 
removal of Streptavidin-Fluor reagent, each sub-array was washed 3 times  
for 2 minutes with Wash Buffer I and then with Wash Buffer II making sure  
to completely remove buffer between washes and after final wash. Glass slides were 
removed from the frame assemblies, placed in provided 30ml centrifuge tubes 
containing approx. 20ml Wash Buffer I and rocked at room temperature  
for 10 minutes. Wash buffer was decanted and washing was repeated once more. 
Then, glass slides were removed from the tube and gently rinsed with deionized 
water. Glass slides were placed again in the tubes and centrifuged at 1000rpm 
(Rotanta RP, Hettich, DE) for 3 minutes to remove water droplets. At last, protected 
from exposure to light glass slides were placed in laminar hood to dry. Glass slides 
were sent to THP Medical Products Vertriebs GmbH (Vienna, Austria) for laser 
scanning using GenePix 4000B Microarray Scanner (Axon Instruments; Molecular 
Devices, CA, US) and raw data processing. Background normalization  
was performed by subtracting from samples the measured value of the negative 
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control sample. Negative control spots are printed with a protein containing  
buffer and detect unspecific binding of Biotin-conjugated anti-cytokines  
and/or Streptavidin-Fluor. After subtracting background signals, measurement values 
were normalized to Positive Control which is a controlled amount of biotinylated 
antibody attracted to the glass slide. The results were expressed as n-fold signal 
intensity compared to positive control samples. For further analysis, these results 
were normalized to number of cells harvested after the collection of conditioned 
media from cells stimulated with 10ng/ml IL1β, 100µg/ml SCF or unstimulated cells. 
In order to estimate differences in protein synthesis between groups, n-fold change 
was calculated between stimulated groups and control.  
2.2.18. Immunochistochemistry 
2.2.18.1. Fixation and cryo-sectioning 
The micromass and type I collagen-hydroxyapatite samples were fixed and kept in 
70% methanol until processing. The day before cryo-sectioning, the samples were 
placed in a 5% sucrose + PBS solution, to replace the methanol. On the following 
day, samples were transferred to the tissue freezing medium (Jung Tissue Specific 
Medium) and incubated for 15 minutes at room temperature before placing on the 
specimen holder and freezing in the 'Cryostat-Microtome HM 560 MV' (Microm, 
Walldorf, Germany). After freezing, 10-12µm sections were cut. The sections were 
carefully transferred onto 'SuperFrostPlus' slides and stored at -20°C until 
immunohistochemical analysis.  
Sectioning of samples was performed by Sandra Thoeny, AO Research Institute 
Davos, AO Foundation, Davos. 
2.2.18.2. Detection of alkaline phosphatase and osteocalcin  
Cryo-sections were used to detect alkaline phosphatase and osteocalcin. Slides were 
brought to room temperature for 5 minutes and rehydrated for 5-10 minutes in 
distilled water. Endogenous peroxidase activity within sections was inactivated by 30 
minutes incubation in 0.03%hydrogen peroxide in methanol. Slides were removed 
from solution, dried and then a Dako pen was used to draw a hydrophobic border 
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around the sections to prevent them from drying during the labelling procedure. 
Subsequently, samples slides were washed twice in PBS (for 1L: 0.32g 
NaH2PO4*H2O, 1.42g Na2HPO4*H2O, 9g NaCl) containing 0.1%'Tween20' (PBS-T) 
for 5 minutes. Sections were then treated for 60 minutes at room temperature with 
horse serum, which was chosen according to the origin of the secondary antibody 
(Tab.2.8). Serum used for blocking was diluted 1:20 in PBS-T and used to mask 
nonspecific binding sides. After removing the blocking solution, the primary 
antibody was applied. The concentration and incubation times are given in Tab.2.8. 
For each sample, one slide was used as negative controls and therefore, not exposed 
to the primary antibody. The slides were washed three times in PBS-T for 5 minutes 
each, to remove non-specifically bound antibody, before incubating with  
the secondary antibody (Tab.2.8). Subsequently, 3 washes with PBS-T were repeated 
as before.  
To detect the antibody-antigen reaction the 'Vectastain ABC Elite kit mouse IgG'  
was used. The 'ABC-complex' was prepared 30 minutes before using by mixing 
960µl PBS-T with 20µl ABC-A and 20µl ABC-B solutions and kept at 4°C. Avidin, 
which binds irreversibly to the biotinylated secondary antibody, is the constituent  
of solution A, while solution B consists of the biotinylated HRP. Avidin contains 
four binding sites for biotin and can effectively enhance the signal intensity. After 30 
minutes incubation of sections with the 'ABC-complex', the slides were washed three 
times with PBS-T (5 minutes each). In the following step, sections were incubated 
with 'ImmPACT™ DAB' reagent for 4 minutes at room temperature in the dark. This 
reagent is a diaminobenzidine based peroxidase substrate which produces a dark 
brown reaction product. To stop the reaction, sections were washed with distilled 
water for 5 minutes. Before cover-slipping, sections were dehydrated in increasing 
ethanol concentrations of 50%, 70%, 96% 100% and 100% (5 minutes each).  Then, 
sections were transferred to a fume hood and incubated in xylene for 5 minutes. This 
incubation step was repeated once more, before applying Eukitt
®
, a quick-hardening 
mounting medium. Finally, sections were cover-slipped and the polymerisation  
of the moun-ting medium was facilitated by incubation of slides for 1 hour at 37°C 
on a heated stretching table (Medite Medizintechnik GmbH, Burgdorf, Germany). 
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Visualisation was performed with Axioplan microscope (Carl Zeiss AG, 
Oberkochen, Germany).  
The immunohistochemistry of samples was performed by Sandra Thoeny and Nora 
Goudsouzian, AO Research Institute Davos, AO Foundation, Davos. Technical 
assistance during visualisation was provided by Christoph Sprecher, AO Research 
Institute Davos, AO Foundation, Davos. 
Table 2.8. Specifications of blocking reagent, primary antibodies and secondary antibody 
used for immunochemistry. min- minutes, RT – room temperature. 
2.2.19. Statistical analyses 
Statistical analysis was performed with the SPSS version 19.0 and version 21.0 
(Chicago, IL, USA) software package. All data was analysed for normal distribution 
by the use of a histogram and the Shapiro-Wilk test. To assess whether variances 
between groups are equal Levene's Test. Statistical significance for normally 
distributed data was analysed with analysis of variance (ANOVA) with Games-
Howell post-hoc test and two-way ANOVA with Least Significant Difference (LSD) 
test.  
For not normally distributed data a nonparametric Kruskal–Wallis ANOVA for more 
than 2 groups was used to define the differences between groups. Subsequent 
analysis using Mann Whitney test with Bonferroni correction was performed to determine 
statistically significant group pairs. In the set of experiments where the comparison  
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was performed for only two groups of not normally distributed data, the statistical analysis 
was performed with Mann-Whitney U test. 
All results which underwent statistical analysis are displayed as means ± standard 
error (SE) of at least three independent experiments. Significance was defined  
as p ≤ 0.05. 
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3.1. Introduction 
Bone is a complex and dynamic vascular mineralized tissue with various functions.  
It serves as an attachment site for muscles and tendons, protects and supports internal 
organs and acts as storage of minerals. During foetal development, bone is formed 
via two different mechanisms, intramembraneous and endochondral ossification. Flat 
bones of the skull, sternum and maxilla are formed by the cells derived from neural 
crest through the process of intramembranous ossification. In this process, 
mesenchymal cells undergo direct transformation to osteoblast cells starting from  
the ossification centres (Aubin and Triffit, 2002). In contrast, long bones are formed 
through endochondral ossification. In this case, bone formation is preceded  
by a cartilaginous template acting as a scaffold. This tissue is then resorbed  
and replaced by mineralized matrix of bone (Shapiro, 2008;Aubin, 1998).  
In adulthood, healthy bone is subjected to a constant remodelling directed by various 
factors, pathways and mechanisms coordinating the action of bone cells.  
Since the first attempt of isolation and in vitro culture of osteoblast cells from adult 
human bone by Bard and co-workers (Bard et al., 1972), a great improvement in the 
knowledge of the biology of bone, and in particular osteoblastic cells, has been 
made. A plethora of osteoblast cell models have emerged to tackle the surge in 
research in this area and to compensate to some degree for the ever present problem 
relating to sustainable supply of primary cells from either healthy or diseased donors. 
These include cells isolated from different species (Abe et al., 2000;Bellows et al., 
1986;Cao et al., 2006;Ecarot-Charrier et al., 1983;Collignon et al., 1997), 
immortalised cell lines (Wang et al., 1999;Harris et al., 1995) malignant cell lines 
(Billiau et al., 1977;Rodan et al., 1987;Ponten and Saksela, 1967), and more recently 
induced pluripotent stem cells (Bilousova et al., 2011;Tashiro et al., 2009).  
All of these cell models are employed for the investigation of the regulation of cell 
differentiation, cytokine and hormonal regulation, synthesis and secretion of matrix 
proteins, molecular mechanisms of bone diseases, and drug pharmacokinetics. 
Nowadays, in the area of bone tissue engineering, cell culture also serves  
as an important step in biomaterial testing before in vivo evaluation. Cyto-
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compatibility and osteogenity of novel biomaterials are tested using cell culture to 
determine potential candidates for bone repair. 
Immortalised cell lines are mostly used due to their advantages, including availability 
of unlimited number of cells, ease of culturing and higher phenotypical stability 
comparing to primary cells (Kartsogiannis and Ng, 2004). Moreover, in the case  
of human derived cell lines, both normal and malignant, the concern about effects  
of species differences can be avoided (Czekanska et al., 2012).  In contrast, the 
reported drawbacks of cell line features are many (Leis et al., 1997;Grigoriadis et al., 
1985;Wang et al., 1999). One of the main issues regarding cell lines is their stage 
specific differentiation profile which essentially limits comprehensive study  
of phenotypic features of associated with primary human osteoblast cells 
(Kartsogiannis and Ng, 2004;Maes et al., 2007). Thus, their use as pre-screening  
in vitro models is somewhat limited. Furthermore, aberrations in cell mitotic 
processes limits their use in long term in vitro investigations as the lack of growth 
inhibition have negative influence on later stages of osteoblast cell phenotype 
development (Read and Strachan, 1999). Despite being characterised  
as phenotypically stable and homogeneous, previous reports suggest cell 
proliferation rate and phenotypical changes between cells from early and late 
passages (Hausser and Brenner, 2005;Leis et al., 1997;Grigoriadis et al., 1985). The 
potential  
of isolating clones from cell lines contradicts the opinion of their homogeneous 
phenotype (Wang et al., 1999;Pierschbacher et al., 1988;Lou et al., 2010). 
In the era of advanced research in pharmacokinetics for bone disease and bone tissue 
engineering there is an increasing need for the reliable and adequate cell culture 
model which would resemble as close as possible the behaviour of primary 
osteoblast cells. While it is often stated that cell lines do not fully recapitulate  
the biology of primary human osteoblasts, few comprehensive comparisons have 
been performed (Saldana et al., 2011;Pautke et al., 2004). Here, we addressed this 
problem and compared three osteoblast cell lines widely used in bone biology 
research, namely MC3T3E1, MG63 and SaOs2 by assessing the phenotypic 
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similarities and differences among those cells and primary human osteoblast cells 
during a 4 week culture period.  
3.2. Results 
3.2.1. A phenotypic comparison of osteoblast cell lines versus human 
primary osteoblasts 
3.2.1.1. Proliferation of osteoblast cell models 
No significant differences in growth kinetics were detected between (HOb)  
and MC3T3E1 cells up to day 10 (Fig.3.1). Both HOb and MC3T3E1 cells presented 
gradual increases in cell number by day 10. SaOs2 at day 8 and 10 demonstrated  
a significant 43% (p=0.017) and 61% (p=0.0001) respective increase in cell number 
compared to HOb’s (Fig.1.). Compared to HOb’s, MG63 cells demonstrated  
a sustained significant increase in cell number from day 2 to day 10 (p<0.05).   
The most significant increase was noted after 6 days when 87% (p= 0.0001) more 
MG63 cells compared to HOb’s were observed (Fig.3.1). By day 10, there was still  
a significant 53% increase (p=0.0001) in the number of MG63 cells compared  
to HOb cells.  
In addition, the differences in cell proliferation among cell lines were reported. 
Similarly as compared to HOb's, MG63 cells had a significantly greater increase  
in growth kinetics from day 2 to day 10 (p<0.05). Moreover, SaOs2 cell number was 
significantly lower than MG63 cells from by day 6 (p<0.05). At later time points  
the number of both cell types equalled. The growth kinetics of SaOs2 and MC3T3E1 
cells presented similar trend up to day 8, whereas at day 10 the 41% increase  
in SaOs2 cell number over MC3T3E1 was found at significant level (p=0.002). 
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Figure 3.1. Cell number quantification of HOb, SaOs2, MG63 and MC3T3E1 cells.  
The diagram represents the mean ± SE from three independent experiments (n=12) for each 
cell type. Data were not normally distributed: Kruskal-Wallis ANOVA was used  
for statistical analysis with statistical significance at p<0.05 (* # &: <0.05; ** ##: < 0.001); 
*: significantly different compared to HOb cell culture; #: significantly different compared  
to SaOs2 cell culture; &: statistically significant compared to MG63 cell culture. 
3.2.1.2. Alkaline phosphatase activity 
The ALP activity was qualitatively and quantitatively detected in osteoblast cells  
at day 1, 7, 14, 21 and 28. At each time point one sample was included as a negative 
control (data not shown). Representative images from three individual experiments 
performed for each cell type are shown (Fig.3.2). 
In vitro ALP activity changed in a time- and cell type dependent manner. HOb’s 
were positive for ALP from day 1 reaching maximum levels by day 14  
(1.0788 ± 0.23), which was confirmed by qualitative results (Fig.3.2&3.3). 
Compared to HOb cells, SaOs2 cells produced a significant 2.4 and 1.7-fold higher 
ALP levels at day 1 (p<0.0001) and day 7 (p=0.001), respectively. After day 7,  
the enzyme level declined in a time dependent manner, reverting by day 28  
to activity levels similar to those observed after 1 day. Interestingly, by day 28  
a significant 2-fold decrease (p=0.029) in ALP activity was observed for SaOs2 cells 
compared to HOb cells (Fig.3.2). Temporal changes in ALP activity in SaOs2 cells 
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were confirmed by qualitative results (Fig.3.2). The intensity of the labelling 
increased by day 7 and was uniform through the cell layer.  At later time points,  
the staining intensity decreased and was localised within the cell layer.  
ALP enzyme activity was significantly lower in MG63 and MC3T3E1 cells during 
the whole culturing time compared to HOb cells (p<0.05) (Fig.3.2). For MG63 cells, 
ALP activity remained at comparable levels during the 28 day culture period with 
only small areas within the monolayer becoming positively labelled for ALP.  
The enzyme activity in MG63 cells reached the maximum levels by day 28, however, 
this was still noted to be approximately 26-fold lower (p=0.00013) compared to HOb 
cells at the same time point (Fig.3.2). While a significantly lower ALP activity  
was observed for MC3T3E1 cells compared to HOb’s, similar temporal changes 
were noted. For both MC3T3E1 and HOb's, the enzyme level increased 
 by day 14 and then reached plateau (Fig.3.2). The staining for ALP corresponded 
with quantitative results, showing an increase in staining intensity by day 14 
followed by decrease at later time points (Fig.3.2). 
 
Figure 3.2. Diagram shows the mean alkaline phosphatase (ALP) activity with  
the standard error of the mean in primary human osteoblast cells (HOb) and osteoblast cell 
lines: SaOs2, MG63 and MC3T3E1 cultured in osteogenic media. For each cell type  
ALP activity was assessed as nmol pNP released per minute and normalised to protein 
content (3 experiments, n=9). Data normally distributed: one-way ANOVA with Games-
Howell. Statistical significance was determined as p<0.05 (*: <0.05; **: < 0.005; ***: 
<0.0001). 
Chapter 3: Osteoblast cell models 
90 
 
 
 
Figure 3.3. Representative micrographs of alkaline phosphatase (ALP) activity at day 1, 7, 
14, 21 and 28 in primary human osteoblast cells (HOb) and osteoblast cell lines: SaOs2, 
MG63 and MC3T3E1 cultured in osteogenic media. Scale bar 200 µm.  
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3.2.1.3. Mineral deposition within ECM of osteoblast cell models 
The visual detection of mineralisation of osteoblast cells was assessed using Alizarin 
Red S staining at day 1, 14, 21 and 28 of culture. Representative images from three 
individual experiments performed for each cell type are shown (Fig.3.4).  
The mineral deposition was detected in HOb cells from day 21 and by day 28 
(Fig.3.4). Similar to HOb, MC3T3E1 cells developed regions rich in calcium  
and by day 28 calcium deposits were detected throughout the whole cell layer. 
Mineral deposition was more scattered throughout cell layer in MC3T3E1 cells than 
in HOb cells (Fig.3.4). SaOs2 cells formed a thick cell multilayer with nodule 
mineralisation noted from day 14 to day 28. In our culture system, no positive 
staining for mineralisation was observed in MG63 cell cultures (Fig.3.4). However, 
similarly to SaOs2 cells, MG63 cells formed a thick cell layer with evident nodules 
after 14 days of culture, however, no calcium deposition within the extracellular 
matrix (ECM) was seen (Fig.3.4). 
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Figure 3.4. Representative micrographs of mineralisation at day 1, 7, 14, 21 and 28  
in primary human osteoblast cells (HOb) and osteoblast cell lines: SaOs2, MG63  
and MC3T3E1 cultured in osteogenic media. Cultures were stained with Alizarin Red S dye 
for deposited within extracellular matrix calcium. Scale bar 200 µm.  
Chapter 3: Osteoblast cell models 
93 
 
3.2.1.4. Expression of osteoblastic genes by osteoblast cell models 
To obtain a more complete insight into the phenotypic profile of different osteoblast 
cells during differentiation, the transcriptional changes of osteoblast-specific genes 
over 28 days were analysed. Gene expression for early, mid-term and late osteoblast 
specific markers was evaluated and made relative to the expression of these genes  
in HOb cells at day 1.  
The expression of the early osteoblastic transcription factor, Runx2, showed  
distinct differences in expression among the different cell types (Fig.3.5A).  
The initial mRNA expression of Runx2 was significantly higher compared to HOb 
cells at day 1 in MG63 (p=0.024) and MC3T3E1 (p=0.008) cells with 51-  
and 73-fold higher expression, respectively. The expression of Runx2 in SaOs2 cells 
was not significantly different (p=0.318) compared to HOb cells at this time point. 
However, after 21 days, a significant increase (p=0.041) in Runx2 was observed  
for SaOs2 cells compared to HOb (Fig.3.5A). MC3T3E1 cells demonstrated  
the highest upreagulation of Runx2 of all the cell types tested. Specifically,  
in relation to HOb Runx2 was significantly higher in MC3T3E1 cells day 7 
(p=0.001), 14 (p=0.005) and 28 (p=0.002). Interestingly, MG63 cells displayed  
a distinct temporal expression of Runx2 compared to HOb cells, however, these 
differences were not observed to be significant after day 7 (Fig.3.5A).   
Expression of type I collagen (COL1) is demonstrated in Fig.3.5B. Again, distinct 
temporal expression was noted between cell types. MC3T3E1 cells were noted  
to have the highest increase in COL1 expression after 1 and 7 days, however, this 
was not observed to be significantly higher compared to HOb cells (Fig.3.5B). 
Comparable levels of COL1 were observed between SaOs2 and HOb cells for day  
1-14, however, by day 21 COL1 mRNA levels were observed to significantly 
decrease by 3.5- and 5.5-fold at day 21 (p=0.001) and 28 (p=0.012), respectively 
(Fig.3.5B). With the exception of day 21, COL1 mRNA was noted to be significantly 
lower in MG63 cells after 1 (p=0.002), 7 (p=0.003), 14 (p= 0.001) and 28 days 
(p<0.001) (Fig.3.5B) compared to HOb cells. 
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SaOs2 cells displayed comparable levels of ALP mRNA levels from day1-28. 
Nevertheless, SaOs2 ALP expression was significantly higher at day 21 (p=0.018) 
compared to the other cells types studied (Fig.3.5C). MC3T3E1 cells demonstrated 
significantly lower ALP expression at day 1 compared to HOb cells (p=0.003)   
(Fig.3.5C). MC3T3-E1 ALP expression then underwent a significant 39-fold 
increase compared to HOb at day 7 This expression was maintained for 14, 21  
and 28 days (p<0.002). No significant differences were found in ALP gene 
expression between MG-63 and HOb cells (Fig.3.5C).  
Similar to ALP and type I collagen, expression levels of the late osteoblast cell 
marker, Osteocalcin (OC), remained at the similar levels in HOb cells through  
the 28 day period (Fig.3.5D). Neither MG63 nor MC3T3E1 cells demonstrated  
any significant distinctions in OC expression compared to HOb over 28 days, 
although levels were generally higher in the two cell lines.  (Fig.3.5D). While SaOs2 
cells displayed a lower OC expression over the 28 days compared to HOb, only  
OC mRNA levels at 28 days were found to be significantly lower (p=0.035) 
compared to HOb cells (Fig.3.5D).  
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Figure 3.5.A-B. Comparative real-time PCR results of Runx2 (A) and type I collagen 
(COL1; B) performed at day 1, 7. 14, 21 and 28 of culture period of primary human 
osteoblast cells (HOb) and osteoblast cell lines: SaOs2, MG63 and MC3T3E1 cultured  
in osteogenic media. Diagrams show the mean fold change in relative gene expression with 
the standard error of the mean (3 experiments, n=9). Gene expression levels were normalised 
to 18S rRNA and were made relative to expression levels in primary human osteoblast cells 
at day 1 of culture. Data not normally distributed: Kruskal-Wallis and Mann-Whitney with 
Bonferroni correction.  Statistical significance was determined as p<0.05 (*: <0.05;  
**: < 0.005; ***: <0.0001). 
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Figure 3.5.C-D. Comparative real-time PCR results of ALP (C), osteocalcin (OC; D)  
performed at day 1, 7. 14, 21 and 28 of culture period of primary human osteoblast cells 
(HOb) and osteoblast cell lines: SaOs2, MG63 and MC3T3E1 cultured in osteogenic media. 
Diagrams show the mean fold change in relative gene expression with the standard error  
of the mean (3 experiments, n=9). Gene expression levels were normalised to 18S rRNA  
and were made relative to expression levels in primary human osteoblast cells  
at day 1 of culture. Data not normally distributed: Kruskal-Wallis and Mann-Whitney with 
Bonferroni correction.  Statistical significance was determined as p<0.05 (*: <0.05;  
**: < 0.005; ***: <0.0001). 
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3.3. Discussion 
Within last few decades there has been increasing interest in different aspects of bone 
cells. The development of various techniques allowing for a more in-depth  
and complex analysis of the osteoblast phenotype and the exceeding need for 
available osteoblast cells for in vitro research has contributed to establishing many 
osteoblast cell models.  
While a number of cell lines have been well characterised, few studies have directly 
compared their behaviour to primary human osteoblasts in order to determine their 
suitability for use in a model. Here, we characterised key aspects of phenotype  
and function of three osteoblast cell lines, SaOs2, MG63 and MC3T3E1,  
and compared them with the phenotypic traits of cells isolated from human bone. 
According to the 'gold standard' of osteoblast cell phenotype development 
established from rat calvarial osteoblastic cells, osteoblasts progress through  
3 phases, proliferation, matrix synthesis and maturation and mineralisation (Stein and 
Lian, 1993). We focused on assessing these stages in two human osteoblast cell lines, 
SaOs2 and MG63 derived  from human osteosarcoma (Billiau et al., 1977;McAllister 
et al., 1971) and MC3T3E1, a non-transformed cell line derived from mouse 
calvarial bone (Wang et al., 1999). These cell types represent the most commonly 
used cell models in in vitro studies focused on physiological and pathological aspects 
of osteoblast cell biology.  
Cell proliferation was similar for primary HOb and the MC3T3E1 cell line with  
the exponential phase being observed between days 2-6, followed by a gradual 
plateau between days 6-10. Thus, MC3T3E1 cells exhibited contact-dependent 
inhibition of proliferation similar to human primary cells. This observation  
for MC3T3E1 proliferation is in line with previous studies examining  
the proliferation of MC3T3E1 cells from different passages on tissue culture 
polystyrene (Peterson et al., 2004). Conversely, the osteosarcoma cell lines SaOs2 
and MG63 both differed significantly compared to primary human osteoblast cells  
in terms of proliferative capacity. Specifically, significant increases in cell number 
were noted at later time points for SaOs2 cells (day 8 and day 10), whereas  
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for MG63 cells produced significant higher proliferative rates as early  
as day 2 in culture. Interestingly, the cell growth kinetics of MG63 cells was 
comparable to HOb cells in that the exponential phase was observed between days  
2-6, which was followed by the plateau phase from day 6-10. In contrast, SaOs2 cells 
appeared to sustain a phase of exponential growth from day 2 onwards, with  
no obvious plateau phases becoming evident by the end of the experiment at day 10. 
Indeed, malignant cells, like SaOs2 and MG63, inherently lack control of their cell 
cycle resulting in infinite proliferation capability in suspension cell cultures in vitro, 
contributing to tumour progression (Read and Strachan, 1999). On the cell culture 
surface, the saturation density is influenced by the cell size. Morphometric analysis 
of primary osteoblast cells and osteosarcoma cell lines indicated the significantly 
lower size and volume mean for tumour cells (Pautke et al., 2004). Hence,  
the saturation density for non-tumour cells is lower, which was reported here  
and by others (Pautke et al., 2004). 
In terms of osteoblast differentiation, SaOs2 and MC3T3E1 cells are commonly 
described as displaying a ‘mature’ differentiated phenotype while MG63 represents 
an ‘immature’ osteoblast phenotype. Compared to the in vitro osteoblastic 
functionality we observed for primary human osteoblasts, our results support 
previous observations regarding the maturity of cell phenotype and their 
mineralisation potential. In vitro ALP is expressed at the early phase in matrix 
synthesis stage and is required for matrix mineralisation to occur. Although 
significantly lower during 28 days in vitro, MC3T3E1 cells presented a similar 
profile of ALP enzyme activity to primary osteoblasts. This is reflected in the later 
onset of mineralisation in mouse cells reported by Alizarin Red S-calcium deposition 
assay at day 28 for MC3T3E1 and at day 21 for HOb cells. The MC3T3E1 cells, 
obtained from newborn mouse calvaria, were already characterized as committed 
immature osteoblast cells sequentially expressing the osteoblastic markers  
and mineralising when culturing in the presence of ascorbic acid and βGP (Sudo et 
al., 1983). 
SaOs2 cells had significantly higher initial level of the enzyme activity confirming 
more mature phenotype of cells. The direct comparison of this cell type with HOb 
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cells in a recent study showed opposite results with initial ALP activity at the same 
level which, similarly as here, was followed by higher increase in SaOs2 cells by day 
7 (Saldana et al., 2011). Nodule formation was observed in SaOs2 cells from  
day 7 which developed with time and mineralised from day 28. Indeed, the potential 
of SaOs2 matrix mineralisation and formation of structures resembling woven bone 
in in vitro have been reported previously (Rodan et al., 1987). During the 28 day cell 
culture we observed a significantly lower ALP activity in MG63 cells than primary 
cells.  The low ALP enzyme level has been reported previously (Scheven et al., 
2002;Kumarasuriyar et al., 2009). Conversely, Kumarasuriyar et al. presented ALP 
temporal changes in MG63 cells with an increase by day 15. However, comparing 
the actual values for ALP activity between the latter study and results obtained here 
MG63 enzyme activity was similar and hence, much lower in MG63 than HOb cells 
(Kumarasuriyar et al., 2009).  
In order to track the phenotypical changes of osteoblast cell models to compare them 
with primary cells, we analysed the expression of key osteoblast specific genes 
during 28 days of culture. This revealed further differences among included in this 
study osteoblast cells. 
We compared the changes in Runx2 gene expression as an early osteoblast marker. 
Runx2 transcription factor, first identified as activating osteocalcin gene expression, 
was subsequently shown to regulate gene expression of all important bone matrix 
proteins, including alkaline phosphatase, osteocalcin, bone sialoprotein and and α1 
type I collagen (Schinke and Karsenty, 2002;Ducy et al., 1997). Moreover,  
it is up-regulated at the stage of mesenchymal condensation in cells differentiating 
into osteoblastic lineage (Ducy et al., 1997). We reported a significantly higher 
Runx2 mRNA level in MC3T3E1 cells than HOb cells and a trend of higher Runx2 
gene expression in SaOs2 during the whole culturing time and MG63, except day 21, 
compared to HOb cells. Furthermore, the expression of ALP and OC genes (with and 
without statistical significance, respectively) was higher in MC3T3E1 than HOb 
cells. This could suggest the positive correlation between the expression of Runx2, 
ALP and OC. Interestingly, at the same time when ALP gene expression  
was significantly up-regulated compared to HOb cells, the enzyme activity was 
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higher in HOb cells. The inversed results regarding gene expression and ALP activity 
could be attributed to poor post-translational efficiency of ALP cells in MC3T3E1 
cells, but not in HOb cells, however this would require further work to confirm. In 
SaOs2 cells the ALP mRNA expression was low and similar to HOb cells, with  
the exception of day 21, whereas the protein synthesis and activity suggest high post-
translational efficiency in human cells. Moreover, results for MG63 cells may imply 
that this efficiency can be high only if the threshold level for ALP expression  
is reached or that due to genetic alterations in tumour cells the post-translational 
processes are aberrant.  
Type I collagen, the most abundant ECM protein in bone, is essential for osteoblast 
cell functionality since improper fibril formation impair subsequent stages  
of phenotypic development (Wenstrup et al., 1996). Specifically, type I collagen 
expression is highly up-regulated in the stage before the matrix mineralisation  
and its fibril formation is essential for further physiological matrix maturation (Lian 
and Stein, 1995). We report similar expression of type I collagen in MC3T3E1 cells 
over 28 days and SaOs2 up to day 21 comparing to HOb cells, whereas lower 
expression was noted in MG63 cells compared to HOb cells. This low expression 
and potentially low protein synthesis and fibril assembly together with low  
ALP activity could suggest the insufficient maturation of collagenous matrix 
precluding mineral deposition for MG63 cells. In fact, the MG63 cells were shown 
previously to express more type III than type I collagen (Jukkola et al., 1993).  
In addition, the synthesis of other ECM constituents by MG63 cells differs 
comparing to primary human osteoblast (Johansen et al., 1992;Pierschbacher et al., 
1988;Pautke et al., 2004).   
Further differences were reported for the expression of late osteoblast cell marker, 
osteocalcin. Although its biological role is not fully understood, its importance  
has been determined in the differentiation of osteoblast progenitor cells  
with significant up-regulation at matrix synthesis and mineralisation stage (Ryoo et 
al., 1997;Kirkham and Cartmell, 2007).  The differences in OC mRNA expression  
in MG-63 and MC3T3E1 compared to HOb cells did not achieve statistical 
significance. Nevertheless, we observed a trend of higher OC gene expression  
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in these cells with specific rebound pattern, which was not the case of HOb cells.  
The expression of OC mRNA is directly linked to the Runx2 expression, the master 
regulatory transcription factor (Ducy et al., 1997). Hence, results obtained here 
suggest a direct correlation in the OC and Runx2 expression in HOb, MG63  
and MC3T3E1. In the case of SaOs2 cells, the trend of lower OC gene expression 
and higher Runx2 may suggest involvement of an alternative regulatory mechanism 
in OC gene expression. This, however, requires additional work to confirm. 
Altogether, the results showed many similarities between primary osteoblast cells 
and MC3T3E1 or SaOs2, but less with MG63 cells. Thus, the use of these osteoblast 
cells models should be considered with caution and explored in more detail to 
include comparisons with primary cells. Although MC3T3E1 has a similar cell 
proliferation rate to HOb and mineralise their matrix in similar manner, the gene 
expression differed significantly from HOb, which is possibly due to species-specific 
differences in gene regulation (Thomas et al., 2000). From the three cell types tested 
here, SaOs2 cells resembled HOb in the best manner regarding mineralisation 
potential, ALP activity and gene regulation, but not with respect to cell proliferation. 
MG63 showed the least similarities with primary human mature osteoblasts; 
however, based on results from previous studies, these cells are reliable  
in recapitulating OC synthesis and regulation, and integrin subunit expression 
(Clover et al., 1992). Moreover, due to their immature phenotype, MG63 cells are  
a suitable cell model to investigate the differentiation process into a mature 
osteoblast phenotype.  
In summary, while cell lines provide a convenient and accessible alternative to HOb, 
their use should be limited to appropriate and specific research questions with careful 
extrapolation of results, rather than as widespread use for recapitulating general bone 
biology and disease as is currently the case.  
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4.1. Introduction  
The behaviour and phenotype of cells are regulated by the 3D network structure  
of extracellular matrix, cell shape and complex cell-cell communication (Hammoudi 
et al., 2012). It is of great interest to define these interactions between various cell 
types which residue in a close proximity within the bone, including the osteogenic 
lineage cells, osteoclasts and blood vessels forming cells. A better knowledge  
of these interactions would be of benefit for the understanding of the bone 
development processes and is crucial for the improvement of the bone tissue 
engineering approaches. In fact, based on the evidence from in vivo investigations 
focusing on stem cell therapy, the beneficial effect of implanted cells on tissue 
regeneration has been shown to occur in various manners. Recently, it became 
evident that in addition to their direct contribution to tissue regeneration  
as a consequence of differentiation into specific phenotypes, implanted cells aid 
regeneration by producing various bioactive molecules, including growth factors, 
cytokines and extracellular matrix molecules (Hsiao et al., 2012;Tsiridis et al., 
2007;Zhukareva et al., 2010). These secreted factors act in an auto- and paracrine 
manner regulating the cell phenotype. The indirect action of progenitor cells 
implanted within a bone healing environment is less understood; nevertheless,  
the importance of various factors secreted by cells present in the fracture milieu  
is known to have great importance on bone regeneration (Kolar et al., 2011).  
The communication among cells in vivo is possible through the three mechanisms, 
including direct cell-cell contact through cell membrane molecules (tight  
and adherence junctions), gap junction communication and complex paracrine 
interaction through cell- or matrix-derived secretion factors (Grellier et al., 2009).  
In vitro co-culture models have been used for investigations aiming to elucidate  
the manner and importance of cells cross-talk. Specifically, direct and indirect in 
vitro co-culture systems have been used. Both types of cultures are mainly based  
on monolayer culture systems. Nevertheless, recently more interest has been directed 
towards 3D co-culture, including spheroids or scaffold systems.  
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Direct models aim to support maximum interaction between different types of cells. 
On the other hand, in this system, it is not easily possible to discriminate the response 
of the cell type of interest from response of the other cell population. This can  
be overcome when applying an indirect co-culture approach where cell cross-talk  
is based on the action of secreted diffusible factors. This type of communication can 
be achieved when one cell type is cultured with conditioned medium or ECM from 
the other cell type. In this case one-way communication is analysed. The two-way 
cross-talk, in which paracrine factors are secreted by both cell types and they affect 
both cell types, can be investigated using porous chambers separating different 
populations of cells. Moreover, the indirect co-culture systems allow  
the determination of the importance and necessity of direct cell-cell contact  
on the secretion of trophic factors (Grellier et al., 2009).   
Taking into account the various cell types present in the bone and its ECM,  
the net of the interactions that occurs is very intricate which makes their  
in vitro investigations challenging. Bone cell-cell communication in vitro focus  
mainly on the interactions between endothelial cells and MSCs (Duttenhoefer et al., 
2013;Hsiao et al., 2012;Chen et al., 2008;Saleh et al., 2011) or endothelial cells  
and osteoblasts (Unger et al., 2007;Fuchs et al., 2009;Hofmann et al., 2008;Stahl et 
al., 2004;Zhang et al., 2010;Hoch et al., 2012). Nevertheless, the communication 
between MSCs and osteoblasts (Tsai et al., 2012;Wang et al., 2007;Ueno et al., 
2001;Buttery et al., 2001;Ilmer et al., 2009) or osteoblasts and osteocytes (Civitelli, 
2008;Jaehn K., 2010;Clarke et al., 2013) attracts more and more attention.  
Based on the published evidence from both direct and indirect in vitro co-culture 
models, MSCs exert multiple effects on endothelial cells, such as stimulation  
of migration, proliferation, capillary-like structure formation and ‘sprouting’  
and wound healing (Hoch et al., 2012;Hsiao et al., 2012;Chen et al., 2008). Similarly, 
through the secretion of various factors, endothelial cells stimulate gene expression 
of osteogenic markers, including alkaline phosphatase (ALP), osteocalcin (OC), 
osteopontin (OP) and osteonectin (ON), and promote the onset of ECM 
mineralisation, which emphasise the importance of endothelial cells and MSCs 
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interaction on osteogenic differentiation of MSCs (Saleh et al., 2011;Kaigler et al., 
2005).  
The standard protocols for in vitro culture of osteoblasts or their progenitors include 
the requirement of various supplements to induce the mineralisation of the ECM.  
Interestingly, the direct co-culture of murine MSC with osteoblast cells was able  
to induce the mineralisation of the ECM in the absence of osteogenic supplements 
(Tsai et al., 2012).  Similarly, evidence from in indirect co-cultures of murine cells 
showed that osteoblasts were able to stimulate differentiation and nodule formation  
in progenitor cells (embryonic cells) cultured in the absence of any exogenous 
osteogenic supplement (Buttery et al., 2001). This indicates that osteoblasts secrete 
factors directing MSC differentiation and ECM mineralisation. Interestingly,  
the influence of co-culture on MSC differentiation highly depends on the phenotype 
of osteoblast cells and their ability to mineralise the ECM, suggesting that cell 
secretome is phenotype dependent (Ueno et al., 2001). More detailed analysis  
of the mechanisms directing the process of osteogenic differentiation in direct  
and indirect co-culture with osteoblast cells showed Wnt and cadherin signalling 
pathways components being implicated in this process (Wang et al., 2007).  
However, while the results from studies focusing on osteoblast communication with 
progenitor cells are valuable; they are mostly based on the research evidence from  
in vitro co-cultures of murine or rat cell models. Therefore, to obtain a better insight 
into the communication modes between cells in human bone, the communication 
between human bone forming cells will be investigated in this chapter. For this 
approach human MSCs will be co-cultured with osteoblast cells. MG63 cells were 
chosen as osteoblast cell model for these investigations as their immature phenotype 
allows for investigation of differentiation process, which is not possible when using 
mature osteoblast cells. Through this, we aim to limit any inconsistency associated 
with the use of primary cells to only one cell type. Ultimately, the importance  
of the type of the cell-cell communication between MSC and osteoblast cells will be 
determined. In addition, a newly developed highly homogeneous GFP expressing 
osteoblast cell line will be presented.  
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4.2. Results 
4.2.1. Indirect co-culture of MSCs and MG63 in monolayer and its 
effect on the osteogenic phenotype of the cells 
A monolayer co-culture model was used to analyse the indirect effects of cell-cell 
communication on the osteogenic differentiation of MSCs and osteoblast phenotype 
maturation. MSCs and MG63 cells were co-cultured for 21 days using BD Falcon
TM
 
cell culture inserts and companion plates. This system includes polyethylene 
terephalate (PET) insert membrane with the pore size 0.4μm and pore density 
2±0.6*106 per cm2. For co-culture, MSCs were cultured on top, i.e. in the insert, 
while MG63 cells were plated in the bottom of the well (bottom). The opposite 
configuration was included as a control group. As further controls MSCs and MG63 
were plated as single cell type cultures in the well (bottom) and in the insert (top). 
The detailed description of the groups is included in paragraph 2.2.11.1 and table 4.1. 
During the culture time, cells were maintained in growth medium (GM) as control  
or differentiation medium (DM). Growth medium consisted of DMEM  
(1g glucose/L), 10% FBS and 1% Penicillin-Streptomycin. Differentiation medium 
had the same components as GM and was supplemented with 50µg/ml L-ascorbic 
acid 2-phosphate sesquimagnesium salt hydrate, 10nM dexamethasone  
and 5mM β-glycerolphosphate.  
The investigation of gene expression, ALP activity, DNA and 
45
Ca incorporation 
included eight groups in DM and eight groups in GM conditions (Tab.4.1). 
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 Group Description 
 MSC CC tp MSCs located in the insert co-cultured with MG63 
 MSC CC bt MSCs located in the well co-cultured with MG63 
 MSC tp single cell type culture of MSCs located in the insert 
 MSC bt single cell type culture of MSCs located in the well 
 MG63 CC tp MG63 located in the insert co-cultured with MSCs 
 MG63 CC bt MG63 located in the well co-cultured with MSCs 
 MG63 tp single cell type culture of MG63 located in the insert 
 MG63 bt single cell type culture of MG63 located in the well 
Table 4.1. Description of groups included in the analysis of indirect co-culture of MSCs  
and MG63 cells in monolayer. 
4.2.1.1. The effect of monolayer co-culture on osteogenic gene expression   
in MSCs 
Regarding MSCs, the location of cells in co-culture (inserts or well) had less 
influence on Runx2, ALP and OC gene expression (Fig.4.1.) than in MG63 cultures 
(Fig.4.4). There were no significant differences in Runx2 mRNA expression between 
MSCs from co-culture DM groups and MSCs cultured alone (Fig.4.1A). However, 
there was a trend of higher Runx2 expression in MSCs on the bottom of the well 
from the single cell type culture in differentiation medium (MSC bt DM) compared  
to other DM groups. When cells were cultured in GM, the Runx2 mRNA was lower 
compared to DM groups. Similarly as for DM groups, the Runx2 gene expression 
was the highest in MSCs single cell type culture in the wells (MSC bt). This trend 
reached significance for MSCs in GM cultured in the well compared to MSC from 
co-culture with MG63 located in the well in GM (p=0.007) and MSC GM from co-
culture located in the insert (p=0.023) (Fig.4.1A). 
In differentiation medium, COL1 expression showed a 2.3- and 2-fold higher level  
in co-cultured MSC and control MSC seeded in the insert compared to co-cultured 
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MSC and control MSC seeded in the well, respectively (Fig.4.1B). These differences 
did not reach significance. Additionally, a trend of higher COL1 expression  
was reported for MSC co-cultured on the top (insert) with MG63 cells in DM and 
control MSC located in the insert in DM compared to their respective GM controls 
(Fig.4.14B). The highest COL1 mRNA expression in GM conditions was detected  
in the control MSCs group in which cells were located in the well compared to co-
cultured with MG63 MSCs located in the insert (p=0.002) or in the well (p=0.015) 
and single cell type MSCs seeded in the insert (p=0.032) (Fig.4.1B). 
The expression of ALP was at similar levels in all GM groups, except of MSCs from 
the co-culture with MG63 maintained in the insert in GM (Fig.4.1C). For this group, 
the ALP mRNA level was significantly lower than in the single cell type culture  
of MSCs in the well cultured in GM (p=0.021). Although, the ALP expression was 
higher in control MSCs GM group located in the well compared to other DM groups, 
no significant differences were determined for ALP expression (Fig.4.1C). For this 
group a high deviation of the mean ALP expression was detected, which explains  
the lack of significance between this and other groups (Fig.4.1C).  
No significant differences were found for OC gene expression between MSCs co-
cultured with MG63 cells or cultured without MG63 cells (Fig.4.1D). In both, DM 
and GM conditions, there was a trend of higher OC gene expression in MSCs 
cultured alone compared to MSC co-cultured with MG63 cells (Fig.4.1D). 
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Figure 4.1. Comparative real-time PCR results of Runx2 (A), type I collagen (B), ALP (C) 
and OC (D) genes expression in MSC at day 21 of indirect co-culture with MG63  
in monolayer. Diagrams show the mean fold change in gene expression with the standard 
error of the mean (3 experiments, n=9). Gene expression was normalised to 18S rRNA  
and made relative to gene expression in MSC cells at day 0. A, B, D: Data normally 
distributed, one-way ANOVA with Games-Howell. C: Data not normally distributed: 
Kruskal-Wallis and Mann-Whitney with Bonferroni correction. Statistical significance was 
determined as p<0.05. MSC CC bt: MSC cells co-cultured with MG63 in the bottom  
of the plate; MSC CC tp: MSC cells co-cultured with MG63 in the cell culture insert; MSC 
bt: MSC cells in the bottom of the plate; MSC CC tp: MSC cells in the cell culture insert.  
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4.2.1.2. The effect of monolayer co-culture on MSC functionality 
The co-culture of MSCs with MG63 cells had no significant effect on ALP protein 
activity in MSCs compared to MSCs cultured alone (Fig.4.2). For cells maintained in 
DM, enzyme activity was at the same level in all groups. Similar results were 
obtained for MSCs located in the well which were co-cultured with MG63 and single 
cell type culture of MSCs plated in the well and maintained in GM. For MSCs in cell 
culture inserts, the ALP activity was slightly higher for co-cultured MSCs  
in the insert group in GM than for control MSC in the insert maintained in GM 
(Fig.4.2). 
 
Figure 4.2. Diagram shows the mean of alkaline phosphatase (ALP) protein activity  
in 30 minutes relative to the amount of DNA at day 14 with the standard error of the mean  
(3 experiments, n=9). MSC and MG63 in monolayer indirect co-cultures or single cell type 
cultures were maintained in differentiation medium (DM) or, as control, in growth medium 
(GM) for 14 days. Data normally distributed, one-way ANOVA with Games-Howell. 
Statistical significance was determined as p<0.05. MSC CC bt: MSC cells co-cultured with 
MG63 in the bottom of the plate; MSC CC tp: MSC cells co-cultured with MG63 in the cell 
culture insert; MSC bt: MSC cells in the bottom of the plate; MSC CC tp: MSC cells  
in the cell culture insert.  
Significant differences were determined between groups for 
45
Ca incorporation 
(Fig.4.3). When MSCs were located in the insert and cultured in GM conditions, 
there was 1.56-fold less calcium detected in co-cultured MSCs compared to control 
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MSCs group (p=0.021). A similar trend was reported in DM conditions for co-
cultured and control MSCs seeded on the insert membrane. Moreover, in DM  
the 
45
Ca level was decreased in MSC co-cultures in the well compared to MSCs 
seeded in the well without co-culture (p=0.014), whereas it was at the same level for 
respective GM groups (Fig.4.3). Results indicated that the location of cells in the co-
culture system influences the 
45
Ca uptake into the MSCs culture. Compared to co-
cultured MSCs seeded in the well in DM  and GM groups there was significantly 
more  
45
Ca incorporation than in co-cultured MSCs located in the insert which were 
maintained in DM (p=0.033) and GM (p=0.001), respectively (Fig.4.3). Analogous 
relation was determined for single cell type cultures. In GM conditions, this trend 
reached significant level for control MSCs in the insert compared MSCs seeded  
in the well (p=0.002) (Fig.4.3).  
 
Figure 4.3. Diagram shows the mean of 
45
Ca incorporation relative to the amount of DNA  
at day 21 with the standard error of the mean (3 experiments, n=9). MSC co-cultured with 
MG63 or cultured alone were maintained in differentiation medium (DM) or, as control,  
in growth medium (GM) for 21 days. Data normally distributed, one-way ANOVA with 
Games-Howell. Statistical significance was determined as p<0.05. MSC CC bt: MSC cells 
co-cultured with MG63 in the bottom of the plate; MSC CC tp: MSC cells co-cultured with 
MG63 in the cell culture insert; MSC bt: MSC cells in the bottom of the plate; MSC CC tp: 
MSC cells in the cell culture insert.  
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4.2.1.3. The effect of monolayer co-culture on osteogenic gene expression in 
osteoblast (MG63) cells   
The analysis of Runx2, COL1, ALP and OC gene expression in MG63 cells co-
cultured with MSCs in monolayer showed a similar expression pattern for Runx2, 
COL1, ALP (Fig.4.4). Moreover, the highest gene expression level for the 
aforementioned genes was reported for MG63 cells in the cell culture insert when in 
co-culture with MSCs in differentiation medium (MG63 CC tp DM group) 
(Fig.4.4A-D). 
Indirect monolayer co-culture of MSCs with MG63 cells had no significant effect  
on Runx2 gene expression at day 21 in groups maintained in GM medium 
(Fig.4.4A.). Moreover, it had no effect on Runx2 expression in these DM groups  
in which MG63 cells were cultured on the bottom. In the case of MG63 cells 
cultured on the cell culture insert in DM, Runx2 mRNA expression was 7.3-fold 
higher in the group of co-cultured MG63 , compared to MG63 cells cultured alone 
(p=0.032) (Fig.4.4A.). 
Similarly as for Runx2, the COL1 gene expression for MG63 located in the insert 
and cultured in DM was significantly higher in co-cultured MG63 compared  
to control MG63 (p=0.029), whereas comparing the analogous groups located  
in the wells the expression was at the same level for MG63 from co-culture  
and control (Fig.4.4B.). There were no significant differences in Runx2 gene 
expression between cells co-cultured in the cell culture insert or in the well in GM 
and their respective controls. Runx2 mRNA expression in co-cultured MG63 located 
in the wells showed the highest expression compared to other GM groups. This trend 
reached significance only for control MG63 located in the insert in GM conditions 
(p=0.018) (Fig.4.4B.). 
The investigation of ALP gene expression revealed significant, 3.1-fold, higher 
expression level in differentiation medium for MG63 located in the insert above 
MSCs group compared to MG63 located in the well below MSCs (Fig.4.4C.). 
Compared to other DM groups, the ALP mRNA expression was also higher in co-
cultured MG63 which were located in the insert (Fig.4.4C.). However, these 
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differences did not reach significance. Expression of ALP was similar in all GM 
groups. Moreover, it was at a similar level as in DM groups except of co-cultured 
MG63 above MSCs in GM conditions. In this group, a trend of lower ALP 
expression than in analogous DM group was detected (Fig.4.4C.). 
Significant differences between groups in DM were determined for the gene 
expression of OC, the late osteoblastic marker (Fig.4.4D.). Similarly as for other 
genes, the OC mRNA expression was the highest for MG63 cultured on the insert 
membrane above MSCs in differentiation medium. Comparing MG63 DM groups 
the OC expression was 2.45-, 2.17- and 1.83-fold higher in co-cultured MG63 
located in the insert than in co-cultured cells in the well (p=0.002), single cell type 
cultures located on the bottom (p=0.003) and single cell type cultures in the insert 
(p=0.048), respectively (Fig.4.4D.). In GM conditions, the expression of OC mRNA 
was at similar level in all groups. Interestingly, in GM conditions for co-cultured 
MG63 located in the well and in single cell type cultures of MG63 seeded in the well 
or in the insert the OC gene expression was higher than in the respective DM groups 
(Fig.4.4D.). 
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Figure 4.4. Comparative real-time PCR results of Runx2 (A), type I collagen (B), ALP (C) 
and OC (D) genes expression in MG63 at day 21 of co-culture with MSC in monolayer. 
Diagrams show the mean fold change in gene expression with the standard error of the mean 
(3 experiments, n=9). Gene expression was normalised to 18S rRNA and made relative  
to gene expression in MG63 cells at day 0. Data normally distributed, one-way ANOVA 
with Games-Howell. Statistical significance was determined as p<0.05. MG63 CC bt: MG63 
cells co-cultured with MSC in the bottom of the plate; MG63 CC tp: MG63 cells co-cultured 
with MSC in the cell culture insert; MG63 bt: MG63 cells in the bottom of the plate; MG63 
CC tp: MG63 cells in the cell culture insert.  
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4.2.1.4. The effect of monolayer co-culture on osteoblast (MG63) 
functionality 
ALP protein activity was analysed in MG63 cultured with or without MSCs  
in growth or differentiation medium at day 14 and made relative to the amount  
of DNA at the same time point. For sample harvesting, inserts were transferred  
to the wells containing no cells to allow the precise analysis of ALP protein activity 
and quantitation of DNA in both cell types. 
The investigation of ALP protein activity in monolayer co-cultures revealed  
no significant differences between groups (Fig.4.5). Nevertheless, a trend of higher 
enzyme activity was observed for MG63 cells co-cultured with MSCs in DM 
compared to MG63 cells cultured alone. Additionally, ALP protein activity was 
higher in DM groups then in GM groups, except of control MG63 group located  
in the insert and maintained in DM and GM. In these control groups the enzyme 
activity was at the same level (Fig.4.5). 
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Figure 4.5. Diagram shows the mean of alkaline phosphatase (ALP) protein activity  
in 30 minutes relative to the amount of DNA at day 14 with the standard error of the mean  
(3 experiments, n=9). MSC and MG63 in monolayer co-cultures or single cell type cultures 
were maintained in differentiation medium (DM) or, as control, in growth medium (GM)  
for 14 days. Data not normally distributed Kruskal-Wallis and Mann Whitney with 
Bonferroni correction. Statistical significance was determined as p<0.05. MG63 CC bt: 
MG63 cells co-cultured with MSC in the bottom of the plate; MG63 CC tp: MG63 cells co-
cultured with MSC in the cell culture insert; MG63 bt: MG63 cells in the bottom of the plate; 
MG63 CC tp: MG63 cells in the cell culture insert.  
Mineral incorporation in the newly formed ECM was investigated by 
45
Ca uptake 
and made relative to the amount of DNA at day 21. As with ALP protein activity 
analysis, co-cultures were separated for each assay. The analysis of 
45
Ca uptake 
revealed significant differences between groups (Fig.4.6). For both, cells in co-
culture and single cell type cultures, the Ca
45
 uptake was higher for MG63 cultured 
in the cell culture insert (Fig.4.6).  
Comparing co-cultured DM groups, 
45
Ca incorporation was 13.2-fold higher  
for MG63 seeded in the insert than for MG63 seeded in the well (p=0.034). This 
comparison for single cell type cultures revealed 9.7-fold difference between control 
MG63 cultured in the insert and control MG63 located on the bottom (p=0.022) 
(Fig.4.6). In both DM groups of co-cultured MG63  and control MG63 in the well 
the 
45
Ca uptake was at the same level. Although, for the DM groups with cells  
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in the cell culture insert 
45
Ca incorporation was 1.75-fold higher in co-cultured 
MG63 than single cell type MG63 cultures, the co-culture with MSCs had  
a significant effect on 
45
Ca incorporation in MG63 cells when these cells were 
cultured in the insert. A similar pattern of 
45
Ca incorporation was reported for GM 
groups (Fig.4.6). Higher results were detected for groups with MG63 cells in the cell 
culture inserts. For cells maintained in GM, the 
45
Ca uptake was 3.8-fold higher  
in co-cultured MG63 insert group than in co-cultured MG63 located in the well 
(p=0.007) and 4.56-fold higher in the control MG63in the insert than the control 
MG63 in the well (p=0.002) (Fig.4.6). Even though not significant, the 
45
Ca uptake 
was lower in GM groups with MG63 in the insert than in the respective DM groups 
(Fig.4.6).  
 
Figure 4.6. Diagram shows the mean of 
45
Ca incorporation relative to the amount of DNA  
at day 21 with the standard error of the mean (3 experiments, n=9). MG63 indirectly co-
cultured with MSC in monolayer or cultured alone were maintained in differentiation 
medium (DM) or, as control, in growth medium (GM) for 21 days. Data normally 
distributed, one-way ANOVA with Games-Howell. Statistical significance was determined 
as p<0.05. MG63 CC bt: MG63 cells co-cultured with MSC in the bottom of the plate; 
MG63 CC tp: MG63 cells co-cultured with MSC in the cell culture insert; MG63 bt: MG63 
cells in the bottom of the plate; MG63 CC tp: MG63 cells in the cell culture insert.  
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4.2.2. Indirect co-culture of MSCs and MG63 in micromass and its 
effect on the osteogenic phenotype of cells 
A micromass culture model was investigated for its potential use as a 3D co-culture 
model for  MSCs and osteoblasts. This model, consisting of a high number of cells 
plated on the culture surface, is supported exclusively by the ECM produced  
by cultured cells. We aimed to investigate paracrine communication between MSC 
and osteoblast cells in 3D environment which provides a physiologically relevant 
context and promotes cell differentiation and maturation. The micromass co-culture 
was prepared as described in paragraph 2.2.11.2. Briefly, a micromass consisted  
of 100000 cells suspended in 5µl medium. For co-cultures and single cell type 
cultures, micromasses of each cell type were seeded in the well of 24-well plate 
ensuring that the distance between them and the edge of the well is the same in each 
sample. Cultures were maintained in growth medium (GM) as control  
or differentiation medium (DM). Growth medium consisted of DMEM  
(1g glucose/L), 10% FBS and 1% Penicillin-Streptomycin. Differentiation medium 
had the same components as GM and was supplemented with 50µg/ml L-ascorbic  
acid 2-phosphate sesquimagnesium salt hydrate, 10nM dexamethasone  
and 5mM β-glycerolphosphate.  
The investigation of gene expression included four groups in DM and four in GM 
conditions (Tab.4.2). The ALP activity, DNA and 
45
Ca incorporation were analysed 
in six groups out of which three groups were maintained in DM and three in GM 
(Tab.4.2). 
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Groups for gene expression analysis 
 Group name Description 
 MSC CC MSCs co-cultured with MG63 
 MG63 CC MG63 co-cultured with MSCs 
 MSC single cell type culture of MSCs = control MSCs 
 MG63 single cell type culture of MG63 = control MG63 
Groups for ALP activity, DNA, 
45
Ca incorporation 
 Group name Description 
 MSCMG63 
Two populations of co-cultured cells (MSCs and 
MG63) together 
 MSC single cell type culture of MSCs = control MSCs 
 MG63 single cell type culture of MG63 = control MG63 
Table 4.2. Description of the groups included for analysis of indirect co-culture of MSCs  
and MG63 in micromass.  
4.2.2.1. The effect of micromass co-culture on osteogenic gene expression in 
MSCs 
The results of Runx2 and COL1 gene expression in MSCs co-cultured with MG63 
cells or cultured alone indicated no significant differences between groups 
(Fig.4.7A&B). Nevertheless, the expression of both genes showed a similar trend.  
In co-cultured MSCs DM and GM groups, gene expression was decreased compared 
to control MSC DM and GM groups, respectively (Fig.4.7A&B). 
The effect of co-culture on MSC cells was more pronounced in the expression  
of ALP mRNA. Similarly, as for the Runx2 and COL1 expression, the ALP 
expression was lower in co-cultured MSCs DM and GM groups than in their 
respective controls (Fig.4.20.C). Specifically, ALP mRNA expression was 2.58-fold 
lower in co-cultured MSC DM than in control MSCs DM (p=0.038), whereas in GM 
groups it was 22.65-fold lower in co-cultured MSCs comparing to their controls 
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(p<0.0001) (Fig.4.7C). The presence of osteogenic supplements had a significant 
effect on ALP expression only in MSCs co-cultured with MG63 cells in micromass. 
This expression was approximately 12-fold higher in co-cultured MSCs  
in the presence of differentiation supplements than in co-cultured MSCs maintained 
in GM (p<0.0001) (Fig.4.7C). 
The investigation of OC mRNA levels revealed no significant differences between 
co-cultured MSCs DM and control MSCs DM groups (Fig.4.7D). Interestingly,  
in co-cultured MSCs GM group the OC expression was 2.38-fold up-regulated 
compared to control MSCs GM group. There was no significant effect  
of differentiation supplements on ALP expression in co-culture or single cell type 
culture groups (Fig.4.7D). 
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Figure 4.7. Comparative real-time PCR results of Runx2 (A), type I collagen (B), ALP (C) 
and OC (D) genes expression in MSC at day 21 of co-culture with MG63. Diagrams show 
the mean fold change in gene expression with the standard error of the mean (3 experiments, 
n=9). Gene expression was normalised to 18S rRNA and made relative to gene expression  
in MSC cells at day 0. Data normally distributed, one-way ANOVA with Games-Howell. 
Statistical significance was determined as p<0.05.   
Chapter 4: In vitro co-culture of progenitors and osteoblasts 
122 
 
In addition to analyses of osteogenic genes, the ratio between specific genes  
and Runx2 transcription factor was analysed (Fig.4.8). Runx2 is considered  
as an early osteoblast marker, whose expression decreases with the progression into 
the osteoblastic phenotype. Although, Runx2 did not show significant differences  
by itself, it showed the trend of lower expression in the MSC co-cultured group than 
in MSC cultured alone. COL1 gene expression relative to Runx2 expression was 
similar between co-cultured MSCs  and control MSCs maintained in differentiation 
medium, whereas in GM conditions  it was significantly lower in co-cultured MSCs  
than in control MSCs group (p=0.003) (Fig.4.8A). 
Similar lower relative gene expression results in GM groups were obtained for  
the ALP/Runx2 ratio (p=0.005) (Fig.4.8B). The ALP/Runx2 ratio was decreased in 
co-cultured MSCs compared to control MSCs when cells were cultured in DM. 
Although this ratio was 2-fold higher in co-cultured MSCs than in control MSCs  
in DM conditions, this trend did not reach significance (Fig.4.8B) In addition,  
the ALP/Runx2 ratio in co-cultured MSCs and control MSCs maintained in GM was 
lower than in respective GM groups. This difference was found to be significant for 
co-cultured MSCs in DM and in GM (p=0.001) (Fig.4.8B). 
The OC/Runx2 ratio showed interesting results. For both DM and GM conditions, 
the OC/Runx2 was higher for co-cultured MSCs (Fig.4.8C). This ratio was 2.22-fold 
higher in co-cultured MSCs than in control MSCs. Specifically, when micromass' 
were cultured in growth medium the OC/Runx2 ratio was 4.5-fold higher (p=0.02)  
in co-cultured MSCs compared to control MSCs (Fig.4.8C). 
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Figure 4.8. Diagrams show the mean of COL1/Runx2 (A), ALP/Runx2 (B) and OC/Runx2 
(C) ratio in gene expression at day 21 with the standard error of the mean (3 experiments, 
n=9). Gene expression was normalised to 18S rRNA and made relative to gene expression  
in MSC cells at day 0. A, B: Data not normally distributed, Kruskal Wallis, Mann Whitney 
with Bonferroni correction. C: Data normally distributed, one-way ANOVA with Games-
Howell. Statistical significance was determined as p<0.05.   
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4.2.2.2. The effect of micromass co-culture on osteogenic gene expression in 
osteoblast (MG63) cells 
The effects of co-culture on the osteoblast phenotype were determined  
by comparative real-time PCR at day 21 of culture. 
No significant differences between cells in co-culture and MG63 in single cell type 
cultures could be detected for Runx2 expression (Fig.4.9A). Gene expression results 
showed that in growth medium (GM) co-culture has no effect on type 1 collagen 
(COL1) mRNA expression (Fig.4.9B). On the contrary, a trend of lower COL1 gene 
expression was reported in MG63 cells from co-culture maintained in differentiation 
medium (MG63 CC DM group) compared to MG63 from single cell type culture  
in DM (MG63 DM group). In both culture systems, COL1 mRNA expression was 
higher in DM groups. For MG63 cultured alone, this difference reached significance 
(p=0.005) (Fig.4.9B). 
The ALP expression of MG63 cultured with MSC or alone in micromass was 
investigated. Significant differences between groups were found only for cells co-
cultured in different media (Fig.4.9C). In co-cultured MG63 DM group ALP gene 
expression was 2.4-fold higher than in co-cultured MG63 GM group (p=0.025). ALP 
expression in MG63 cultured alone in different media was at the same level at day 21 
of culture. Compared to the expression of COL1 in co-cultured MG63 and control 
MG63 maintained in DM, the ALP results showed an opposite trend of higher 
mRNA expression in co-culture group. Similarly as for COL1, this trend did not 
reach statistical significance (Fig.4.9C). 
The co-culture had no effect on the expression of the late osteoblastic marker gene, 
OC, in co-cultured MG63 DM and GM groups compared with control MG63 
micromass cultures in DM and GM, respectively (Fig.4.9D). In both culture models, 
the OC mRNA expression was higher in differentiation medium. The difference 
between DM and GM was significantly higher for groups of co-cultured MG63 
(Fig.4.9D). 
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Figure 4.9. Comparative real-time PCR results of Runx2 (A), type I collagen (B), ALP (C) 
and OC (D) genes expression in MG63 at day 21 of co-culture with MSC. Diagrams show 
the mean fold change in gene expression with the standard error of the mean (3 experiments, 
n=9). Gene expression was normalised to 18S rRNA and made relative to gene expression  
in MG63 cells at day 0. A, B: data not normally distributed: Kruskal-Wallis and Mann-
Whitney with Bonferroni correction. C, D: normally distributed, one-way ANOVA with 
Games-Howell. Statistical significance was determined as p<0.05 (*).   
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4.2.2.3. The effect of micromass co-culture on ALP and mineralisation   
ALP protein activity was analysed in micromass cultures maintained in growth  
or differentiation medium at day 14 and made relative to the amount of DNA  
at the same time point. For this analysis co-cultured cell types were not separated 
hence, the ALP activity in co-cultures was measured in samples harvested from both 
cell types at the same time (MG63MSC group). 
The ALP activity in micromass cultures showed significant differences between co-
cultured cells and single cell type cultures (Fig.4.10). The enzyme activity was 
significantly higher in co-cultured group maintained in DM compared to MG63 cells 
cultured alone in DM (p=0.00003). Conversely, the ALP activity was dramatically 
lower in MG63MSC co-culture in DM than in single control MSC DM group 
(p=0.001). A similar pattern of ALP activity was reported for cultures in GM, where 
the co-culture group had a higher enzyme activity than control MG63 (p=0.017).  
At the same time, it was 6-fold lower in co-culture group than in control MSC group 
(p=0.04) (Fig.4.10). The culture conditions of micromass co-cultures and micromass 
single cell type cultures had significant effects on ALP activity. In general, lower 
enzyme activity was reported for all groups in GM. Interestingly, for all groups the 
presence of differentiation supplements in medium had similar effect on ALP 
activity. Enzyme level was 3.16-fold higher in micromass from co-culture 
maintained in differentiation medium than in growth medium (p=0.0002).  
For control MG63 micromasses cultured in DM the ALP activity was 3.6-fold 
greater compared to control MG63 in growth medium (p=0.018), whereas for MSCs 
micromasses this difference equalled 2.85-fold between cultures in differentiation 
and growth medium (p=0.01) (Fig.4.10). 
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Figure 4.10. Diagram shows the mean of alkaline phosphatase (ALP) activity in 30 minutes 
relative to the amount of DNA at day 14 with the standard error of the mean (3 experiments, 
n=9). MSC and MG63 micromass co-cultures (MG63MSC) or single cell type cultures 
(MG63; MSC) were maintained in differentiation medium (DM) or, as control, in growth 
medium (GM) for 14 days. Data normally distributed, one-way ANOVA with Games-
Howell. Statistical significance was determined as p<0.05.   
Mineral incorporation detected by 
45
Ca uptake at day 21 revealed significant 
differences between groups (Fig.4.11). In co-cultures the calcium incorporation 
significantly increased compared to the control MG63 DM group (p=0.019).  
The opposite relation in DM conditions was reported for co-cultures and control 
MSCs, where the calcium incorporation was 2-fold higher in the control MSCs group 
(p=0.002) (Fig.4.11). There were no significant changes in calcium uptake between 
GM groups. Moreover, for each culture group there were significant differences 
between DM and GM groups. Interestingly, for MG63 the calcium incorporation was 
lower in the DM than the GM group (p=0.001), whereas in micromass co-cultures 
and control MSCs cultures this was higher in DM groups compared to GM groups 
(p=0.043 and p<0.0001, respectively) (Fig.4.11). 
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Figure 4.11. Diagram shows the mean of 
45
Ca incorporation relative to the amount of DNA 
at day 21 with the standard error of the mean (3 experiments, n=9). MSC and MG63 
micromass co-cultures (MG63MSC) or single cell type cultures (MG63; MSC) were 
maintained in differentiation medium (DM) or, as control, in growth medium (GM) for 21 
days. Data normally distributed, one-way ANOVA with Games-Howell. Statistical 
significance was determined as p<0.05.   
4.2.3. Generation and functionality of MG63 cells expressing GFP  
4.2.3.1. Transduction efficacy and cell colonies selection 
MG63 cells were selected for transduction with pMX retroviral expression vector 
containing a GFP insert. When cells reached approximately 80% confluence,  
the transduction efficiency and selection of GFP positive cells was analysed with 
fluorescence-activated cell sorting (FACS). The analysed cells had the homogeneous 
morphology (Fig.4.12) which was the same as for non-transduced MG63 cells (data 
not shown). For the further analysis of the visualisation of the expression of the 
fluorescence approximately 96% of cells were included (Fig.4.12A). These cells 
included two population of cells which were GFP negative and GFP positive 
(Fig.4.12B&C). From these populations 14.2% of cells were expression GFP. 
Positive cells were selected. The post-sort analysis of separated populations of cells 
confirmed the successful separation of GFP negative (Fig.4.13A-C) from GFP 
positive cells (Fig.4.13D-F). In this analysis, for the selected GFP positive cells there 
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were 91.3% cells which appeared in the gate of positive cells and 2.4% cells were  
in the gate of negative cells.  
 
Figure 4.12. Diagrams show the transduction efficiency of MG63 cells with GFP.  
A: Population of cells selected for the analysis. B: Selection of populations GFP negative 
(blue) and positive (green) cells. C: Gated populations of GFP negative (left histogram) and 
positive (right histogram) cells. 
The population of GFP positive and negative cells was plated for further expansion. 
The morphology of both types of cells was the same indicating that the transduction 
itself does not have any influence on cell morphology (Fig.4.14A-D). 
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Figure 4.13. Diagrams show the post-sort of cells separated with FACS after  
the transduction with GFP. Analysis of GFP negative cells population (A-C) and GFP 
positive cells population (D-F). 
 
 
Figure 4.14. Representative microphotographs of MG63 expressing GFP (A, B) and MG63 
(C, D) cells in culture. A, C: cultures visualized with phase contrast. B, D: cultures 
visualised using Olympus CK40 microscope with associated 500-nm emission filter 
(Olympus CX-DMB-2 cube).  
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After the expansion, the GFP positive cells were analysed again with FACS 
(Fig.4.15.A-C). With applying the same gating as previously, 97.5% of cells were 
included in the gate for/of the positive cells (Fig.4.15.A). To ensure the pure, 100%, 
population of MG63 expressing GFP cells, single cell colonies were established  
in a 96-well plate.  
 
Figure 4.15. Diagrams show the analysis of MG63 cells expressing GFP used  
for establishing single cell colonies. A: Population of cells selected for the analysis.  
B: Selection of populations GFP negative (blue) and positive (green) cells. C: Gated 
populations of GFP negative (left histogram) and positive (right histogram) cells. 
Based on the visual assessment of the GFP intensity, six cell colonies were selected 
and expanded further. All these cell populations originating from single cell colonies 
were analysed with FACS. The analysis revealed the presence of 99.2-99.6% 
positive cells. Additionally, expression of GFP different intensity levels by three out 
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of six colonies was confirmed by FACS (Fig.4.16). The median of GFP intensity  
in MG63 cells (negative control) was at the level of 138, whereas for GFP expressing 
cells it was at the level of 18570 (colony 1), 26167 (colony 2) and 40137 (colony 3). 
Colony with the highest GFP intensity level was named as MGreen63 cells and was 
selected for the evaluation of the cellular functionality. Furthermore,  
the phenotype of these cells was compared to the parental MG63 cells. 
 
Figure 4.16. Diagram shows the overlay of histograms of GFP intensity of 3 selected 
colonies obtained after seeding single cell colonies (red – colony 1, blue - colony 2, green - 
colony 3) and MG63 cells (negative control; grey histogram).  
4.2.3.2. Phenotypic assessment of MGreen63 cell line   
4.2.3.2.1. Proliferation of MGreen63 cell line 
Proliferation of cells was assessed with DNA-binding Hoechst assay. MG63 and 
MGreen63 presented similar trend of proliferation (FIG). The gradual increase in 
DNA amount was reported from day 2 to day 10 of cell culture. No significant 
differences at any time point were detected in growth kinetics between MG63 and 
MGreen63 (Fig.4.17).   
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Figure 4.17. The amount of mean DNA quantified during the culture of MG63  
and MGreen63 at day 2, 4, 6, 8 and 10. The diagram presents the mean with the standard 
error of the mean (3 experiments, n=9). Data normally distributed: two-way ANOVA with 
Least Significant Difference adjustment for multiple comparisons. Statistical significance 
was determined as p<0.05.  
4.2.3.2.2. Analysis of osteoblastic functions (ALP & mineralisation) 
The ALP activity was quantitatively detected in MGreen63 and MG63 cells at day 2, 
7, 14 and 21. The enzyme activity in MGreen63 in DM and GM was compared  
to the MG63 DM and GM, respectively. 
In vitro ALP activity changed in a time-dependent manner (Fig.4.18). There were no 
significant differences for enzyme activity at any time point in both cell types 
maintained in DM medium. Nevertheless, over time the ALP activity decreased  
in MGreen63 DM, whereas for MG63 DM the decrease (Fig.4.18) was at lower level 
(Fig.4.18). In GM medium, the ALP activity decreased from day 2 to day 21, while 
for MG63 ALP was at similar level over time. The ALP activity was higher  
in MGreen 63 GM at day 2 and 7, with significant level reported for day 2 (p=0.049) 
(Fig.4.18).  
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Figure 4.18. Diagram shows the mean alkaline phosphatase (ALP) activity with the standard 
error of the mean in MG63 and MGreen63 cells cultured in osteogenic (DM) or growth 
(GM) medium. For each cell type ALP activity was assessed as nmol pNP released in 30 
minutes and normalised to the amount of DNA (3 experiments, n=9). Data normally 
distributed: two-way ANOVA with Least Significant Difference adjustment for multiple 
comparisons. Statistical significance was determined as p<0.05. *: MGreeen63 DM 
compared to MG63 DM; #: MG63 DM compared to MG63 GM. 
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The visual detection of mineralisation of MGreen63 and MG63 was assessed using 
Alizarin Red S (ARS) staining at day 21 of culture. Representative images from three 
individual experiments performed for each cell type are shown (Fig.4.19). Both cell 
types maintained in DM and GM were negative for ARS at day 21 (Fig.4.19.E-H). 
 
Figure 4.19. Representative microphotographs of MGreen63 (A, B, E, F) and MG63 (B, C, 
G, H) cells at day 21. Both cell types were maintained in DM (A, C, E, G) or GM (B, D, F, 
H) medium for 21 days before the analysis. A, B, C, D: cultures visualised using Olympus 
CK40 microscope with associated 500nm emission filter (Olympus CX-DMB-2 cube). E, F, 
G, H: cultures visualized with phase contrast after staining with Alizarin Red S.  
4.2.3.2.3. Osteogenic genes expression in MGreen63 cell line 
The transcriptional changes of early, mid-term and late osteoblast specific genes over 
21 days were analysed in MGreen63 and MG63 cells. Gene expression was made 
relative to the expression of genes in MG63 cells at day 0.  
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For both cell types in DM and GM groups, the expression of Runx2 showed  
an increase over time. The expression levels were lower for MGreen63 than MG63 
in DM groups (Fig.4.20A). This trend reached significant level at day 7 (p=0.003) 
and day 21 (p=0.024). At these time points, the Runx2 expression was 2.6- and 1.5-
fold, respectively, lower in MGreen63 DM group compared to MG63 DM group.  
For cells in GM groups, the Runx2 mRNA expression was significantly higher  
in MGreen63 compared to MG63 only on day 14 (p=0.003) (Fig.4.20A). 
Comparable levels of COL1 were observed between Mgreen63 and HOb cells for 
day 2,14 and 21, however, at day 7 COL1 mRNA levels were observed significantly 
lower in MGreen63 compared to MG63 (p<0.001) (Fig.4.20B). In GM groups,  
the COL1 gene expression was significantly lower in MGreen63 compared to MG63 
only at day 2 (p=0.018), whereas at later time points the same levels of COL1 
mRNA were observed in both cell types (Fig.4.20B). 
The ALP gene expression showed the temporal changes for both cell types, with  
the highest expression at day 7. For MGreen63 DM group, ALP mRNA level was 
significantly lower at day 7 (p=0.004) compared to MG63 DM group (Fig.4.20C). 
 In GM groups at day 14, the 2.38-fold higher expression of ALP in MGreen63 cells 
compared to MG63 cells reached the significance (p=0.022) (Fig.4.20C). 
The expression of OC mRNA expression in MGreen63 DM and GM groups showed 
similar trend compared to MG63 DM and GM groups, respectively (Fig.4.20D).  
The only significant difference was determined for lower OC mRNA expression  
in MGreen63 DM compared to MG63 DM at day 7 (p<0.001) (Fig.4.20D).  
The expression of E11 was at the same level in MGreen63 and MG63 maintained  
in DM or GM medium except day 7 for DM groups. At this time point, E11 
expression was significantly lower in MGreen63 DM compared to MG63 DM 
(p<0.001) (Fig.4.20E). 
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Figure 4.20A-C. Comparative real-time PCR results of Runx2 (A), type I collagen (COL1; 
B) and ALP (C) was performed at day 2, 7, 14 and 21 of culture period of MG63  
and MGreen63 cell lines cultured in osteogenic (DM) or growth medium (GM). Diagrams 
show the mean fold change in relative gene expression with the standard error of the mean  
(3 experiments, n=9). Gene expression levels were normalised to RPL13a and were made 
relative to expression levels in MG63 cells at day 0 of culture. Data normally distributed: 
two-way ANOVA with Least Significant Difference adjustment for multiple comparisons. 
Statistical significance was determined as p<0.05. *: MGreen63 DM compared to MG63 
DM; #: MGreen63 GM compared to MG63 GM. 
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Figure 4.20D-E. Comparative real-time PCR results of osteocalcin (OC; D) and E11 (E) was 
performed at day 2, 7, 14 and 21 of culture period of MG63 and MGreen63 cell lines 
cultured in osteogenic (DM) or growth medium (GM). Diagrams show the mean fold change 
in relative gene expression with the standard error of the mean (3 experiments, n=9). Gene 
expression levels were normalised to RPL13a and were made relative to expression levels  
in MG63 cells at day 0 of culture. Data normally distributed: two-way ANOVA with Least 
Significant Difference adjustment for multiple comparisons. Statistical significance was 
determined as p<0.05. *: MGreen63 DM compared to MG63 DM; #: MGreen63 GM 
compared to MG63 GM. 
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4.3. Discussion 
Within this chapter the effects of co-culture of osteoblast lineage cells have been 
investigated. In particular, indirect co-culture models have been used to evaluate  
the importance of the mode of cell-cell communication on cell differentiation 
towards the osteoblast phenotype. This was to determine the effect of two-way 
communication on the osteoblastic phenotype development within monolayer  
or micromass co-culture systems. 
MSCs co-cultured with MG63 cells in monolayer showed similar ALP enzyme 
activity in DM at day 14 compared to control cultures. In GM cultures there was  
a trend of higher ALP activity in cells from co-cultures with MG63, but only  
in MSCs located on the porous membrane. On day 21 the ALP gene expression was 
lower in MSCs co-cultured with MG63 cells. Similar trends were reported for 
Runx2, an early osteogenic marker and master transcriptional factors regulating 
osteogenic differentiation (Eames et al., 2004). Runx2 is up-regulated during the 
mesenchymal condensation, which leads to the formation of pre-osteoblasts (Ducy et 
al., 1997).  Osteocalcin is a small calcium-binding protein found predominantly  
in the ECM of bone and is considered as a late marker for osteogenic differentiation 
(Poser and Price, 1979;Hauschka et al., 1989).  Similarly to ALP and Runx2 mRNA 
results, the OC gene expression was slightly lower in MSCs from the co-culture 
group compared to controls. Considering the location of MSCs in co-culture, a trend  
of lower Runx2, ALP and OC mRNA was reported in cells cultured  
on the membrane of the insert. The opposite trend was reported for COL1 gene 
expression in MSCs co-cultured or cultured alone in DM medium, whereas in GM 
groups it was higher only for the control group with MSCs located in the well. 
Interestingly, the co-culture of MSCs with MG63 in DM had no effect on COL1 
gene expression. For MSC groups cultured in DM or GM on a porous membrane,  
the 
45
Ca incorporation was significantly higher than for cells from bottom groups. 
Moreover, the 
45
Ca uptake was at a lower level in co-cultured cells compared to their 
controls in the monolayer co-culture system. Type I collagen is the main protein  
of the ECM within the bone which synthesis and presence is essential  
for the deposition of inorganic matrix, with Ca
2+
 being one of the constituent (Lynch 
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et al., 1995). The lower expression of Runx2, ALP and OC genes in MSCs co-
cultured with MG63 is in agreement with the 
45
Ca uptake results. Altogether, these 
results suggest a delayed osteogenic differentiation process compared to MSCs 
cultured alone.  
As mentioned above, the location of cells in the co-culture (inserts or wells) had  
an influence on cell performance. Two factors need to be mentioned here which 
could be related to the results, such as oxygen diffusion, availability of growth 
factors and substrate/surface topography. Even though in the MSC-MG63 monolayer 
co-culture experiments the permeable PET membranes (0.4µm inserts with the pore 
density (2±0.2*106/cm2)), the penetration and availability of oxygen and growth 
factors could differ between two compartments of the co-culture system. Single cell 
type culture of MSCs or MG63 cells in wells concurrent with single cell type 
cultures on PET located on the bottom of the well would be essential to explore  
if the differences in cell performance are associated with gas and nutrients diffusion 
through the membrane. As indicated above, another factor, the topography  
of the membrane, could be related to the differences in the results from the same type 
of cells located on the membrane and in the well. The porous PET membrane used 
within this study with the pore size 0.4µm is in the range of spectrum of roughness 
between 0.2–2µm. It has been suggested that this range is sensed by cells as 'rough' 
which result in reduced cell spreading and induces the expression and function  
of osteoblastic genes through the conformational changes in focal adhesions 
(Richards, 2008). Mechanotransduction arising from the nanotopography  
is the principal mechanism involved in the regulation of the morphological  
and functional changes in cells. Direct mechanotransduction utilizes changes 
 in focal adhesions and cytoskeletal conformation to pass information about the ECM 
(or substrate) topography to the nucleus as mechanical signals (Dalby et al., 2005). 
The information of the nanotopography sensed by cells is transmitted to the nucleus 
by the tension of the laminar network (Dahl et al., 2004). Compared to smooth 
topography within the 'rough' surface range, cells showed reduced spreading, a dense 
lamina network and relaxation of nucleus size and changes in chromosome 
positioning influencing regulation of genes (Dahl et al., 2004;Dalby et al., 2007). 
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At day 14, MG63 co-cultured with MSCs in a monolayer in DM showed a trend  
of higher ALP protein activity compared to MG63 cultured alone. In GM conditions, 
the enzyme activity was at the same level between groups. For ALP results in DM, 
the statistical power was not reached. In fact, MG63 present in the early stage  
of osteoblastic phenotype. As presented in chapter 3 and by others, the ALP enzyme 
activity is hardly detectable in MG63 cells (Pierschbacher et al., 1988;Czekanska et 
al., 2013;Saldana et al., 2011). It appears that co-culture with MSCs did not influence 
this feature of MG63. Interestingly, gene expression results showed higher 
expression of Runx2, ALP, COL1 and OC in the co-cultured MG63 groups located 
on the insert membrane and maintained in DM compared to the other MG63 groups. 
For MG63 cells located in the well there was no influence of co-culture on Runx2, 
ALP, COL1 and OC gene expression. Similarly, a trend for the 
45
Ca uptake as for 
MSC groups was reported for MG63 cells. At day 21, higher 
45
Ca incorporation was 
found in MG63 groups cultured on the membrane compared to the groups cultured  
at the bottom of the wells. For cells located in the well, the 
45
Ca uptake was  
at the same level in MG63 with or without MSCs. In the monolayer system, the co-
culture of MSCs with MG63 cells positively influenced the expression of osteogenic 
genes in MG63 cells, whereas it has an opposite effect on MSCs differentiation.  
In addition, the different response of both cell types associated with the location  
in the co-culture indicates that not only paracrine factors influence the cell activity.  
Following the investigation in monolayer, we investigated if similar effects  
of co-culture on osteogenic differentiation occur in a micromass system. Similarly  
as in the monolayer system, at day 21, the expression of Runx2, ALP and COL1  
in MSCs co-cultured with MG63 was lower than in MSCs cultured alone. Although, 
the co-culture had no effect on OC gene expression in DM, the OC/Runx2 ratio was 
significantly higher in MSCs co-cultured with MG63. In GM medium, both  
OC mRNA and OC/Runx2 ratio were significantly higher in co-cultured MSCs 
compared to MSCs cultured alone. This result indicates the positive effect of the co-
culture of MSCs with MG63 on osteogenic differentiation of MSCs in the absence  
of osteogenic supplements. The mRNA results from day 21 with lower Runx2, 
COL1, ALP and at the same time higher OC/Runx2 ratio in MSCs from co-culture 
could suggest a more differentiated stage of cells compared to MSCs from single cell 
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type culture. The micromass co-culture with MSCs had no significant influence on 
Runx2, ALP, COL1 and OC gene expression in MG63 DM or GM groups compared 
to their respective controls. In DM conditions, there was a trend of decreased COL1 
mRNA and increased ALP mRNA expression in the co-cultured MG63 compared  
to MG63 alone.  
Since the micromass co-cultures were located side-by-side in the wells of the 24-well 
plate, the ALP activity and 
45
Ca uptake analysis was performed without  
the separation of the two cell types of the culture. There were significant differences 
in ALP activity in the co-cultures and single cell type cultures at day 14 in DM  
and GM. For co-cultures, enzyme activity was significantly lower than MSCs and 
higher compared to MG63 cultures. If there was no effect of the co-culture on ALP 
activity, then the value of the enzyme level for the co-culture would be 
approximately an average of the results from the single cell type cultures. Here, ALP 
activity in the co-cultures was much below the expected average of the single cell 
type cultures suggesting the lower ALP activity of MSCs in the co-cultures than  
in the single cell type cultures. One possible reason for this is that ALP activity  
in MSCs peaks earlier in the co-culture than when cells are cultured alone. This  
is in agreement with gene expression results and supports the hypothesis  
of stimulated osteogenesis of MSCs in co-cultures. Analysing the ALP activity  
at earlier time points than day 14 would help to evaluate the validity of this 
hypothesis.  
The 
45
Ca incorporation data showed significant differences between the co-cultures  
and single cell type cultures in DM at day 21, whereas it was at the same level in all 
GM groups. MG63 cells showed little 
45
Ca uptake compared to co-cultures.  
The predominant cells in the co-culture responsible for the 
45
Ca incorporation seem  
to be MSCs. These cells in the micromass from single cell type cultures incorporated 
approximately 2-fold more 
45
Ca than cells in the co-culture group. Even though, 
there were significant differences between groups, the micromass co-culture  
of MSCs and MG63 in DM have no effect on 
45
Ca incorporation at day 21.  
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Interestingly, for the MSC alone cultures the ALP activity was at similar level  
in the monolayer and micromass cultures GM groups, whereas it was higher  
in the micromass than in the monolayer culture in DM medium. For MG63 cells,  
the cell culture system had no influence on ALP activity, which again supports  
the previous observations (Saldana et al., 2011;Czekanska et al., 2013) .  
For both MG63 and MSC single cell type cultures, the 
45
Ca incorporation was higher 
in the monolayer cell culture system. It has to be taken into account that  
in micromass, where cells are in close cell to cell contact and ECM is dense,  
the reagent diffusion towards the centre of the micromass is difficult. Moreover,  
in a dense 3D system, like pellets or micromass, the uptake is limited  
to the population of cells located on the surface; hence limiting the availability  
of the reagent for the cells located more in the centre. To overcome this problem,  
we performed a preliminary experiment to clarify whether 4-hour pre-incubation  
of cells with medium containing 
45
CaCl2 at 4°C will have an influence on the final 
the 
45
Ca uptake results. This strategy would slow down the metabolic activity of cells 
on the surface and increase the penetration of the reagent within the micromass.  
No significant differences were reported between the cultures pre-incubated at 4°C 
compared to the cultures without pre-incubation (data not shown). Still, we believe 
that the obtained results are reliable for the comparison of the micromass cultures.  
Even though, the MG63 cell line presented fewer similarities with HOb cells than 
SaOs2 and MC3T3-E1 regarding the development of the osteoblastic phenotype  
(chapter 3), this cell line was selected for establishing stable and homogeneous cell 
line expressing GFP. In addition, many studies exploring cell-material interactions 
utilise various cell types, including MG63, SaOs2 cell lines and primary animal 
osteoblast cells (Zinger et al., 2005;Bitar et al., 2008;Oh et al., 2006;Hansen et al., 
2007). By generating a MG63 cell line expressing GFP, we aimed to establish a cell 
line which would serve as a cell model for studies aiming to assess the importance  
of direct cell-cell communication and for the live assessment of cytotoxicity  
and cytocompatibility of biomaterials. From both a biological and tissue engineering 
point of view, it is important to track and understand the integrin-mediated cell-
surface interactions. It has been shown that MG63 cells express similar integrin 
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subunits profile, including α2, α5, αV, β1, β3, to HOb cells (Sinha and Tuan, 
1996;Clover et al., 1992). An early osteoblastic phenotype, similar morphology and 
integrin subunits profile to HOb cells, makes MG63 cells an attractive candidate for 
initial assessment and cytocompatibility of biomaterials. The transduction of MG63 
cells with GFP retroviral vector and subsequent selection of cells resulted in 
generation of cell line with stable expression of GFP. The further approach of 
proliferating colonies from single cell cultures resulted in selection of highly 
homogeneous populations of cells. One of these colonies, MGreen63, which was 
investigated in more details, presented similar characteristics as MG63 cells, 
including proliferation rate and osteoblastic phenotype development.  
Taken together these results suggest there is an active signalling pathway between 
MSCs and osteoblasts. The direct co-culture of MSCs with newly generated 
osteoblast cell line expressing GFP, MGreen63, would provide more detailed 
information regarding the cell-cell communication. 
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ENHANCING INFLAMMATORY AND CHEMOTACTIC 
SIGNALS TO REGULATE BONE REGENERATION 
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5.1. Introduction  
Various strategies have been developed and applied to aid the regeneration process 
of injured tissue. These include separate or combined implantation of specific cell 
types, biomaterials and factors. Cell therapy alone, or in combination with supportive 
biomaterials and factors, is of particular interest for clinical application to treat  
a wide array of acute or chronic conditions due to the inherent potential of stem cells 
to differentiate into various cell types (Pittenger et al., 1999). Currently, more than 
9600 ongoing cell therapy clinical trials have been registered worldwide 
(www.clinicaltrail.gov). Specifically, much attention and hope is put in single 
surgical procedure cell therapies. This strategy integrates the autologous cell 
harvesting, processing and re-implantation into injured site. Intraoperative 
autologous stem cell therapy brings advantages regarding the usage of patient's own 
cells which allows avoiding of the activation of an immune response, extensive  
in vitro cell expansion and manipulation, requirements for Good Manufacture 
Practice facilities, secondary procedure and potential contamination (Coelho et al., 
2012).  
In addition to their direct contribution to tissue regeneration as a consequence  
of differentiation into a specific phenotype, implanted cells aid regeneration  
by producing various bioactive molecules, including growth factors, cytokines and 
extracellular matrix molecules (Hsiao et al., 2012;Tsiridis et al., 2007;Zhukareva et 
al., 2010). These secreted factors act in an auto- and paracrine manner regulating  
the cell phenotype. The importance of paracrine actions in the host tissue have been 
studied extensively in repair and regeneration of the central nervous system (Drago 
et al., 2013), heart (Gnecchi et al., 2006;Hwang et al., 2012) and skin (Schlosser et 
al., 2012). The indirect action of progenitor cells implanted within a bone healing 
environment is less understood; nevertheless, the importance of various factors 
secreted by cells present in fracture milieu is known to have great importance on 
bone regeneration.  
Conventionally, fracture healing is divided into consecutive but overlapping stages, 
namely inflammation, soft callus formation, hard callus formation and remodelling. 
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During inflammation many factors are released by various cells present at the injury 
site. These factors have their role in attracting cells, promoting differentiation  
of MSCs, initiating angiogenesis and enhancing ECM synthesis. The importance  
of inflammation occurring after bone fracture has been demonstrated directly by the 
increased levels of various factors at the molecular and protein level, as well as 
indirectly by removing the fracture hematoma (Kolar et al., 2011). Combating 
inflammation and, as a consequence, the wide spectrum of factors secreted by the 
immune and progenitor cells present at the fracture site has also been shown to have 
a role (Simon et al., 2002). The local increased levels of mRNA expression  
of interleukin 8 (IL8), vascular endothelial growth factor (VEGF) together with 
interleukin 6 (IL6), CXC chemokine receptor type 4 (CXCR4) and secreted 
phosphoprotein 1 (SPP1) in fracture hematomas indicate their importance for 
chemotaxis, angiogenesis and osteogenesis (Kolar et al., 2011). The removal of the 
hematoma, together with the cells contained within, or combating the inflammation 
with non-steroid anti-inflammatory drugs prolonged the time of fracture healing 
compared to fracture with hematoma (Kolar et al., 2011;Simon et al., 
2002;Mountziaris et al., 2011) .  
As shown in the subcutaneous in vivo mice models, implantation of a hydroxyapatite 
(HAP) scaffold with exogenous MSCs resulted in the recruitment of endothelial  
and osteprogenitor cells, followed by ectopic bone formation by the host cells (Tasso 
et al., 2010). In addition, the fact that endothelial cells were identified in implants 
seeded with MSCs, but not osteoblast cells, indicates that MSCs secrete a more broad 
range of factors than osteoblast cells (Tortelli et al., 2010). Hence, in a fracture repair 
setting, MSCs in addition to having a direct role in differentiating into osteoblast 
lineage cells and forming new bone, also promote new bone formation by indirect 
cell-cell communication due to a localized release of factors attracting host cells and 
enhancing their differentiation potential.  
To increase the production of specific factors by cells various strategies can  
be applied including genetic engineering and preconditioning of cells. Since  
the secretion of trophic factors is modulated in vivo by chemotactic and 
inflammatory factors, the use of these factors could provide a strategy to enhance the 
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paracrine actions of cells. Driven by this hypothesis, for this study, we selected four 
factors which are the players in the early stages of bone healing cascade, namely 
Stem Cell Factor (SCF), interleukin 1β (IL1β), stromal cell-derived factor 1 (SDF1)  
and granulocyte colony-stimulating factor (GCSF). Based on the literature reports, 
the in vitro and in vivo research on cell behaviour are currently limited to the direct 
effects when treating cells with GCSF, SDF1, SCF or IL1β (McNiece and Briddell, 
1995;Pan et al., 2013;Zhou et al., 2007;Kitaori et al., 2009;Hara et al., 2011;Tang et 
al., 2009;Konig et al., 1988;Boyce et al., 1989;Lee et al., 2010). In addition, from 
these 4 factors only IL1β has been given significant attention, whereas the effects 
and applicability of other factors are overlooked in relation to bone regeneration.  
To overcome this impediment, we chose these factors, having differential action  
on cells during tissue regeneration, for assessing their direct and indirect effects  
on cells. As mentioned above, understanding the mechanisms involved in indirect 
effects of preconditioning, i.e. due to the enhancement of secretion of trophic factors 
acting in paracrine manner, would be of great interest for cell-based regenerative 
therapies. Therefore, we sought to elucidate the cytokine profile of MSCs after 
stimulation with these factors and the relevance of the secreted factors in supporting 
MSC proliferation and differentiation towards the osteoblastic lineage.  
 
 
 
 
 
 
 
 
Chapter 5: Enhancing inflammatory and chemotactic signals  
to regulate bone regeneration 
 
149 
 
5.2. Results 
5.2.1. Direct influence of MSCs stimulation with cytokines on MSCs  
5.2.1.1. Effects of stimulation with cytokines on gene and protein expression 
profile of MSCs 
Mesenchymal stem cells (MSC) for this study were isolated from the bone marrow 
aspirates of 9 different donors within an average age of 43±21 years-old (age range: 
18-65) from the iliac crest or vertebral body (Tab.5.1). Moreover, cells which 
underwent 6.082±0.83 population doublings after thawing from cryopreservation 
were used. In the first part, cells were stimulated with 4 different factors (IL1β, SCF, 
SDF1 and GCSF) for 2 hours in monolayer cell culture (Tab.5.1). After that time, 
cells were washed with PBS after which medium containing 10% FBS was added. 
The effect of the stimulation was assessed at the gene expression level 72 hours later. 
In the later part, experiments focused on assessing in more detail the effects of short 
term stimulation with IL1 β and SCF (Tab.5.1.). The experimental design was 
modified in order to investigate not only the effects of stimulation on gene 
expression, but also the protein expression. Therefore, after stimulation, cells were 
maintained in serum free DMEM low glucose with 1% Penicillin-Streptomycin  
for 48 hours. Stimulation was always performed in medium containing 10% FBS  
and 1% Penicillin-Streptomycin. 
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Donor # Gender Age 
Isolation 
site 
Stimulation 
Analysis 
IL1β SCF SDF1 GCSF 
1 female 65 n.k. x 
  
x 
Cytokine gene 
expression 
profile 
2 male 41 iliac crest 
 
x x x 
3 female 64 n.k. x x x x 
4 female 40 iliac crest x x x x 
5 female 18 vertebra x x     
Cytokine gene 
and protein 
expression 
profile 
6 female 20 n.k x 
   7 female 40 iliac crest x x 
  8 male 41 iliac crest x 
   9 female 55 iliac crest x x     
Table 5.1. Details about MSC donor isolation site and short-term stimulation experiment 
outline; n.k. – not known. 
5.2.1.1.1. MSCs cytokine gene expression after culture in serum 
containing medium 
Real-time PCR analysis of cytokine and growth factor expression levels in MSC 
stimulated with different factors revealed that the response to 2 hour stimulation  
is highly donor dependent. Yet, consistent effects at the mRNA level 72 hours after 
stimulation were observed. For stimulation with each factor, three different donors 
were included. Response to the treatment was assessed as positive if up-  
or down-regulation of a gene occurred in cells obtained from at least 2 donors when 
compared to untreated controls. Out of the four donors included in the experiment, 
donor 4 varied the most in response to SCF, SDF1 and GCSF treatment when 
compared with other donors (Fig.5.1B-D). Interestingly, donor 1 showed the highest 
response to GCSF and the lowest to IL1β stimulation (Fig.5.1C&A) whereas cells 
from donor 3 showed the highest sensitivity to IL1β in comparison to other  
donors (Fig.5.1A). Due to differential sensitivity of cells from different donors  
to the stimulation, results are presented for each individual donor. 
Two hour stimulation of cells with 10ng/ml IL1β resulted in the up-regulation  
of a wide range of cytokine genes. The highest up-regulation was detected for BMP2, 
IL8, TNFSF11 and IL6 in cells from all three donors. BMP6 and NODAL were up-
Chapter 5: Enhancing inflammatory and chemotactic signals  
to regulate bone regeneration 
 
151 
 
regulated in 2 out of 3 donors. In addition, 2 cytokines, GDF5 and IL17B were 
down-regulated in response to the treatment in all three donors (Fig.5.1A).  
GCSF stimulation resulted in a pronounced up-regulation of mRNA expression  
of 5 cytokines (BMP2, GDF9, IL8, IL10, NODAL) and down-regulation of one 
cytokine (INFA1). Cells from all three donors consistently down-regulated INFA1 
gene expression compared to unstimulated cells (Fig.5.1B).  
As seen with GCSF stimulation, cells from donor 4 stimulated with SCF showed  
the lowest level of response. MSC stimulation with 100ng/ml SCF resulted in high 
up-regulation of IL1A and NODAL in all donors. In addition, two of the donors 
(1&2) positively responded to stimulation by increasing the expression of GDF9  
and TNFSF11 compared to unstimulated cells. Interestingly, donor 4, which showed 
the lowest up-regulation in IL1A and NODAL expression out of all donors, showed 
an opposite response regarding GDF9 and TNFSF11 in comparison to the 2 other 
donors (Fig.5.1C).  
A high up-regulation of NODAL gene expression was detected in response to SDF1 
treatment in all three donors. Additionally, stimulation had positive effects on two 
other cytokines, BMP8B and IL10, whereas IL1β was strongly down-regulated  
in 2 out of 3 donors (Fig.5.1D). The positive response to SDF1 stimulation in IL1β 
regulation was reported in cells from donor 3. As previously described, cells from 
donor 3 were also highly responsive to 10ng/ml IL1β stimulation.   
Out of the effects reported for the 4 factors investigated, IL1β resulted  
in the regulation of cytokine genes influencing the broadest range of biological 
processes. Cytokines, which responded to the IL1β treatment, take part in bone 
formation (BMP2, BMP6), angiogenesis (IL6, IL8), osteoclastogenesis (TNFSF11), 
development (NODAL), chondrogenesis (GDF5) and immunomodulation (IL17B). 
Specifically, only IL1β regulated the expression of BMP6, IL6, TNSFF11 and GDF5 
(Fig.5.1A). SCF stimulation showed no effect on the gene expression of cytokines 
implicated in angiogenesis or bone formation, but still it up-regulated genes involved 
in chondrogenesis (GDF9) immunomodulation (IL1A) and development (NODAL) 
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(Fig.5.1B). Short-term stimulation of MSCs with GCSF resulted in a positive 
response on the mRNA level of cytokines involved in bone formation (BMP2), 
chondrogenesis (GDF9), angiogenesis (IL8, IL10) and development (NODAL) while 
decreasing the expression of IFNA1, which is involved in immunological responses 
(Fig.5.1C). SDF1 stimulation of MSCs uniquely regulated gene expression of one 
bone formation factor (BMP8b) (Fig.5.1D). In addition, it stimulated the expression 
of an angiogenic factor (IL10) and down-regulated expression of IL1β cytokine 
which effects multiple actions on cells (a wide spectrum of actions). Similarly, as 
with stimulation with other factors, a cytokine involved in developmental processes, 
NODAL, was up-regulated in response to SDF-1 stimulation (Fig.5.1D). 
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Figure 5.1. Diagrams show the mRNA levels of cytokines in MSC cells stimulated by IL1β 
(A), SCF (B), GCSF (C) and SDF1 (D). Cells in monolayer were stimulated with specific 
factor for 2 hours. Cells without any stimulation were included as controls for assessing 
regulatory effects of stimulation. Gene expression level in stimulated cells was made relative 
to control samples.  
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5.2.1.1.2. MSCs cytokine gene expression after culture in serum-free 
medium  
The effect of IL1β or SCF stimulation on mRNA levels was analysed in MSCs (n=5 
donors) 48 hours after exposure. In the time between stimulating the cells with either 
IL1β or SCF and mRNA sample collection, cells were maintained in DMEM 
medium supplemented only with 1% penicillin-streptomycin. No serum was included 
in the medium in order to eliminate any potential synergic or antagonistic effects  
of selected factors with any protein present in the serum. Forty-eight hours after  
the stimulation with IL1β, mRNA expression of 20 cytokine genes were similarly 
regulated in at least of 3 out of 5 donors (Fig.5.2). In addition, 3 out of 5 donors (5, 6 
and 7) showed the most similar trend in the response to the treatment with IL1β. 
Cells isolated from donor 8 responded to the IL1β stimulation by increasing  
the greatest number of genes compared to other donors, whereas cells from donor 9 
showed the opposite trend. In general, cells from donor 5 showed the highest fold 
change in cytokine mRNA expression relative to unstimulated cells in comparison  
to MSCs from other donors.   
Stimulation of MSCs with IL1β resulted in an up-regulation of TNFRSF11B and 
IL1β and a down-regulation of GDF5 gene expression in all 5 donors (Fig.5.2).  
An increased mRNA expression in stimulated cells was detected for: BMP6, CD70, 
IL1a, IL6, IL8 and IL12A in 4 out of 5 donors. On the other hand, various BMP-
family members (BMP3, 4, 5 and 7), TGFb3, GDF8, LTA and IL5 were down-
regulated in 4 donors. A positive response in GDF9 and GMCSF gene regulation was 
detected in cells from 3 donors. Similarly, 3 from 5 donors down-regulated BMP2 
gene expression after 2 hours stimulation with IL1β (Fig.5.2).  
MSCs from 3 donors were treated for 2 hours with SCF. As a result, 12 cytokine 
genes showed response to the stimulation in at least 2 donors (Fig.5.3). Eight of these 
genes were up-regulated in cells from all 3 donors. More specifically, the mRNA 
level in stimulated cells relative to unstimulated cells was higher for BMP4, 
TNFRSF11B, TNFSF14, TGFβ2, INHBA, NODAL, IL1A and IL18. Due  
to an opposite response in regulation of TNFSF4, IL1β, IL17b and IL21 in cells from 
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donor 5 or 9 (compared to other donors), these genes were up-regulated in 2  
out of 3 donors (Fig.5.3). 
It has to be highlighted that overall the magnitude of the response was lower 
compared to the effect of IL1β on cytokine gene regulation. Approximately a 2–fold 
increase in gene regulation, relative to unstimulated controls, was detected after SCF 
stimulation. As an exception, cells from donor 7 were the most sensitive to SCF 
stimulation, which was marked by the highest increase of TNFSF14, IL1a, IL1β, 
IL18, IL21 and TNFSF4 mRNA level among all 3 donors (Fig.5.3).  
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Figure 5.2. Gene expression levels of cytokines in MSC cells stimulated with IL1β. Cells  
in monolayer were stimulated with 10ng/ml IL1β for 2 hours. Cells without any stimulation 
were included as controls for assessing regulatory effects of stimulation. The gene 
expression level from stimulated cells was made relative to control samples. 
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Figure 5.3. Gene expression levels of cytokines in MSC cells stimulated with SCF. Cells  
in monolayer were stimulated with 100ng/ml SCF for 2 hours. Cells without any stimulation 
were included as controls for assessing regulatory effects of stimulation. The gene 
expression level from stimulated cells was made relative to control samples. 
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5.2.1.1.3. Regulation of osteogenic and Wnt signalling genes in 
stimulated MSCs  
In addition to array analysis of a wide array of cytokine genes regulated in response 
to the stimulation with IL1β and SCF, gene expression was assessed with real-time 
PCR using the TaqMan real-time PCR method. In this analysis the expression of IL6, 
IL8, BMP2, RANKL was included to confirm the results obtained from RT
2
 PCR 
array analysis. Additionally, the direct influence of IL1β and SCF stimulation  
on components of the canonical and non-canonical Wnt signalling pathways  
and osteogenic markers was assessed at the gene expression level. Similarly  
to results from the cytokine gene expression arrays, the gene regulation in response 
to the stimulation was donor dependent. From 5 number of donors, cells from donor 
9 showed the opposite response to IL1β treatment than cells from other donors 
included in the analysis (Fig.5.4A&C). Cells from donors 5-8 showed a similar trend 
in the response to IL1β. Hence, donor 9, as an outlier, was excluded from  
the statistical analysis. For stimulation with SCF, cells from all donors were included 
for the analysis of any significant differences in response to the stimulation.  
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Figure 5.4. Diagrams show the fold change gene expression in relative to control from each 
donor with the standard deviation, quantified by real-time PCR 48 hours after the stimulation 
of MSC with IL1 β or SCF for 2 hours. A& C: Cells stimulated with IL1β; B&D: Cells 
stimulated with SCF. Cells from 5 and 3 donors were stimulated with IL1β or SCF, 
respectively. 
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IL1β stimulation significantly down-regulated mRNA expression of bone markers, 
including Runx2 (p=0.02), Sox9 (p=0.02), BMP2 (p=0.01) and RANKL (p=0.01) 
(Fig.5.5A). Even though there were significant changes in Runx2 and Sox9 gene 
expression, IL1β stimulation had no effect on the overall Runx2/Sox9 ratio compared 
to unstimulated cells (p=0.468). Treatment with IL1β increased the expression of IL6 
and IL8. Yet, this increase was significant only for IL8 (p<0.001). Stimulation with 
SCF showed a negative effect on the regulation of Runx2, Sox9, BMP2, RANKL, 
IL6 and IL8 genes (Fig.5.4B&5.5A). However, this decreased expression compared 
to the untreated cells only reached significance for Sox9 (p=0.05), RANKL 
(p=0.004) and IL8 (p=0.004) (Fig.5.5A).  
It was only possible to detect Wnt4 expression in cells from donor 8 and in donor 5 
after the stimulation with IL1β and SCF (Fig.5.4C&D). Moreover, mRNA 
expression of Wnt3 was not detected in any donor. Although, there were  
no significant differences in gene expression of Wnt5a (p=0.748), Wnt7b (p=0.3)  
or βcatenin (p=0.748) between stimulated with IL1β and unstimulated cells, there 
was a trend of higher expression of Wnt7b compared to control (Fig.5.5B). 
Stimulation of MSCs with SCF had no influence on the mRNA expression of Wnt5a 
(p=0.256) or βcatenin (p=0.73), whereas it significantly decreased Wnt7b expression 
(p=0.008) compared to control (Fig.5.5B).  
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Figure 5.5. Diagrams show the mean fold change gene expression relative to control with  
the standard error of the mean, quantified by real-time PCR 48 hours after the stimulation  
of MSC with IL1β or SCF for 2 hours. A: Expression of genes: Runx2, Sox9, Runx2/Sox9, 
BMP2, RANKL, IL6, IL8; B: Expression of Wnt5a, Wnt7b and βcatenin. Gene expression 
was normalised to RPL13a and made relative to expression of genes in unstimulated cells. 
Statistical significance at p<0.05 (*) of genes compared to unstimulated cells was determined 
with Mann-Whitney U test.  
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5.2.1.1.4. Influence of stimulation on cytokine protein secretion by MSCs 
in serum-free medium cell culture  
Similarly to results from gene expression arrays, the regulation of 174 cytokine 
proteins in response to IL1β or SCF stimulation was highly donor dependent.  
As a consequence, for each donor secretion of each protein was regulated  
to a different extent, which prevented presentation of the averaged results. 
Nevertheless, it was possible to analyse results in a similar manner to the gene 
expression results.  
The initial analysis of the fluorescence intensity of the medium samples collected 
from unstimulated cells revealed that of 174 cytokine proteins assessed, 139 proteins 
were secreated by cells from donor 5, 152 from donor 6 and 9, 154 from donor 7  
and 153 from donor 8 (Appendix 4). For both treatments, the expression  
of proteins in conditioned medium was made relative to protein secretion into 
medium by unstimulated (control) cells. In case of IL1β stimulation, if cells from  
at least 3 out of 5 donors showed similar regulation of proteins, the effect  
of stimulation was assessed as positive (Fig.5.6). Similar conclusions were made  
for SCF stimulation, when cells from at least 2 out of 3 donors responded  
to stimulation in a similar fashion (Fig.5.7). All regulated cytokine proteins were 
grouped depending on their function (Tab.5.2.). This showed that 2 hour stimulation 
with IL1β mostly influenced the secretion of proteins involved in chemotaxis, 
inflammation, angiogenesis and bone formation. On the other hand, stimulation with 
SCF affected mitogenic, ECM and differentiation markers.  
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Function Cytokine 
Chemotactic GCP2, RANTES, MIP1β, MIP3α, IL2Rα, ENA78, IL8, MDC, 
B7-1 
Mitogenic Amphiregulin, NAP2, IGFBP3, basic FGF, FGF4, sTNFRII 
Proinflammatory GRO, I309, GROα, ICAM3 
Immunoregulation MIF, IL8, IL2Rα, GITR, LIGHT 
Bone formation FGF4, Amphiregulin, Activin A, IL6, IGFBP3 
Angiogenesis GCP2, FGF9, IL6, IL8, RANTES, ENA78 (indirectly) 
Chondrogenesis  BMP6 
ECM regulation TIMP1, TIMP4 
Table 5.2. Functional grouping of cytokines regulated by 2 hour stimulation of bone marrow 
derived MSC cells with 10ng/ml IL1β or 100ng/ml SCF. Colours indicate response  
to the stimulation: dark green - up-regulation after stimulation with 10ng/ml IL1β, light 
green – down-regulation after 10ng/ml IL1β stimulation, dark blue – up-regulation after 
stimulation with 100ng/ml SCF, light blue – down-regulation, dark brown – up-regulation by 
10ng/ml IL1β and 100ng/ml SCF, light brown - down-regulation by 10ng/ml IL1β and 
100ng/ml SCF. B7-1=CD80 - cluster of differentiation 80; basic FGF - basic fibroblast 
growth factor; BMP4 – bone morphogenic protein 4; BMP6 - bone morphogenic protein 6; 
ENA78/CXCL5 - epithelial-derived neutrophil-activating peptide 78; FGF4 – fibroblast 
growth factor 4; GCP2 - granulocyte chemotactic protein; GITR/TNFRSF18 - glucocorticoid 
induced tumour necrosis factor receptor family related gene; GRO - growth-related 
oncogene; GROα - growth-related oncogene alpha; I309=CCL1 - chemokine (C-C motif) 
ligand 1; ICAM3/CD50 - intercellular adhesion molecule 3; IGFBP3 - insulin-like growth 
factor binding protein-3; IL2Rα - interleukin 2 receptor alpha; IL1β – interleukin 1 beta; IL6 
– interleukin 6; IL8 – interleukin 8; LIGHT=TNFSF14 - tumour necrosis factor ligand 
superfamily member 14; MIF - Macrophage migration inhibitory factor; MIP1β/CCL4 - 
Macrophage inflammatory protein-1 beta; MIP3α - Macrophage inflammatory protein-
3alpha; NAP2 - neutrophil-activating protein-2; RANTES/CCL5 - regulated on 
activation, normal T cell expressed and secreted; SCF – stem cell factor; sTNFRII - 
soluble tumour necrosis factor receptor type II; TIMP1 - tissue inhibitor  
of metalloproteinase-1; TIMP4 - tissue inhibitor of metalloproteinase-4. 
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Stimulation with IL1β influenced protein synthesis and secretion in MSC cells.  
In detail, 18 out of 174 analysed proteins were up-regulated in the conditioned 
medium collected 48 hours from cells stimulated with IL1β in comparison  
to conditioned medium from unstimulated cells (Fig.5.6). At the same time, a lower 
secretion of 2 proteins, namely B7-1 and MIF was observed in response to IL1β 
stimulation. Out of the up-regulated 18 proteins, 9 of them, namely GCP2, GRO, 
ICAM3, IL8, MIP3α, RANTES, I309, IL6, IL2Rα and MCP3, were up-regulated  
in cells isolated from all 5 donors.  This strongly indicates the regulatory role of IL1β 
on these cytokines. An increased expression of a further 9 proteins, including Activin 
A, Amphiregulin, ENA78, FGF4, FGF9, GROα and LIGHT, was detected 48 hours 
after IL1β stimulation in at least 3 of 5 donors (Fig.5.6).   
Among 174 proteins analysed from medium conditioned by MSCs stimulated with 
SCF, secretion of 15 of them were specifically regulated in response  
to the stimulation (Fig.5.7). In relation to results from controls, SCF stimulation 
showed a negative effect on B7-1, sTNFRII and TIMP4 protein secretion in cells 
from all 3 donors. On the other hand, all donors showed a positive response to SCF 
stimulation by increased secretion of Amphiregulin, NAP2, FGF4, GITR, IGFBP3, 
LIGHT, MDC, TIMP1. Basic FGF, BMP6, MIP1beta and TRAILR3 were up-
regulated in 2 out of 3 donors, with Donor number 9 being the exception (Fig.5.7).  
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Figure 5.6. Protein levels of cytokines in medium conditioned by MSCs stimulated with 
IL1β. Monolayer cells were stimulated for 2 hours with 10ng/ml IL1β. After stimulation, 
cells were washed with DMEM and maintained in DMEM with 1% Penicillin-Streptomycin 
for 48 hours. After that time conditioned medium was collected for the analysis of secreted 
proteins. 
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Figure 5.7. Protein levels of cytokines in medium conditioned by MSCs stimulated with 
SCF. Monolayer cells were stimulated for 2 hours with 100ng/ml SCF. After stimulation, 
cells were washed with DMEM and maintained in DMEM with 1% Penicillin-Streptomycin 
for 48 hours. After that time conditioned medium was collected for the protein secretion 
analysis.  
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5.2.2. Indirect effects of MSCs stimulation with cytokines on osteogenic 
differentiation of MSCs  
To investigate the functional effects on cell proliferation of the secreted proteins, 
modulated in response to stimulation, an experiment with conditioned medium was 
performed. Unstimulated MSCs collected from one donor (6) were cultured in two 
types of media. As control medium (growth medium; 'GM'),  50% of conditioned 
medium from unstimulated or stimulated cells mixed with 50% of growth medium  
composed of DMEM supplemented with 1% Penicillin-Streptomycin and 2% FBS 
was used. The differentiation medium ('DM') was composed of 'GM' supplemented 
with 50µg/ml ascorbic acid, 10nM dexamethasone and 5mM β-glycerolphosphate. 
5.2.2.1. Conditioned medium from stimulated cells inhibits the proliferation 
of MSCs 
The analysis of the amount of DNA from cell cultures revealed the inhibition  
of proliferation when cells were cultured in conditioned medium harvested from 
IL1β or SCF stimulated cells. Compared to day 2, there was a 58% increase in DNA 
amount at day 10, whereas in IL1β and SCF groups this increase was 16% and 25%, 
respectively. The highest increase between control, IL1β and SCF groups  
was reported from day 8 to day 10. Indeed, at day 10 the amount of DNA  
was significantly higher in the control group compared to IL1β (p=0.018) and SCF 
(p=0.034) groups (Fig.5.8). 
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Figure 5.8. Diagram showing the amount of mean DNA (Hoechst) with the standard error  
of the mean, quantified during the culture of MSC cells in GM medium with the addition  
of conditioned medium collected 48 hours after the stimulation with 10ng/ml IL1β  
or 100ng/ml SCF. As control, conditioned medium from unstimulated cells was used. DNA 
results were normally distributed and significance between control and IL1β or SCF groups 
was determined at p<0.05 (*) using one-way ANOVA with Games-Howell. 
5.2.2.2. Regulation of osteogenic genes in response to co-culture with 
conditioned media 
The relative gene expression of Runx2, Sox9, ALP, type I collagen (COL1)  
and osteocalcin (OC) was investigated during monolayer cell culture of MSCs  
in conditioned medium. In addition to this, the relation of Runx2/Sox9 as well  
as ALP/Runx2, COL1/Runx2, OC/Runx2 was assessed.  
Culturing cells with conditioned media from stimulated cells had no effect on Sox9 
gene expression when compared to the results from the control groups (Fig.5.9A).  
In fact, the level of Sox9 mRNA at day 7 was similar among DM and GM groups.  
At this time point, only IL CM+DM group had significantly higher expression  
of Sox9 when compared to IL CM+GM (p=0.035). Moreover, even though  
not significant, IL CM+DM showed a slightly higher level of Sox9 mRNA compared  
to Control CM+DM group. There was higher increase in Sox9 gene expression 
between day 7 and day 14 for all 'DM' groups. Furthermore, at day 14, a trend  
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for higher Sox9 expression in 'DM' groups over their respective 'GM' controls was 
detected (Fig.5.9A). 
At day 7 the expression of Runx2 mRNA was at the same level among DM groups  
as well as among GM groups (Fig.5.9B). Yet, the Runx2 gene expression was 
significantly higher in Control CM+DM (p=0.009) IL CM+DM (p=0.041) and SCF 
CM+DM (p=0.034) when compared to its 'GM' controls. There were no significant 
changes in Runx2 gene expression at day 14.  
Type I collagen expression at day 7 was lower in GM groups compared to DM 
groups (Fig.5.9C). There were no differences in COL1 expression between Control 
DM+GM and IL1 CM+DM or SCF CM+DM groups at day 7 and 14. Similar results 
were reported for day 14. Only at day 7, the COL1 expression between Control 
CM+DM (p=0.001), IL1 CM+DM (p=0.002) and SCF CM+DM (p=0.001)  
and respective GM groups reached statistical significance. The expression of COL1 
in IL CM+DM and SCF CM+DM decreased from day 7 to day 14, whereas for the 
Control CM+DM group it remained at the same level.   
The gene expression of ALP at day 7 was significantly higher in all DM groups 
compared to their specific GM controls (p<0.001) (Fig.5.9D). Yet, the combination 
of DM or GM medium with conditioned medium from stimulated cells had no 
influence on ALP mRNA expression at that time point compared to Control 
CM+DM or Control CM+GM groups, respectively. There was a decrease in ALP 
mRNA gene expression between day 7 and 14 in all DM groups. At the same time,  
it showed slight increase in GM groups (Fig.5.9D).  
The gene expression of the late osteoblast marker, osteocalcin (OC), was higher  
in GM groups at day 7 and day 14 (Fig.5.9E). At the former time point,  
the expression of OC mRNA was significantly higher in Control CM+GM (p=0.028) 
and SCF CM+GM (p=0.012) groups compared to Control CM+DM and SCF 
GM+DM groups, respectively. Additionally, at day 7 the OC gene expression was 
higher in IL CM+DM (p=0.049) than Control CM+DM. At day 14, the OC gene 
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expression was at the same level as at day 14 except IL CM+ GM group. For this 
group the gene expression increased from day 7 to day 14.  
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Figure 5.9A-C. Diagrams show the mean fold change in expression of Sox9 (A), Runx2 (B) 
and type I collagen (C) genes at day 7 and 14 in relative to Control CM+GM at day 2 with 
the standard error of the mean (3 experiments, n=9). Gene expression was normalised to 
RPL13a. Statistical significance at p<0.05 was determined using one-way ANOVA with 
Games-Howell. *: compared to Control CM+GM; # compared to IL CM+GM; &: 
statistically significant compared to SCF CM+GM; a: compared to Control CM+DM. 
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Figure 5.9D-E. Diagrams show the mean fold change in expression of ALP (D) and OC (E) 
genes at day 7 and 14 in relative to Control CM+GM at day 2 with the standard error  
of the mean (3 experiments, n=9). Gene expression was normalised to RPL13a. Statistical 
significance at p<0.05 was determined using one-way ANOVA with Games-Howell. *: 
compared to Control CM+GM; # compared to IL CM+GM; &: statistically significant 
compared to SCF CM+GM; a: compared to Control CM+DM. 
In addition to osteogenic genes, the ratio between specific genes and Runx2 
transcription factor or between transcription factors, Runx2 and Sox9, were analysed 
(Fig.5.10.).  
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The analysis of Runx2 to Sox9 ratio, indicating the osteogenic potential of cells, 
showed similar results at day 7 and 14 for IL CM+DM and SCF CM+DM or IL 
CM+GM and SCF CM+GM to Control CM+DM and Control CM+GM groups, 
respectively (Fig.5.10A). Yet, the Runx2/Sox9 was significantly higher in SCF 
CM+DM (p=0.034) than in SCF CM+GM at day 7. Interestingly, the ratio decreased 
in DM groups from day 7 to day 14, whereas in GM it stayed at the same level over 
time. The expression of ALP relative to Runx2 was higher in all DM groups at day 7 
and decreased by day 14 (Fig.5.10B). At the later time point, ALP/Runx2 was  
at the same level in DM and GM groups. At day 7, the ratio in Control CM+DM 
(p<0.001), IL CM+DM (p<0.001) and SCF CM+DM (p<0.001) was significantly 
higher than in respective GM groups. There were no differences in COLl1/Runx2 
between groups at any time point. Although, at day 7 the ratio was higher in DM 
groups compared to their respective GM controls, this trend did not reach statistical 
significance (Fig.5.10C). The OC/Runx2 ratio at day 7 and 14 in IL CM+DM  
and SCF CM+DM was the same as for Control CM+DM (Fig.5.10D). At both time 
points, the OC/Runx2 was lower in Control CM+DM (p<0.001 for d7 and p=0.003 
for d14) and SCF CM+DM (p<0.001 for d7&d14) compared to the respective GM 
groups. For IL CM+DM group at day 7, the OC/Runx2 ratio was significantly lower 
(p=0.039) compared to IL CM+GM.  Moreover, at this time point, the IL1 CM+DM 
group showed lower OC/Runx2 results compared to Control CM+GM. Interestingly, 
the ratio remained at the same level for this group at day 7 and 14, whereas  
it decreased over time for Control CM+GM and SCF CM+GM (Fig.5.10D). 
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Figure 5.10A-B. Diagrams show the gene expression ratio of Runx2/Sox9 (A) and 
ALP/Runx2 (B) at day 7 and 14 with the standard error of the mean. Gene expression was 
normalised to RPL13a and made relative to Control CM+GM at day 2 (3experiments, n=9). 
Statistical significance at p<0.05 was determined using one-way ANOVA with Games-
Howell. *: compared to Control CM+GM; # compared to IL CM+GM; &: compared to SCF 
CM+GM. 
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Figure 5.10C-D. Diagrams show the gene expression ratio of COL1/Runx2 (C) and 
OC/Runx2 (D) at day 7 and 14 with the standard error of the mean. Gene expression was 
normalised to RPL13a and made relative to Control CM+GM at day 2 (3experiments, n=9). 
Statistical significance at p<0.05 was determined using one-way ANOVA with Games-
Howell. *: compared to Control CM+GM; # compared to IL CM+GM; &: compared to SCF 
CM+GM. 
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5.2.2.3. Influence of MSCs co-culture with conditioned media on cell 
functionality (ALP activity and mineral deposition in newly formed 
ECM) 
In addition to investigating the expression of bone related genes, ALP protein 
activity was analysed in MSCs cultured with 50% of conditioned medium.  
The analysis of ALP activity at day 7 and 14 revealed no significant differences 
between stimulated and control 'DM' or 'GM' groups (Fig.5.11). At day 7,  
the enzyme activity showed a trend of lower level in IL CM+DM (p=0.487)  
and SCF CM+DM (p=0.516) groups compared to Control CM+DM group. At both 
time points, the enzyme activity was significantly higher in cells cultured in DM 
medium compared to results from GM groups. There was 2.7-fold higher ALP level 
in Control CM+DM group than in Control CM+GM group (p=0.006) at day 7. 
Similarly, a 2.6- and 3.2-fold difference, was detected for IL CM+DM vs IL 
CM+GM groups (p=0.002) and SCF CM+DM vs SCF CM+GM (p=0.020) groups, 
respectively (Fig.5.11).  
At day 14 there were no differences when comparing Control CM+DM  
and IL CM+DM (p=0.920) or SCF+DM (p=0.929) groups (Fig.5.11). Similarly,  
the ALP activity was at the same level in all 'GM' groups (p>0.7 for all 
comparisons). The ALP activity in DM groups was significantly higher than 
respective GM groups at day 14. The increase between DM and GM was similar  
for all treatments. Specifically, it was 1.74-, 1.80- and 1.62-fold higher between 
Control CM+DM and Control CM+DM (p=0.003), IL CM+DM and IL CM+DM 
(p=0.001), SCF CM+DM and SCF CM+DM (p=0.020), respectively. 
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Figure 5.11. Diagram shows the mean alkaline phosphatase (ALP) activity in 30 minutes 
relative to the amount of DNA with the standard error of the mean (3 experiments, n=9). 
Statistical significance at p<0.05 was determined using Kruskal-Wallis with Mann Whitney 
test for pairwise comparisons. *: compared to Control CM+GM; # compared to IL CM+GM; 
&: compared to SCF CM+GM. 
The mineralisation of newly in vitro formed ECM was determined with Alizarin Red 
S staining and quantitation assay as described in paragraph 2.2.15.1 and 2.2.15.2. 
The amount of bound ARS to calcium was evaluated relative to the amount of DNA. 
MSC cells from one donor were cultured with conditioned medium from 
unstimulated or stimulated cells harvested from MSC cells from 3 different donors 
(#5, #7 and #9). After 2 weeks of in vitro cell culture with conditioned medium from 
donor 5, monolayer cultures tend to contract and fold preventing the analysis  
of ECM mineralisation in these cell cultures.  
The ARS staining at day 28 of cell culture was positive in all cultures maintained 
with the addition of differentiation supplements (DM medium) (Fig.5.12A-C). 
Interestingly, in IL CM+DM and SCF CM+DM groups cells developed regions with 
thicker multilayer and larger nodules compared to the Control CM+DM group.  
In the latter, mineral deposition was more scattered throughout the whole cell layer 
(Fig.5.12). Although, the staining results could indicate higher mineralisation  
in cultures with the addition of conditioned medium from stimulated cells,  
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the quantitation analysis relative to the amount of DNA revealed no significant 
differences in the ARS bound to the ECM relative to DNA (Fig.5.13). The amount  
of bound ARS for all DM groups was in the range 4.60-4.98nmol bound ARS per µg 
DNA. MSCs maintained in GM with the addition of different conditioned media 
developed nodules (Fig.5.12D-F). Yet, it seemed that similarly to DM groups, this 
was more advanced in cultures with the addition of IL CM and SCF CM. However, 
in any GM group no calcium deposition within the ECM was reported with ARS 
staining. The quantification analysis showed no difference between Control CM+GM 
and IL CM+GM or SCF CM+GM groups (Fig.5.13). 
 
Figure 5.12. Representative images of Alizarin Red S staining of MSC at day 28. Cells were 
cultured in conditioned medium with the addition of DM (A-C) or GM (D-F); Conditioned 
medium was collected from unstimulated cells (A, D) and cells stimulated with 10ng/ml 
IL1β (B, E) and 100ng/ml SCF (C, F). Scale bar 1 mm. 
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Figure 5.13. Diagram shows the mean amount of bound Alizarin Red S (ARS) with  
the standard deviation of the mean (n=6), at day 28 the culture of MSC cells in DM or GM 
medium with the addition of conditioned medium collected 48 hours after the stimulation 
with 10ng/ml IL1β or 100ng/ml SCF. As control, conditioned medium from unstimulated 
cells was used.  
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5.3. Discussion 
Investigations within this chapter focused on the influence of one-way cell-cell 
communication on MSCs differentiation into osteoblastic phenotype and whether this 
differentiation can be enhanced indirectly. In addition, the direct effects of cells 
stimulation with chemotactic and inflammatory factors were investigated. 
Preconditioning of cells and genetic engineering are two approaches to increase  
the production of specific factors by cells. We hypothesised that since the secretion 
of tropic factors is modulated in vivo by chemotactic and inflammatory factors,  
the use of these factors could provide a strategy to enhance the paracrine actions  
of cells. Four factors, which are the players in the early stages of bone healing 
cascade, namely Stem Cell Factor (SCF) and interleukin 1β (IL1β), stromal cell-
derived factor 1 (SDF1) and granulocyte colony-stimulating factor (GCSF), were 
included for this analysis.  
At first, the effect of all 4 factors, IL1β, SCF, GCSF and SDF1, on cytokine gene 
expression in MSCs was analysed. Only 2 hours stimulation of cells with each  
of these factors resulted in a cell response which was still pronounced 72 hours after 
the treatment. Compared to other factors, the stimulation with IL1β regulated the 
mRNA expression of the highest number of cytokine genes emphasising  
the multifunctional role of this cytokine. Interestingly, only one cytokine gene, 
NODAL, was up-regulated by all 4 factors. The functional analysis regulated factors 
demonstrated that, on a gene expression level, IL1β, SCF, GCSF and SDF1 influence 
the expression of cytokines important at different stages of the bone healing process. 
The widest range of genes was regulated by IL1β. This cytokine induced regulation 
of genes involved in bone formation, osteoclastogenesis, chondrogenesis  
and immunomodulation indicating its multiple actions and importance in bone 
healing process. Similarly, the results obtained from cells stimulated by GCSF 
indicated the influence of this cytokine on differentiation pathways, such as 
osteogenic, chondrogenic and angiogenic. Except for NODAL gene expression, SCF 
and SDF1 stimulation resulted in regulation of different cytokine genes compared  
to response of IL1β treatment. Interestingly, the synergic effects of SCF and GCSF 
on stimulating proliferation and inhibiting differentiation of rabbit MSCs have been 
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reported (Tang et al., 2009). Hence, it would be of interest to analyse whether  
the combined stimulation of MSCs with all or some of factors included in this study 
synergises and results in stronger response.  
Due to the high interest in IL1β-regulated osteogenic differentiation (Ferreira et al., 
2012;Sonomoto et al., 2012;Mumme et al., 2012;Lee et al., 2010) and recent 
promising influences of SCF on tissue regeneration (Kim et al., 2011;Pan et al., 
2013), our further investigations focused on a more detailed analysis  
of the direct and indirect effects of these two cytokines. Interestingly, 48 hours after  
the stimulation, the treatment with IL1β or SCF showed more pronounced effects  
on the cytokine gene expression compared to results of the analysis made 72 hours 
after the stimulation. After IL1β stimulation, 11 cytokine genes were up-regulated  
and 9 cytokine genes were down-regulated, whereas SCF resulted in the up-
regulation of 13 cytokine genes.  BMP2, BMP6, IL6, IL8 and GDF5 showed  
the same response to IL1β treatment 48 and 72 hours after the stimulation. No effect 
on TNSFSFF11, NODAL and IL117b was found 48 hours after IL1β treatment,  
but the up-regulation of TNSFSFF11, NODAL and down-regulation of IL17b was 
detected after an additional 24 hours, suggesting these may be downstream events. 
Similarly, only TNFSF14 and IL1α, but not GDF9 and NODAL gene expression 
were up-regulated 48 hours after SCF stimulation, whereas all of these cytokines 
were up-regulated 72 hours after the SCF treatment. These partial variances  
in the response to the IL1β and SCF stimulation could be attributed to the differences 
in the experimental setting. First of all, the effect of IL1β and SCF treatment on cells 
was evaluated after 48 or 72 hours. It is highly probable that the expression of some  
of the genes increases or diminishes in the 24 hour frame between both time points, 
especially as some genes may be induced by the factors induced during the early 
time points and may not be directly responsive to the cytokine used. It also has to be 
emphasised that the stimulation with 10ng/ml IL1β and 100ng/ml SCF was 
performed in the same conditions (DMEM, 10% FCS and 1% penicillin-
streptomycin), but following the stimulation cells were maintained for 48 hours in 
medium without serum and for 72 hours in medium with serum.   
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Serum contains a wide range of minor components including nutrients, hormones, 
growth factors, minerals and lipids. Although, serum has been globally used in cell 
culture protocols, the concentrations and actions of all these components are not fully 
determined and the existence of variations between batches of serum is known.  
The latter issue may result in significant variation in MSCs properties and osteogenic 
differentiation behaviour.  The presence of the serum constituents could affect  
the regulation of various signalling pathways and the expression of cytokine genes. 
Although, within this study, all the analysis of the direct effects of short term 
stimulation with different factors was made relative to the untreated cells, it would be 
interesting to directly assess/evaluate to what extend the stimulation of MSCs with 
different factors is affected by the serum.  
However, our initial approach was to analyse the direct effects of stimulation  
of MSCs, regarding the indirect effects of short-term stimulation of MSCs with IL1β 
and SCF. Being aware of the potential influence that the serum can cause, the further 
analysis of gene expression and protein secretion by cells in response to IL1β  
and SCF was analysed in cultures maintained in a serum-free medium.  
IL1β and SCF regulated the expression of members of interleukin family, including 
IL1α, IL1β, IL5, IL6, IL8, IL12A, IL17, IL18, IL21 and IL2Rα. These cytokines 
have been recognized for their proinflammatory role and destructive effects on bone 
in pathological conditions including OA (Kapoor et al., 2011;Fernandes et al., 2002). 
Paradoxically, in the context of bone regeneration, the presence of some of these 
proinflammatory cytokines promotes the bone regeneration in multiple ways. 
Importantly, this positive effect strongly depends on the timing of their expression. 
Both, IL12 and IL18 have been shown to inhibit in vitro osteoclast differentiation.  
In addition, IL18 directly induces IL6 production, which is known for its potent roles 
at early stages of the bone healing process (Gracie et al., 2003). In fact, IL6 together 
with IL8 are the major angiogenic factors stimulating vascular endothelial growth 
factor (VEGF) during fracture healing (Martin et al., 2009;Kolar et al., 2011). IL1β 
treatment increased the gene and protein expression of IL6 and IL8, whereas SCF 
had an opposite effect on gene expression of these cytokines (Fig.4.5A) suggesting 
the involvement of IL1β, but not SCF, in triggering angiogenesis. On the other hand, 
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the SCF stimulatory effects on angiogenesis could be mediated through  
the up-regulation of IL18 cytokine gene expression which induces production of IL6 
(Gracie et al., 2003).  
The gene expression of osteoblastic phenotype regulatory factors, such as BMP2, 
BMP3, BMP4, BMP5, BMP7, TGFβ3, GDF5 and GDF8, was lower in cells after 
IL1β treatment. BMPs are important for proliferation, osteoblastic and chondrogenic 
differentiation, morphogenesis and apoptosis. A heterodimeric association  
of BMP4/7 and BMP2/7 regulates the proliferation of MSCs and induces  
the differentiation of MSCs into osteoblastic lineage (Tsiridis et al., 2007). Similarly, 
BMP5 and TGFβ3 possess osteoinductive properties (Wozney, 2002). At the same 
time, BMP6, a factor implicated in chondrocyte maturation, was up-regulated after 
the stimulation with IL1β. GDF5 and GDF8 are involved in chondrogenesis  
and callus formation. GDF8, a known negative regulator of skeletal muscle growth, 
stimulates the adipogenic differentiation in mesenchymal stem cells whereas its 
absence increases osteogenic differentiation (Artaza et al., 2005;Hamrick et al., 
2007). Interestingly, Kellum and co-workers reported a positive correlation of GDF8 
deficiency and fracture callus size in a mouse in vivo model (Kellum et al., 2009). 
The down-regulation of BMP together with the down-regulation of Wnt molecules 
upon stimulation suggest the inhibitory effects of IL1β on osteogenic differentiation 
of MSCs. On the other hand the increased expression of chondrogenic messengers 
recapitulates the sequence of early events occurring during fracture healing where 
fracture callus formation and angiogenesis precede osteogenesis. 
In addition to the assessment of cytokine genes in response to 2 hours stimulation  
of cells with IL1β and SCF, the expression of Wnt signalling pathway components 
and their relation to Sox9 and Runx2 transcription factor gene expression was 
analysed 48 hours after the treatment. The analysis of Wnt 3a, 4, 5a, 7b and βcatenin 
mRNA expression in cells stimulated with IL1β or SCF relative to untreated cells 
was strongly donor dependent. Interestingly, in the experimental setting within this 
study, the expression of Wnt3a was not detected in cells, neither with nor without  
the stimulation with IL1β or SCF. In cells from 2 donors (#5 and # 8) the Wnt4 gene 
expression was detectable in control samples and in treated cells; whereas Wnt5a, 7b 
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and βcatenin were expressed in stimulated and unstimulated cells. Both, Wnt3a  
and Wnt4 together with βcatenin are involved in the canonical Wnt pathway which  
is known to stimulate the expression of important osteogenic molecules, such  
as alkaline phosphatase (ALP), osteocalcin (OC), bone morphogenic protein 2 
(BMP2) and the transcriptional factor Runx2 (Kim et al., 2013), and inhibit the non-
canonical pathway (Boland et al., 2004). Importantly, the effect of canonical Wnt 
signalling on osteogenesis is highly dependent on the stage of target cells (Ling et al., 
2009). Wnt5a and Wnt7b activate the non-canonical Wnt signalling pathway which 
induces several cascades, including planar-cell polarity (PCP), c-Jun N-terminal 
kinase (JNK), Nemo-like kinase (NLK) and Rho-associated kinase (ROK) signalling 
(Ling et al., 2009).  
Results within this chapter indicated that although the stimulation with IL1β had no 
significant effect on Wnt5a, Wnt7b and βcatenin gene expression, Wnt7b showed a 
trend of increased expression upon the treatment with IL1β (Fig.4.5). This was in 
conjunction with significant decrease in Runx2 and Sox9 gene expression (Fig.4.5). 
The treatment with SCF showed a similar trend in Wnt5a, Wnt7b, Runx2 and Sox9 
gene expression as reported for IL1β stimulation.  However, in case of SCF 
stimulation, the expression of Wnt7b was significantly down-regulated. Based on 
research evidence, the canonical Wnt signalling stimulates the differentiation  
of MSCs which are committed to osteogenic lineage, whereas it suppresses the 
terminal differentiation of mature osteoblasts (Ling et al., 2009). The former process 
is promoted through the up-regulation of Runx2, which along with Sox9,  
is a transcriptional effector of the canonical Wnt signalling (Parr et al., 1993;Eames 
et al., 2004). Interestingly, Runx2 expression is also regulated by Wnt5a in the non-
canonical Wnt pathway (Arnsdorf et al., 2009). Although, the expression of Runx2 
and Sox9 was down-regulated upon the stimulation of MSCs with IL1β  
or SCF, the Runx2/Sox9 ratio remained at the same level.  
In fact, experiments within our group showed the chronic stimulation of cells with 
IL1β induces proliferation and osteogenic differentiation of MSCs with subsequent 
promotion of ECM mineralisation (Loebel et al., 2014b). The promotion of 
osteogenic differentiation by IL1β is dependent on the non-canonical Wnt pathway 
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stimulating Runx2 gene expression (Sonomoto et al., 2012). Results presented within 
this chapter and our further observations showed that the short term treatment 
induces other mechanisms and outcomes in MSCs osteogenic differentiation  
in a monolayer cultures. The direct two hours treatment with IL1β was not sufficient 
to induce the same effects on the MSCs osteogenic differentiation as the chronic 
treatment (unpublished results). Moreover, as presented in this chapter, both IL1β 
and SCF inhibit mRNA expression of molecules involved in the induction  
of osteogenic differentiation, including components of the canonical and non-
canonical Wnt and BMP2. There is no previous evidence comparing the short and 
chronic effects of SCF on the osteogenic differentiation. Hence, it is difficult  
to speculate whether SCF has any influential direct role on the osteogenic 
differentiation. Nevertheless, the protein analysis of conditioned medium revealed 
the increased secretion by MSCs of a number of proteins involved in the bone 
formation process (Tab.4.2) in response to the short term stimulation with IL1β  
or SCF. In line with mRNA results, no BMP2 was present in the condition medium. 
Instead, IL1β promoted the secretion of wide range of proteins with chemotactic, 
proinflammatory and angiogenic properties, whereas SCF regulated the expression of 
proteins involved in proliferation, chondrogenesis and ECM regulation. 
Interestingly, the presented results from post-stimulation serum-free cultures showed 
the mRNA expression of receptor activator of NF-κβ ligand (RANKL) was down-
regulated, whereas at the same time TNFRSF11b was up-regulated in response to  
the stimulation with IL1β or SCF. RANKL is a paracrine factor involved  
in osteoblast-osteoclast progenitor cells cross-talk. Secreted RANKL protein binds  
to RANK receptor on the osteoclast progenitor cell surface activating  
the differentiation of the osteoclast phenotype (Udagawa et al., 1999).TNFRSF11b  
is gene coding the osteoprotegerin (OPG) protein known as inhibitor  
of osteoclastogenesis and activation of mature osteoclasts. In detail, OPG  
is the decoy receptor for RANKL expressed and secreted by osteoblasts  
and osteoprogenitor cells. Moreover, studies showed the regulation of OPG  
and RANKL is Wnt signalling dependent (Maeda et al., 2013;Maeda et al., 2012). 
Although, the protein level of OPG in the conditioned medium 48 hours after  
the stimulation of MSCs with IL1β or SCF was at the same level as in untreated cells 
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(data not shown), based on the mRNA expression level results, short term 
stimulation with IL1β or SCF suggest the indirect inhibitory effects of IL1β and SCF 
on the differentiation of osteoclasts. Additionally, Wnt gene expression results 
indicated that the regulation of OPG and RANKL in response to IL1β and SCF  
is independent on the Wnt pathway. Together with results regarding OPG  
and RANKL, the mRNA expression of additional factors inhibiting osteo-
clastogenesis was positively regulated in response to the stimulation with IL1β and 
SCF. The latter up-regulated the expression of IL18, stimulating the production  
of osteoclast differentiation inhibitor, granulocyte macrophage colony-stimulating 
factor (GM-CSF), by T-cells (Horwood et al., 1998;Gracie et al., 2003). In case  
of short-term stimulation of MSCs with IL1β, the expression of GM-SCF gene was 
directly up-regulated after the treatment.   
Understanding the mechanisms involved in the indirect effects of preconditioning, 
i.e. due to the enhancement of the secretion of trophic factors acting in a paracrine 
manner, would be of great interest for cell-based regenerative therapies. Therefore, 
the relevance of the secreted factors, in supporting MSC proliferation  
and differentiation towards the osteoblastic lineage, was analysed. In order to reduce 
the influence of proteins present in the medium on osteogenic differentiation,  
the final concentration of FBS included in medium was 1%. Moreover, being aware 
of the donor variability, all repeats of the conditioned medium (CM) experiments 
were performed with cells obtained from one MSCs donor, which was previously 
evaluated in our laboratory as positive for undergoing osteogenic differentiation.  
For proliferation and differentiation evaluation these cells were cultured in CM 
collected from cells isolated from a bone marrow harvested from 3 donors.  
Within the monolayer indirect co-culture system, the conditioned medium collected 
from unstimulated (Control CM+GM) and stimulated cells with IL1β (IL1 CM+GM) 
or SCF (SCF CM+GM) had a significant effect on MSC proliferation. Although, 
stimulation of MSCs with SCF or IL1 up-regulated some mitogenic proteins,  
IL1 CM+GM and SCF CM+GM had an inhibitory effect on MSC proliferation 
during the 10 day culture period. In Control CM+GM group an increase of DNA 
amount was observed from day 2 to day 10.  
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Further investigations were made to analyse the osteogenic differentiation of MSCs 
cultured in the conditioned medium with the addition of growth or differentiation 
media.  
The differentiation of MSCs is regulated by the transcription factors which 'switch 
on' the specific differentiation programme. Runx2 has been described as an early 
osteogenic differentiation marker as it is up-regulated during the mesenchymal 
condensation, which leads to the formation of pre-osteoblasts (Ducy et al., 1997). 
Sox9 activates the expression of genes specific for cartilage phenotype, including 
type II collagen and aggrecan. The results from in vivo investigations indicated that  
in endochondral ossification Sox9 expression precedes the expression of Runx2 
(Eames et al., 2004). The recent results from our laboratory indicated that in vitro  
the osteogenic differentiation of cells correlated with the relative expression  
of Runx2 to Sox9 ratio within 7 days of culture (Loebel et al., 2014a). The gene 
expression analysis of Sox9, Runx2 and Runx2/Sox9 revealed no differences 
between groups maintained in different CM with DM or CM with GM. Although, 
there was an increase in gene expression from day 7 to day 14 for both Runx2  
and Sox9, there were no significant differences in Runx2/Sox9 ratio for all groups  
at either time point. The expression of later osteogenic markers, type I collagen,  
ALP and osteocalcin was at a similar level in IL CM and SCF CM compared  
to the respective control CM DM or GM groups. ALP/Runx2, COL1/Runx2  
and OC/Runx2 ratios were analysed as differentiation index indicative of more 
advanced osteogenic differentiation with the higher ratio values. The differentiation 
indexes showed similar results between IL CM and SCF CM and the respective 
control CM DM or GM groups. The Alizarin Red S staining results could suggest 
that culturing MSC cells in DM with the addition of IL CM and SCF DM promotes 
the nodule formation compared to DM with control CM. However, there was  
no correlation of these observations with the quantitative results relative to the DNA 
amount. Similarly, no differences were reported for ALP activity in cultures 
maintained in the DM or GM media containing control CM, IL CM or SCF CM. 
According to the results from the CM co-culture model, the range of proteins 
produced by cells in response to IL1β or SCF treatment has no pronounced effects  
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on the osteogenic differentiation of MSCs over the effects of proteins secreted  
by the unstimulated cells. 
Regarding gene expression analysis, the OC mRNA was reported at a higher level  
in GM than DM conditions, whereas an inverse relation was reported for other 
osteogenic differentiation markers. It has been suggested that the supplementation  
of cell culture medium with dexamethasone, 1,25(OH)2D3, β-glycerophosphate, 
ascorbic acid and BMPs, is effective in directing osteoblast mineralisation  
(Arnett, 1990;Jorgensen et al., 2004). It has been shown that dexamethasone,  
in a physiological range 10
-7 
to 10
-9 
M
 
promotes more differentiated osteoblast cells 
phenotype and nodule formation (Yang et al., 2003;Bellows et al., 1987). 
Nevertheless, the conflicting results regarding cell proliferation, ALP activity, type  
I collagen synthesis and osteocalcin have been reported (Yang et al., 2003;Sutherland 
et al., 1995;Wong et al., 1990;Lian et al., 1997;Chen and Fry, 1999;Kim et al., 1999). 
One of the reasons to which these differences are related is the origin of cells.  
In contrary to observations from rat osteoblast cell cultures, the chronic exposure  
of mouse osteoblast cells to dexamethasone initiated during the proliferation period, 
blocked osteoblast differentiation indicating differential species-specific mechanisms 
of response to dexamethasone administration (Lian et al., 1997;Chen and Fry, 1999). 
Similarly, the dexamethasone supplementation of cell culture medium for MSCs 
decreased proliferation rate, type I collagen mRNA and protein expression  
and osteocalcin production (Kim et al., 1999;Jorgensen et al., 2004). Similar results 
regarding osteocalcin production were seen for primary human osteoblasts (Viereck 
et al., 2002). The here reported lower expression of OC in medium supplemented 
with dexamethasone supports previous observations and suggest negative effect  
of this glucocorticoid on the development of the mature osteoblastic phenotype. 
It has to be mentioned that for the CM study, the monolayer culture system was 
applied which may not be the best and can sorely affect results. SCF and IL1β are 
released at the inflammation phase of secondary bone healing analogous  
to endochondral bone formation (Shapiro, 2008). It is challenging to recapitulate 
endochondral ossification in an in vitro culture. However, the controlled stimulation 
of the chondrogenic differentiation followed by the osteogenic differentiation  
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of MSCs in a 3D in vitro culture results in formation of bone tissue via  
an endochondral ossification (Muraglia et al., 2003;Scotti et al., 2010). 
Differentiation of MSCs in monolayer cell culture focuses on the direct stimulation 
of osteogenesis which is alike intramembranous ossification. In vivo this process  
is related to the primary bone healing in which hematoma does not occur (Kolar et 
al., 2011;Giannoudis et al., 2007). As consequence, the influx of inflammatory cells 
and the release of the inflammatory and chemotactic factors are absent. Hence,  
the primary bone healing is not affected by inflammation causing changes in cells 
present at the fracture site. Furthermore, the parameters, such as surface roughness, 
are critical for cell behaviour. The recent research evidences regarding the short term 
stimulation of human adipose derived stem cells to enhance osteogenic 
differentiation showed superior results in a 3D biphasic calcium phosphate scaffold 
(pore size 100-500um) compared to a 2D culture on tissue polystyrene (Overman et 
al., 2013a). Moreover, in response to short term pre-treatment of cells with BMP2 the 
gene expression of trophic factors was differentially regulated in cells cultured in 3D 
compared to monolayer (Overman et al., 2013b). With respect to these results,  
a monolayer culture system is a clear limitation of our study. Therefore, it seems  
that the analysis of the indirect effects of MSCs stimulation with IL1β or SCF  
in a 3D in vitro model investigating endochondral ossification rather than osteo-
genesis would provide more relevant and unambiguous results. 
Taken together the secrotome of MSCs can be modified over longer periods by way 
of a short stimulation which could be performed intra-operatively. However,  
to investigate these effects more reliably a 3D endochondral model may be more 
suitable.
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6.1. Introduction 
Since the first attempt of isolation and in vitro culture of osteoblast cells from adult 
human bone (Bard et al., 1972), a great improvement in the knowledge of the biology 
of bone and, in particular, osteoblastic cells has been made. Most of this has been 
achieved through the analysis of various aspects of bone cell phenotype in an in vitro 
monolayer cell culture. In fact, this simplified system is considered as the gold 
standard in vitro culture model as it ensures the controlled culture environment. 
Nevertheless, within bone, cells are embedded in a mineralised organic matrix 
composed of type I collagen, non-collagenous proteins and hydroxyapatite. In this 
milieu, bone cells interact with each other and with the ECM through soluble factors 
or direct cell-cell and cell-matrix interactions. Having this in mind, it is evident that 
in monolayer culture system many of these interactions occurring in vivo are 
neglected.  
For a better understanding of the processes occurring in bone, the requirement  
of a reliable in vitro cell culture model is critical. When considering the composition 
of bone, it is clear that formulating an in vitro cell culture model based on naturally 
occurring components would be the most advantageous. In this chapter the focus is 
directed towards the osteogenic differentiation of bone progenitor cells in order  
to compare this process in a 2D monolayer and two types of 3D in vitro culture 
models, with the emphasis on 3D models which are supported by the naturally 
occurring components in the bone.  The following paragraphs of this introduction 
bring the concept of the influence of the in vitro cell culture environment on the 
osteoblast-like phenotype. 
In vitro differentiation of osteoblast cells has been extensively studied  
in 2D monolayer conditions. Indeed, the full differentiation process,  
from proliferation to mineral deposition can be recapitulated in monolayer cell 
culture for osteogenic cells. The generally accepted temporal sequence of expression 
osteoblast markers during cell phenotype development was established  
in low-density seeded monolayer culture of rat calvaria derived cells by Lian  
and Stein (Lian and Stein, 1992). A similar progression in phenotype has been 
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reported for cells from other origins including primary cells from animals and some 
cell lines (Wang et al., 1999;Buttery et al., 2001). Although, primary human 
osteoblast cells of foetal origin undergo a progress similar to rat osteoblast cells from 
proliferation, through matrix production and maturation, to mineralisation of ECM; it 
has been shown that adult human derived HOb's not always are able to complete 
osteogenesis up to mineral deposition in vitro in monolayer cell culture (Hughes and 
Aubin, 1998;Di Silvio and Gurav, 2001). These findings emphasise the limitation  
of the monolayer culture systems in studying the late stages of osteogenesis. It is also 
evident that monolayer cell culture system is not physiologically relevant. 
To overcome this limitation, and provide a physiologically more relevant context, 
culturing osteoblast cells in a 3D environment has attracted a lot of interest. 
Maintaining cells in 3D systems, such as spheroids, micromass and pellets, promotes 
progression in osteoblastic differentiation leading to osteoblast cell maturation  
(Kale et al., 2000;Gerber and ap Gwynn, 2002;Jahn et al., 2010). These simple  
3D models are supported by the ECM produced by cultured cells and were utilised 
for culturing primary human or rat osteoblast cells. Results from 3D high density cell 
cultures revealed considerable differences compared to standard monolayer 
conditions. Cells in micromass promote earlier differentiation by increasing collagen 
production, together with decreasing proliferation due cell-cell contact being 
established early (Gerber and ap Gwynn, 2002). Similarly, osteoblast cell phenotype 
progression was observed for human osteoblast cells in pellet and spheroids cultures 
compared to monolayer cultures (Kale et al., 2000;Jahn et al., 2010). Human bone 
precursor or osteoblast cells in spheroids, formed by induction with TGFβ1,  
had increased osteonectin and alkaline phosphatase gene expression and collagen 
synthesis compared to monolayer cells (Kale et al., 2000). Moreover, 3D bone cell 
cultures based on high cell numbers contributed to the establishment of a more 
complex model for endochondral bone development. Formation of osteochondral 
structures within pellets was achieved from bone-derived MSC cells and cells from 
human foetal femurs (Muraglia et al., 2003;El-Serafi et al., 2011;Tortelli et al., 
2010). 
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Bone tissue engineering approaches focus on combining stem cell therapy with 
scaffolds, membranes, sponges, natural and synthetic hydrogels, which can  
be implanted into the body and would enhance tissue regeneration process.  
Type I collagen is the major component of ECM, constituting 90% of the organic 
material in bone (Currey, 2008). Therefore, a huge attention has been directed 
towards the use of the collagen gels as biomimetic substrates or scaffolds  
in cell-driven remodelling events. Type I collagen can be extracted from various 
sources, including rat, bovine and equine tendon, porcine skin, and human and ovine 
placenta. Commercially available products, such as Collapat II (BioMet, Inc), Healos 
(Deputy Spine, Inc), Collagreaft (Neucoll, Inc; Zimmer, Inc) or Biostate (Vebas, 
s.r.l), for hard tissue repair are based on bovine and equine type I collagen 
components (Wahl and Czernuszka, 2006).  
Type I collagen has been shown to be fundamental for the developmental expression 
of the osteoblast phenotype and the formation of mineralised matrix (Owen et al., 
1990;Lynch et al., 1995). Culturing cells on type I collagen enhances expression  
of osteoblastic markers and results in uniform mineralisation of ECM (Lynch et al., 
1995). Interaction of type I collagen with α2β1 integrin on the cell surface  
is crucial for initiation of osteoblastic phenotype differentiation. Upon interaction  
the mitogen-activated protein kinase (MAPK) pathway is activated. This activation 
results in phosphorylation and activation of Runx2 (Wenstrup et al., 1996), which  
is required for the activation of the osteocalcin promoter within the nucleus (Xiao et 
al., 1998). The discrepancies in the response of cells in monolayer or type I collagen 
gels are evident. The typical temporal monolayer cultures pattern of specific gene 
expression, is shifted in cells cultured on collagen gels (Lian and Stein, 1995). ALP 
activity was observed before the proliferation phase of cells cultured on collagen gels 
was completed (Lian and Stein, 1995;Lynch et al., 1995). Recent results, showed that 
murine osteoblast cells seeded on top of type I collagen gel were able to migrate into 
the collagen gel and differentiate towards an osteocyte-like phenotype (Uchihashi et 
al., 2012). Similar stimulation of differentiation towards mature osteoblasts  
and osteocytes was reported for cells within dense type I collagen gel achieved  
by plastic compression (Buxton et al., 2008). 
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This chapter will investigate the influence of the in vitro cell culture environment  
on the osteoblast-like phenotype. Specifically, monolayer culture will be compared 
with 3D culture models. Two 3D culture models will be used, including standard 
high density micromass culture and a novel type I collagen-hydroxyapatite hydrogel. 
Through employing two different systems, the importance of the ECM for osteoblast 
and bone derived MSC cell phenotype development will be investigated.  
We aim to establish a 3D osteoblast cell model resembling a more natural milieu 
allowing for a better understanding of osteoblastic cell development. 
6.2. Results 
6.2.1. Type I collagen gel-hydroxyapatite gel formulation and opti-
misation process 
Prior the culturing of cells within 3D type I collagen system, the collagen hydrogel 
polymerisation and stability were optimised (Tab.6.1.). Specifically, the con-
centration had a huge impact on polymerisation efficacy. In addition, since the gel 
was not cross-linked with any agent, the stability of gel with cells was low. Gel 
shrinkage in DMEM culture medium was observed from day 5. The addition  
of 1mg hydroxyapatite (HAP) particles (80-200µm) per 1ml of the gel dramatically 
improved gel stability.  In order to prevent the formation of a cell monolayer below 
the gel, the collagen-hydroxyapatite (CHAP) gels containing cells were placed  
on the surface pre-coated with 2% agarose. However, due to compromised gel 
stability during long-term cell culture, pre-coating the tissue culture polystyrene with 
type I collagen gel was investigated and dramatically improved long term stability  
of CHAP (Tab.6.1).  
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Table 6.1. The description of the type I collagen-hydroxyapatite optimisation process. HAP-
hydroxyapatite. 
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The initial experiments focusing on the qualitative analysis of human MSC viability 
within CHAP gels revealed no negative influence of type I collagen-hydroxyapatite 
gel on MSC cell viability (Fig.6.1.). At day 2, cells were alive and started spreading 
on the collagen (Fig.6.1.). Additionally, the high level of viability is sustained  
up to day 37 of culture. At this time point, cells had spindle morphology and were 
well interconnected (Fig.6.1.). 
 
Figure 6.1. Representative microphotographs showing the viability of MSCs cultured within 
type I collagen-hydroxyapatite gel (CHAP) at day 2 (A, B) and day 37 (C, D). A&C: live 
(green) cells labelled with calcein AM, B&D: dead (red) cells labelled with ethidium 
homodimer-1. Scale bar 100µm. 
6.2.2. Comparison of in vitro culture systems 
6.2.2.1. ALP activity & immunolabelling 
The ALP protein activity was analysed in human MSCs cultured in monolayer, 
micromass and type I collagen-hydroxyapatite gel in differentiation (DM) or growth 
(control; GM) medium. The composition of 'GM' medium was the same as indicated 
in paragraph 2.2.1.1. The 'DM' medium was composed of 'GM' supplemented with 
50µg/ml ascorbic acid, 10nM dexamethasone and 5mM β-glycerolphosphate.  
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The analysis of ALP activity at day 2, 7, 14 and 21 revealed no significant 
differences between MSCs cultured in micromass or type I collagen-hydroxyapatite 
compared to cells monolayer in DM (Fig.6.2). In DM conditions, micromass  
and type I collagen-hydroxyapatite demonstrated a trend of lower ALP activity 
compared to monolayer at day 2. An interesting trend was observed for the enzyme 
activity for DM groups at day 14. At that time point, ALP reached its maximum level 
in all culture systems. This level was the same for monolayer and type I collagen-
hydroxyapatite cultures, whereas it was 1.65-fold higher for micromass (Fig.6.2).  
At day 7 and 21 the ALP activity was at the same level in all DM groups (Fig.6.2). 
Similarly as for DM groups, the maximum ALP activity for cells in different culture 
systems maintained in GM was reported at day 14 (Fig.6.2). In these conditions,  
the enzyme activity was lower in micromass and type I collagen-hydroxyapatite 
cultures compared to monolayer at day 2. Similar results were reported at day 14  
and 21. At day 14 the ALP activity in MSCs cultured in micromass in GM was 2.9-
fold lower compared to monolayer GM group (p=0.018) (Fig.6.2). 
 
Figure 6.2. Diagram shows the mean alkaline phosphatase (ALP) activity in 30 minutes 
relative to the amount of DNA with the standard error of the mean (3 experiments, n=9). 
MSCs were cultured in monolayer (ML), micromass (MM) and type I collagen-
hydroxyapatite gel (CHAP) in differentiation medium (DM) or growth medium (GM) for 2, 
7, 14 and 21 days. Statistical significance at p<0.05 was determined using two-way ANOVA 
with Least Significant Difference adjustment for multiple comparisons. *: compared to ML 
DM at that time point; #: compared to ML GM compared at that time point.  
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In addition to the quantitative analysis, the location of ALP activity within  
micromass and type I collagen-hydroxyapatite gel cultures at day 14 of culture  
in DM and GM was determined by immunohistochemistry. A uniform labelling 
throughout micromass and type I collagen-hydroxyapatite was demonstrated at day 
14 (Fig.6.3). Compared to GM groups, immune-labelling was more intense in DM 
for both, micromass and type I collagen-hydroxyapatite groups indicating higher 
ALP activity in DM groups. Lower activity was observed for type I collagen-
hydroxyapatite groups compared to micromass groups (Fig.6.3). These observations 
are consistent with the protein activity data at the same time point (Fig.6.2).  
 
Figure 6.3. Micrographs show immuno-labelling of alkaline phosphatase detected within 
micromass (A, B) and type 1 collagen-hydroxyapatite (C, D) of MSCs (♂ 22 years old) at 
day 14 of culture in differentiation medium (A, C) and growth (control) medium (B, D). 
ALP positive cells are indicated by blue arrow.  
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Immunolabelling of osteocalcin protein within ECM during micromass and type  
I collagen-hydroxyapatite culture of MSCs was performed. When maintained in DM, 
cells remained in spherical shaped micromass, whereas MSCs cultured in GM tend  
to spread out and form more a loosely connected sphere-like structure (Fig.6.4).  
For micromass, the OC labelling was more pronounced in GM groups compared  
to DM. More intense cellular and ECM labelling was demonstrated for micromass 
groups than type 1 collagen-hydroxyapatite groups (Fig.6.4). Similar osteocalcin 
labelling was detected between CHAP GM and CHAP DM groups (Fig.6.4). 
   
Figure 6.4. Micrographs show immuno-labelling of osteocalcin detected within micromass 
(A, B) and type 1 collagen-hydroxyapatite (C, D) of MSCs (♂ 22 years old) at day 14 
of culture in differentiation medium (A, C) and growth (control) medium (B, D). Osteocalcin 
positive cells are indicated by blue arrow.  
6.2.2.2. Expression of osteogenic genes in MSCs cultured in 2D and 3D 
The analysis of the expression of osteoblastic genes in MSCs cultured in the different 
culture systems revealed high variation between cells obtained from different donors. 
These donors presented differing magnitudes of regulation of osteoblastic genes 
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(Appendix 5).  Nevertheless, it was possible to perform statistical analysis  
of the gene expression of osteogenic markers.   
In MSC monolayer cultures, maintained in differentiation or growth medium (DM 
and GM, respectively), Sox9 gene expression remained at the same level until day 14 
(Fig.6.5A). Micromass (MM) culture gene expression levels were similar to that  
of monolayer. Interestingly, significant differences in Sox9 mRNA expression were 
detected between MSCs cultured in type I collagen gel-hydroxyapatite (CHAP)  
and in monolayer (ML) after 7 days of culture (Fig.6.5A). In detail, when MSCs 
were cultured in DM, 4.17- (p=0.003) and 5.2-fold (p<0.0001) higher Sox9 mRNA 
level was demonstrated for CHAP compared to monolayer at day 7 and day 14, 
respectively (Fig.6.5A). A similar trend was reported for MSCs cultured in these 
models in GM conditions with significantly higher level of Sox9 in CHAP cultures 
compared to monolayer at day 7 (p<0.0001) and 14 (p=0.003) (Fig.6.5A). 
The culture environment has significant influence on the expression of early 
osteogenic marker, Runx2 (Fig.6.5B). In the presence of differentiation supplements 
in the medium, significant up-regulation of Runx2 mRNA was demonstrated  
for MSCs cultured in micromass (p=0.01) compared to cells in monolayer at day 2 
(Fig.6.5B). Although, at later time points Runx2 expression decreased in micromass, 
a trend of higher mRNA expression level of this transcription factor was reported.  
In contrast, similar Runx2 gene expression over the culture time was reported for 
MSCs in monolayer and micromass cultures which were maintained in GM 
(Fig.6.5B). A higher level of Runx2 gene expression was demonstrated for MSCs 
cultured in type I collagen-hydroxyapatite in DM and GM conditions. At day 2, 
significant up-regulation of Runx2 mRNA was revealed for CHAP group (p<0.0001) 
compared to monolayer maintained in GM, whereas in DM the significant level was 
demonstrated for these groups at day 7 (p<0.0001) and 14 (p=0.039) (Fig.6.5B). 
The Runx2 to Sox9 ratio, which was assessed to indicate the early osteogenic 
potential of MSCs, showed similar results between DM or GM groups at day 7  
and 14 for cells in different culture systems (Fig.6.5C). At day 2 for MSCs in GM, 
the Runx2/Sox9 ratio was significantly higher in micromass (p<0.0001) and type  
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I collagen-hydroxyapatite gel (p=0.001) compared to monolayer (Fig.6.5C). 
Similarly as for GM groups, in differentiation medium, the Runx2/Sox9 ratio was 
higher in MSCs cultured micromass and type I collagen-hydroxyapatite than  
in monolayer (Fig.6.5C). However, this trend did not reach statistical significance. 
The ratio decreased in all DM groups with the culture time (Fig.6.5C). 
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Figure 6.5. Diagrams show the gene expression of Sox9 (A), Runx2 (B) and Runx2/Sox9  
ratio (C) with the standard error of the mean. MSCs were cultured in monolayer (ML),  
micromass (MM) and type I collagen-hydroxyapatite gel (CHAP) in differentiation medium 
(DM) or growth medium (GM) for 2, 7 and 14 days. Gene expression was normalised  
to RPL13a and made relative to ML GM at day 2 (3 experiments, n=9). Statistical 
significance at p<0.05 was determined using two-way ANOVA with Least Significant 
Difference adjustment for multiple comparisons. *: compared to ML DM at that time point; 
#: compared to ML GM compared at that time point. 
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The expression of type I collagen (COL1) in MSCs cultured in three different culture 
models revealed no significant differences in the expression level in cells cultured  
in monolayer and micromass (Fig.6.6A). In addition, the expression of this gene was 
independent from the influence of the differentiation supplements in these culture 
models, which was indicated by the similar level of COL1 mRNA expression in DM 
and GM. On the other hand, COL1 gene expression was differentially regulated  
in DM and GM when MSCs were cultured in type I collagen-hydroxyapatite gel. 
Importantly, when MSC cultured CHAP and maintained in differentiation medium 
the expression of COL1 was 2.45-, 8.18- and 6-fold higher compared to monolayer  
at day 2, 7 and 14, respectively (Fig.6.6A). The significant differences were 
determined between these groups for day 7 (p<0.0001) and 14 (p=0.02). In GM 
conditions, the COL1 mRNA was significantly higher at day 2 (p=0.0001) and 14 
(p=0.046) in MSCs cultured in type I collagen-hydroxyapatite gel compared  
to monolayer (Fig.6.6A). 
Gene expression analysis demonstrated an increase in ALP mRNA level by day 7  
in monolayer MSCs cultures maintained in DM, while in micromass the gene 
expression showed constant increase throughout the 14 day culture period (Fig.6.6B). 
These results obtained for MSCs in micromass are consistent with the ALP protein 
data (Fig.6.2). The statistical analysis of the results revealed no significant 
differences in gene expression between monolayer and micromass culture models  
in DM conditions. Moreover, in these culture models of MSCs maintained in growth 
medium, ALP mRNA remained at the same level during the whole culture time, 
which in the case of MM GM group deviates from the protein data (Fig.6.6B&6.2). 
MSCs in the gel showed a similar pattern of ALP gene expression in DM conditions 
as MSCs in monolayer. Although, the magnitude of the gene regulation was higher  
in CHAP group compared to monolayer, there were no significant differences 
reported (Fig.6.6B). Interestingly, when cells were maintained in GM conditions, 
significant up-regulation of ALP gene expression was revealed in the CHAP group 
compared to ML group. In detail, the ALP mRNA level was 7.05- (p=0.002), 23.55- 
(p<0.0001) and 40.27-fold (p=0.0026) higher in CHAP GM at day 2, 7 and 14, 
respectively (Fig.6.6B). These results deviate from ALP protein activity data 
(Fig.6.6B&6.2). 
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Significant differences in the expression of the late osteoblast phenotype marker, 
osteocalcin (OC), were reported between MSCs in type I collagen-hydroxyapatite 
and monolayer DM and GM groups (Fig.6.6C). In both conditions, the up-regulation 
of OC mRNA to a high extent was demonstrated for MSCs in CHAP groups.  
At day 2 and 14, 2.74- (p=0.008) and 3.31-fold (p=0.0001), respectively, up-
regulation was reported for MSCs in CHAP DM compared to cells in ML DM 
(Fig.6.6C). At the same time, MSCs in type I collagen-hydroxyapatite in GM 
conditions had the highest up-regulation of OC mRNA on day 2, which was 4.9-fold 
(p<0.0001) higher compared to MSCs in monolayer (Fig.6.6C). While the expression 
decreased at later time points in CHAP GM groups, it was still significantly higher 
compared to ML GM groups (p=0.0001 for day 7 and p=0.002 for day 14) 
(Fig.6.6C). 
Gene expression of E11, which is considered to be expressed by mature osteoblast 
cells and osteocytes (Aubin, 1998), was significantly up-regulated in both 3D culture 
models compared to ML (Fig.6.6D). The gene expression was at similar level  
for micromass cultures in DM and GM and type I collagen-hydroxyapatite gel  
in both culture conditions. During the whole culture time, E11 expression remained 
at the same level in micromass groups, which was approx. 5-fold higher compared  
to monolayer groups. E11 up-regulation was demonstrated when comparing  
the results obtained from micromass and monolayer cultures in DM at day 2 
(p=0.021), 7 (p=0.023) and 14 (p<0.0001), respectively (Fig.6.6D). Similar results 
were reported for these groups during the culture in GM conditions (p=0.045 for day 
2, p=0.016 for day 7 and p=0.004 for day 14) (Fig.6.6D). In CHAP groups,  
the expression of E11 mRNA reached the maximum level at day 7. Specifically,  
at this time point 50.76- and 25.48-fold higher expression was reported for CHAP 
DM (p<0.0001) and CHAP GM (p<0.0001) compared to the respective monolayer 
groups (Fig.6.6D). In addition, the statistical analysis of the E11 gene expression 
results obtained from MSCs cultured in the gel and in the monolayer, indicated  
the up-regulation of E11 mRNA at significant level in CHAP groups at day (p=0.012 
for DM and p=0.0001 for GM) and day 14 (p<0.0001 for DM and p=0.004 for GM) 
(Fig.6.6D). 
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Figure 6.6.A-B. Diagrams show the gene expression of COL1 (A) and ALP (B)  
with the standard error of the mean. MSCs were cultured in monolayer (ML), micromass 
(MM) and type I collagen-hydroxyapatite gel (CHAP) in differentiation medium (DM)  
or growth medium (GM) for 2, 7 and 14 days. Gene expression was normalised to RPL13a 
and made relative to ML GM at day 2 (3 experiments, n=9). Statistical significance at p<0.05 
was determined using two-way ANOVA with Least Significant Difference adjustment  
for multiple comparisons. *: compared to ML DM at that time point; #: compared to ML GM 
compared at that time point. 
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Figure 6.6.C-D. Diagrams show the gene expression ratio of OC (C) and E11 (D)  
with the standard error of the mean. MSCs were cultured in monolayer (ML), micromass 
(MM) and type I collagen-hydroxyapatite gel (CHAP) in differentiation medium (DM)  
or growth medium (GM) for 2, 7 and 14 days. Gene expression was normalised to RPL13a 
and made relative to ML GM at day 2 (3 experiments, n=9). Statistical significance at p<0.05 
was determined using two-way ANOVA with Least Significant Difference adjustment  
for multiple comparisons. *: compared to ML DM at that time point; #: compared to ML GM 
compared at that time point. 
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6.3. Discussion 
Studies on the influence of the in vitro cell culture environment on the osteoblast-like 
phenotype were performed in this chapter. The differentiation of MSCs was analysed 
in monolayer (ML), micromass (MM) and type I collagen-hydroxyapatite (CHAP) 
culture systems.  
The main objective of this study was to assess the osteogenic differentiation of MSCs 
in a 3D environment in vitro which would be physiologically relevant. Hence,  
the in vitro cell culture model utilising type I collagen and hydroxyapatite was 
established at the early phase of this study. After the successful initial optimisation  
of the formulation of the gel, hydroxyapatite concentration and retained cellular 
viability in the gel by day 37, it was used for further analysis of MSC differentiation. 
Based on the fact that the micromass, a high density cell culture, is supported  
by the proteins secreted by the cells which remain in the close cell-cell contact,  
it was employed as a second 3D in vitro model. The results obtained for MSCs 
cultured in these culture systems were compared to those from MSCs cultured  
in monolayer. For decades, the monolayer culture model has been used to investigate 
the osteogenic differentiation of various MSCs and osteoblasts cell models. 
Therefore, to relate and compare results from 3D culture models, the monolayer 
culture was used as a control in this study.  
The results presented in this chapter indicated a strong influence of the culture model 
on the MSCs osteogenic differentiation. Specifically the 3D environment stimulated 
the osteogenic potential of MSCs compared to monolayer. Sox9 gene expression 
showed strong up-regulation in MSCs cultured in type I collagen-hydroxyapatite gel 
and Runx2 in both 3D culture models. The further analysis of the Runx2/Sox9 ratio 
at day 2 obtained in this study indicate the promotion of the osteogenic potential  
of MSCs to the higher extent in micromass and type I collagen-hydroxyapatite  
gel compared to monolayer. Based on recent evidence, the importance  
of the Runx2/Sox9 ratio for the prediction of MSCs differentiation and ECM 
mineralisation was shown for MSCs in monolayer cell culture. In detail, improved 
osteogenic differentiation of MSCs can be expected in cells with high Runx2/Sox9 
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ratio at the early stages of cell culture (Loebel et al., 2014a). Moreover, the reported 
high difference in Runx2/Sox9 ratio reported for monolayer in DM and GM and,  
at the same time, minimal differences in results for 3D cultures in DM and GM 
suggest the necessity of strong stimulus for triggering the MSCs' osteogenic potential 
in monolayer culture. 
The further results from the analysis of the expression of osteoblast markers support 
the conclusions drawn from the assessment of the Runx2/Sox9 ratio. Interestingly, 
the expression of early and mid-term, type I collagen and ALP genes, respectively, 
but not late osteogenic genes, including OC and E11, demonstrated the temporal 
changes during 14 day culture of MSCs in monolayer. At the same, late osteogenic 
genes were regulated over 14 days in micromass and type I collagen-hydroxyapatite 
gel cultures of MSCs. In addition, the magnitude of gene expression was 
dramatically higher in MSCs cultured in type I collagen-hydroxyapatite gel 
compared to MSCs in monolayer. 
In detail, in monolayer culture of MSCs type I collagen gene expression decreased 
with culture time in differentiation medium, which was positively correlated with  
the increase in of the ALP gene and protein expression in monolayer culture. There 
were only small changes in COL1 and ALP gene expression for MSCs in monolayer 
cultured in the absence of the differentiation supplements. In contrast, the expression 
of COL1 gene expression demonstrated a small increase in MSCs cultured  
in micromass in both type of media. This increase in differentiation medium was 
positively correlated with the ALP gene expression and protein activity by day 14, 
while in micromass maintained in growth medium, the ALP expression and activity 
showed only little up-regulation with time of culture. The highest enzyme activity 
was demonstrated for MSCs cultured in micromass in differentiation medium 
compared to the other groups in both, differentiation and growth, media types. 
Interestingly,  
the enzyme activity was lower for MSCs cultured in type I collagen-hydroxyapatite 
gel than in monolayer. The qualitative analysis of ALP protein distribution 
performed for micromass and type I collagen-hydroxyapatite groups confirmed  
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the quantitative results regarding the extent of the ALP activity in micromass and 
lower in type I collagen-hydroxyapatite gel.  
The ALP activity demonstrated by the immunolabelling in CHAP cultured in DM 
and GM demonstrated stronger intensity in DM groups. Interestingly, on the gene 
expression level ALP and COL1 were strongly up-regulated in MSCs cultured  
in CHAP in medium with and without differentiation supplements. In fact,  
in significant up-regulation of ALP and COL1 genes was demonstrated for CHAP  
in GM compared to ML. It has been suggested that dexamethasone stimulation  
of cells stimulates the osteogenic differentiation of cells in in vitro culture through 
up-regulation of ALP gene and protein expression (Wong et al., 1990). Since that 
time the formulation of medium used for osteogenic differentiation includes 
dexamethasone in the 10-100nM concentration range (Wong et al., 1990;Bellows et 
al., 1994;Yang et al., 2003). Our results suggest that the interaction of MSCs with the 
ECM protein, type I collagen, is as powerful a stimulus to induce ALP gene 
expression in MSCs as dexamethasone. Although, ALP protein activity was similar 
in both type I collagen-hydroxyapatite and monolayer culture, this could be due  
to the differential post-translational processes in 2D and 3D culture or the incomplete 
lysis of the samples collected for ALP assay. Indeed, the same protocol was used for 
monolayer, micromass and type I collagen-hydroxyapatite to extract samples  
for the assay. It remains to be evaluated whether a prolonged lysis over 3 hours has 
an influence on the assay results. 
The mRNA results of OC and E11 expression clearly demonstrated the differential 
regulation in 2D and 3D cultures. OC is considered as late osteoblast marker since its 
accumulation in ECM of the bone was timed after the initiation of mineral deposition 
(Price et al., 1981;Owen et al., 1990). The expression of E11 is considered  
as reflecting an even more advanced stage of osteogenic differentiation  
and formation of cell processes associated with osteoblast-osteocyte transformation 
(Zhang et al., 2006;Franz-Odendaal et al., 2006). In our culture systems,  
the significant up-regulation of OC compared to monolayer was reported during  
the whole culture time for MSCs cultured in CHAP but not in micromass. Although, 
there was no difference in OC gene expression in micromass cultured  
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in differentiation and growth medium, a more intense staining was observed for 
cultures in growth medium, while similar expression of OC in both types of media 
was observed for MSCs cultured in the gel. At the same time, in both 3D culture 
models, E11 gene expression was up-regulated. These results clearly indicate that  
the regulation of E11 gene is induced in 3D culture, but OC gene expression  
is specifically regulated only in type I collagen-hydroxyapatite culture. Based  
on the previous evidence, the osteogenic differentiation of cells in monolayer 
progress towards maturation after matrix synthesis, and it can be stimulated  
in monolayer culture when the substrate is coated with the ECM protein (Lian and 
Stein, 1995;Lynch et al., 1995). Our results support this observation, indicating that 
the expression and synthesis of type I collagen, the main bone ECM protein,  
is essential to induce expression of the late osteoblast marker gene, osteocalcin.  
Interestingly, a clear correlation in the decrease of OC and increase of E11 gene 
expression for type I collagen-hydroxyapatite (CHAP) and micromass was evident, 
while the expression of both genes remained at the basic level during the whole 
culture time in monolayer. In addition, the expression of both OC and E11 
demonstrated time-dependent expression changes in the only in CHAP samples, 
indicating the active regulation of these genes in the gel culture model. Altogether, 
the presented results suggest strong stimulatory effect of the interaction of MSCs 
with type I collagen on the osteogenic differentiation of MSCs. This is emphasised 
by the fact that when MSCs were maintained in medium without any exogenous 
supplements the expression of osteogenic markers was significantly higher in type  
I collagen-hydroxyapatite than in monolayer culture. We did not focus on the 
statistical analysis of the results between micromass and type I collagen-
hydroxyapatite culture per se as our aim was to directly compare 3D models with 
monolayer culture which is a standard model for investigating osteogenic 
differentiation of cells but it could be observed that the differentiation of MSCs  
can reach more advanced stage in type I collagen-hydroxyapatite than micromass  
by day 14.  
It would be of interest to investigate the osteogenic differentiation of MSCs  
in different culture models in more details including the analysis of events at later 
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time points than day 14. Regarding the osteogenic differentiation in vitro  
the temporal analysis progression of differentiation is conducted during 28 days' time 
frame. With the extension of the investigations, a more detailed analysis focused  
on the elucidation of processes associated with maturation of cells could be included. 
In particular, it is not clearly known how primary human cells undergo the transition 
towards mature osteoblast cells and differentiate further into osteocytes. It is known 
that the investigations of these processes are not possible in monolayer cell culture 
model. We believe that by applying the introduced in this chapter type I collagen-
hydroxyapatite gel a more detailed analysis of the late stages of differentiation would 
be possible. In fact, in a similar model based on type I collagen, as presented in this 
chapter, osteoblast cells were able to migrate in the collagen gel and expressed 
osteocyte specific genes, including sclerostin (SOST), phosphate-regulating neutral 
endopeptidase X-linked (PHEX), dentin matrix acidic phosphoprotein 1 (DMP1) 
after 21 days of culture (Uchihashi et al., 2012). Yet, in the aforementioned study  
the murine osteoblast cells, MC3T3E1, were used which raise the concern regarding 
the species associated differences. In fact, most evidences on the subject of terminal 
differentiation of osteoblasts originate from the analysis performed using in vitro 
rodent cell models. Therefore, the analysis based on the results from primary human 
cells would bring a great value to the current state of knowledge. In addition,  
the comparative analysis of differentiation in micromass and CHAP could elucidate 
on the appropriateness of the culture model to investigate the specific type  
of ossification process.  
In summary, the results presented in this chapter demonstrated three different 
patterns of MSC differentiation in all three cell culture models. The comparison  
of the osteogenic potential and progression in osteogenesis based on gene expression 
and protein analysis revealed strong influence of culture model on MSCs 
differentiation (Fig.6.7). Each culture model triggered the gene regulation in a 
different manner. Based on these results, a careful consideration of selection of the 
culture model prior any future in vitro studies is strongly advised. 
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Figure 6.7. Stages of osteoblast lineage cells differentiation implying the results obtained 
from MSCs cultured in monolayer (ML), micromass (MM) and type I collagen-
hydroxyapatite (CHAP) for 14 days. Based on the analysis of gene (Sox9, Runx2, ALP, 
COL1, OC, E11) and protein (ALP, OC) expression, it is proposed that MSCs cultured  
in monolayer undergo differentiation process up to the stage of preosteoblasts, while  
in micromass MSCs reach the stage of mature osteoblast phenotype. In CHAP, MSCs could 
reach a more differentiated stage leading to osteocyte phenotype. Runx2 – runt-related 
transcription factor 2, Osx – osterix (=Sp7), COL1 – type I collagen, ALP – alkaline 
phosphatase, OC – osteocalcin, OP – osteopontin, BSP – bone sialoprotein, E11=podoplanin, 
SOST – sclerostin.  
 
 
 213 
 
 
 
CHAPTER 7  
 
 
 
 
 
GENERAL DISCUSSION 
  
Chapter 7: General discussion 
 
214 
 
Bone is a unique tissue with high potential for self-regeneration. Yet, the treatment  
of traumatized and degenerated tissue is still a major clinical need. Tissue 
engineering and stem cell therapy are a big hope to support the regeneration process 
of bone. However, before clinical application, a detailed in vitro analysis and 
understanding of the processes occurring in vivo is required. This thesis highlights 
the importance of reliable and physiologically relevant in vitro cell and culture 
models. Its main objective is to support the development of new strategies for bone 
regeneration through defining and evaluating the relevancy of in vitro models.  
For this, the first part of this thesis aimed to investigate different osteoblast cell lines 
which are currently widely used to determine their relevance in bone-related 
research, including the evaluation of novel biomaterials. The second part focuses  
on the evaluation of various in vitro 3D culture models to determine the relevance  
of in vitro culture models in relation to the regulation of osteogenic differentiation  
of osteoblastic lineage cells. Finally, the role of paracrine signalling by MSCs  
was investigated for determining the potential role of these cells in directing bone 
regeneration.  
7.1. Cell culture models  
Within this thesis, four types of osteoblast cells were investigated, including primary 
human long bone osteoblast cells, SaOs2, MG63 and MC3T3E1. All of these cell 
types are generally used as osteoblast cell culture models in many areas of bone 
research, such as developmental, pharmacological, pathophysiology and biomaterial 
investigations  (Zinger et al., 2005;Bitar et al., 2008;Peter et al., 2005;Nakayama et 
al., 2004;Siddiqi et al., 2014). It becomes evident that for studies focusing on human 
bone biology, the use of human osteoblast cells is the most relevant. Nevertheless, 
the limited availability and donor-related variations in osteoblast phenotype, 
contributed to the development of various osteoblast cell lines from different origins. 
These cell lines have been well characterised; however, few studies have directly 
compared the phenotype of these cells to primary human osteoblasts (Pautke et al., 
2004;Saldana et al., 2011;Clover and Gowen, 1994). Hence, as a response to this, 
SaOs2, MG63 and MC3T3E1 cells were compared with primary human osteoblast 
Chapter 7: General discussion 
 
215 
 
cells in chapter 3. We based our investigations on the previously established and 
accepted model of primary osteoblast cell phenotype progression in monolayer 
culture (Lian and Stein, 1992).  
SaOs2, MG63 and MC3T3E1 cell lines were selected for comparison of their 
phenotype with primary human osteoblast cells due to their presence as osteoblast 
cell models in an increasing number of scientific reports focused on the evaluation  
of novel biomaterials for bone research (Degasne et al., 1999;Lincks et al., 
1998;Maekawa et al., 2008;Zinger et al., 2005). It is of utmost importance to provide 
a reliable and adequate cell culture model which would closely resemble  
the behaviour of primary human osteoblast cells.  
Differences in the growth kinetics, ECM mineralisation and regulation in osteoblast 
specific genes between cell types were evident. From all included cell lines, 
MC3T3E1, immortalised mouse calvarial osteoblasts, displayed similar proliferation 
kinetics to HOb’s. MG63 and SaOs2 displayed a greater deviation from HOb 
proliferation kinetics. MG63 showed similar pattern of growth kinetics, but at much 
higher rate than HOb’s. In case of SaOs2, cells did not reach plateau. Instead  
a sustained phase of exponential growth was reported. Considering these differences 
in results, the origin of cells has to be kept in mind. Both MG63 and SaOs2 are cell 
lines of human origin from osteosarcoma in which cells proliferation capability  
is infinite due to defective control on their cell cycle (Read and Strachan, 1999).  
Primary human cells that were used in this study developed a mature phenotype, 
which was confirmed by mineral deposition within the ECM after 3 weeks of culture. 
The mineralisation was preceded by an increase in ALP protein activity which 
reached a maximum at day 14 of cell culture. Interestingly, the expression of  type  
I collagen (COL1) showed temporal changes in the analysed population of primary 
human osteoblast cells, while Runx2, ALP and OC mRNA expression remained 
constant in these cells. The analysis ALP protein and ECM mineralisation indicated 
differences in the regulation of gene expression and mineralisation potential  
of SaOs2, MG63 and MC3T3E1. Ultimately, results from chapter 3 indicated that 
SaOs2 cells were shown to behave in the most similar way regarding the regulation 
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of gene expression and ALP activity, while MC3T3E1 mineralisation potential  
was similar to HOb’s. MG63 cells presented the least similarities regarding  
the osteogenic gene expression and mineralisation potential compared to mature 
HOb’s.  
There is vast knowledge regarding the maturation of MC3T3E1; however,  
to our knowledge, the side-by-side comparison to the primary human osteoblast cells 
has not been performed. Our results indicated the similarities of these cells regarding 
the proliferation of cells and mineralisation potential. Although, the responsiveness 
to dexamethasone was distinct for MC3T3E1 from results obtained for human cells  
(Lian et al., 1997;Haynesworth et al., 1992), the mineralisation potential  
of MC3T3E1 was not compromised compared to primary human osteoblast cells 
(chapter 3). In fact, there was a similar mineralisation potential of these cells 
compared to primary HOb’s after 21 days in culture when both cell types were plated 
at the same initial cell density (5000 cells per cm
2
) and cultured in the presence  
of dexamethasone. However, it would be of interest to further analyse this similarity 
of HOb’s and MC3T3E1 regarding the nature of deposited substrate. While 
MC3T3E1 cells were shown to mineralise their matrix (Sudo et al., 1983;Franceschi 
and Iyer, 1992), detailed Fourier transform infrared spectroscopy (FTIR) analysis  
of the deposits demonstrated a lack of calcium phosphate mineralisation and  
the presence of dystrophic mineralization of unknown origin (Bonewald et al., 2003).   
The obtained results regarding the osteogenic phenotype of primary human  
and osteosarcoma cells are in agreement with previously published reports (Clover 
and Gowen, 1994;Pautke et al., 2004;Saldana et al., 2011). Similarly as presented in 
chapter 3, the high ALP activity and mineralisation potential of SaOs2 has been 
previously demonstrated (Rao et al., 1996;Rodan et al., 1987;Saldana et al., 2011). 
Moreover, similar growth inhibition and ALP activity in SaOs2 and HOb’s  
on a clinically relevant material Titanium-6% Aluminium-4% Vanadium (Ti6Al4V) 
alloy and Ti particles indicates the potential of this cell type in the assessment  
of biomaterials (Saldana et al., 2011). However, compared to HOb’s, gene 
expression, differences in SaOs2 were demonstrated for Runx2, COL1 and OC.  
It has to be noted that for COL1 and Runx2 these differences were significant only 
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for later time points. Runx2 demonstrated an evident trend of higher expression  
in SaOs2 compared to HOb’s with statistical significance at day 21. These results 
suggest a more mature phenotype of SaOs2 cells than the HOb population used  
in this study. In fact, with the Alizarin Red S staining for mineral deposition, a more 
advanced formation of nodules was reported for SaOs2 compared to HOb’s. This 
conclusion supports previously published work (Pautke et al., 2004;Rao et al., 
1996;Rodan et al., 1987). Since SaOs2 cells have a mature osteoblastic phenotype 
and possess high matrix mineralisation capacity, they should not be used for studies 
determining the progression in osteoblasic phenotype or assessing material 
osteoconductivity.  
MG63 cells displayed opposite results than SaOs2 cells compared to HOb’s.  
The ALP activity was marginal in this cell type. With increasing time only a small 
population of cells was ALP positive. These results were reflected at the gene 
expression level. During the time course of this study, ALP gene expression was 
lower in MG63 than in HOb’s. Similar trends were reported for COL1 and OC gene 
expression. In the former, this trend only became significant on day 21. Interestingly, 
an opposite trend to COL1 was detected for Runx2, where Runx2 was up-regulated 
compared to HOb’s except on day 21. In addition, the lower expression of osteoblast 
specific proteins, such as ALP and type I collagen, has been recognised before 
(Pautke et al., 2004). These results suggest a differential regulation of more mature 
osteoblast genes in MG63 and HOb’s, which is not necessary directed by Runx2, 
known as master transcription factor for osteoblast differentiation (Ducy, 2000).  
In addition, on both, tissue culture polystyrene and Ti6Al4V, the regulation of ALP 
activity up to day 7 was at lower level in MG63 compared to HOb’s (Saldana et al., 
2011). Within chapter 3, MG63 presented a very immature phenotype compared  
to HOb’s; this was emphasised by the lack of calcium deposition. Therefore, MG63 
cells are only a suitable cell model to examine closer the processes directing 
osteoblastic differentiation of cells over time and factors stimulating this process. 
Having this in mind, we used this cell line for investigations whether the interaction 
of MG63 and MSCs has a mutual influence on the development of more mature 
osteoblastic phenotype (chapter 4). In addition, due to the fact that MG63 has 
similarities  
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to primary human osteoblast cells regarding the expression of integrin subunits, 
including α2, α5, αV, β1, β3, (Sinha and Tuan, 1996;Clover et al., 1992), they may be  
a good alternative for studies interested in initial attachment to various materials. 
Although, in this thesis, we focused on indirect cell-cell communication (chapter 4), 
the further analysis of the direct cell-cell contact on osteogenic differentiation would 
bring more information regarding the signalling pathways regulation of osteogenesis 
in different cell-cell contact modes. 
Therefore, we developed an osteoblast cell line with a stable and homogeneous 
expression of green fluorescent protein (GFP; chapter 4), which was based on MG63 
cells. With the approach of selecting colonies from single cell cultures we obtained 
highly homogeneous populations of cells. In result, similar characteristics, including 
proliferation rate and osteoblastic phenotype development, of these cells compared  
to the 'mother cell line' MG63 were confirmed. This cell line provides  
the opportunity to discriminate two cell types in direct monolayer or 3D co-culture 
for subsequent analysis. In addition, MGreen63 cell line could serve as a reliable 
model for non-destructive, on-line monitoring of cytotoxicity and cytocompatibility 
of biomaterials over time. In addition, it allows the analysis of direct cell-cell 
communication with proper discrimination between two cell populations to be 
performed. The same approach can be applied to a more mature osteoblast cell line  
to enable mineralization studies to be performed.   
It has to be mentioned that even though the direct comparison of cell lines was 
performed with primary human osteoblast cells, limitations of this study are present 
which leaves room for further investigations. One of these is related to HOb’s which 
were used as reference cell type for our investigations. Precisely, primary osteoblast 
cells from one donor were included for comparison with SaOs2, MG63  
and MC3T3E1 cell lines. It has been recognised that the phenotype and activity  
of primary human osteoblast cells is highly dependent on such parameters as age, 
gender, origin site/site of origin and the isolation method (Battmann et al., 
1997;Katzburg et al., 1999;Zhang et al., 2004;Jonsson et al., 1999). Therefore, rather 
than postulating on existing differences between cell lines and primary human 
osteoblast cells from human population from our results, it is more relevant in this 
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case to refer to specific population of primary osteoblast cells. Specifically, HOb’s 
used in this study were isolated from proximal tibia of 6 years old female donor.  
We believe that these osteoblast cells are represent population of highly active 
osteoblast cells and therefore are relevant for this study. However, it is evident that 
including osteoblast cells from more donors, particularly adult cells, would be 
beneficial for this study considering the significant analysis of statistical population 
and biological relevance of obtained results. In addition, including cells obtained 
from donors with pathological conditions, such as oateoporosis or osteoarthritis, 
would help to select the cell models which could be used for screening of new 
pharmacological agents. 
In addition, the formulation of culture medium for each cell type differed from that 
used for HOb’s. In detail, for each cell type medium included the supplementation 
with the same concentration of ascorbic acid (50µg/ml), but differed  
in the concentration of dexamethasone and b-glycerolphosphate (βGP). Results from 
the initial experiments, in which cell lines were maintained in the medium with  
the same formulation as the one for HOb’s, demonstrated a negative effect  
of medium supplement, βGP, on SaOs2 viability even at a  low dose of 2 mM (data 
not shown). Previous reports demonstrated the supplementation of medium with βGP 
in small doses for cells with high osteogenic potential (Orriss et al., 2012). Since this 
strategy did not bring any benefit/improvement for SaOs2 cells viability,  
the comparison of cell phenotype was conducted in the conditions supporting  
the viability and behaviour of each cell type in the best way (reviewed in (Czekanska 
et al., 2012)). 
7.2. In vitro 2D and 3D co-culture models 
Part of the studies for this thesis concentrated on the investigation of cell 
differentiation (chapter 6) and communication (chapter 4&5) of bone cells.  
The analysis of the indirect communication of osteoblast with progenitor cells was 
motivated by the fact that currently there are limited and conflicting evidence 
regarding the influence of crosstalk between these cells on their osteogenic 
phenotype development (Csaki et al., 2009;Buttery et al., 2001;Tsai et al., 2012;Kim 
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et al., 2003). What is more, out of these reports, only few investigate the effects  
of crosstalk between human MSCs and osteoblasts (Ilmer, Seto). This limits  
the discussion of our results in relation to the previously published data,  
but at the same time indicates the need for further exploration of MSCs-osteoblast 
crosstalk effects.   
The first set of experiments focused on analysing of the influence of cell crosstalk  
in indirect monolayer co-culture followed by investigations in high density 
(micromass; MM) indirect co-culture.  
The results from the ALP protein activity assay at day 14, gene expression analysis, 
and Ca incorporation assay suggested the delayed osteogenic differentiation in MSCs 
co- cultured with MG63, compared to single cell type cultures (control) of MSCs  
in monolayer. In more detail, while the ALP protein activity was at the same level  
in co-cultured and control MSCs at day 14, the mRNA level at day 21 of Runx2, 
ALP and OC was lower in co-cultured MSCs. At the same time Ca incorporation 
showed a trend of lower uptake in MSCs from co-cultures than in control MSCs 
cultures.  
A more pronounced effect of the co-culture of MSCs with MG63 was reported  
on the osteoblast cells. When MG63 cells were located on the insert membrane  
in  differentiation medium, the expression of Runx2, ALP, COL1 and OC mRNA  
as well as and Ca incorporation at day 21 were at higher level in co-cultured cells 
than in MG63 cultured alone. For cells located in the well no influence of the co-
culture on MG63 phenotype was reported. In both configurations of the co-culture, 
i.e. when MG63 cells were cultured on the membrane or in the well, the ALP activity 
was at the same level in co-cultured cells as in single cell type cultures. As presented 
in chapter 3 and in other reports, MG63 cells demonstrate low ALP protein activity 
(Pierschbacher et al., 1988;Saldana et al., 2011;Czekanska et al., 2013). Hence,  
the indirect co-culture of MG63 with MSCs is not a sufficient stimulus to regulate 
the ALP activity in MG63 cells. The obtained results from indirect monolayer co-
culture indicated a positive influence on osteogenic gene expression and 
45
Ca uptake 
in MG63 cells, whereas it has an opposite effect on MSCs.  
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Following the investigation of cell crosstalk in monolayer, the attention was directed 
towards indirect cell-cell communication in a micromass culture system.  
Our objective was to analyse the cell crosstalk in a 3D culture system which would  
be a step closer and, therefore, more relevant to the to the cells natural in vivo 
environment.  
Additionally, in the setting of micromass co-culture side-by-side in the well we could 
exclude the potential variables related to the different location and growth surface 
parameters, which had a prominent effect in monolayer co-culture.  
In contrary to the results obtained for MG63 cell in monolayer co-cultures,  
no differences in the expression of osteoblast genes, including Runx2, COL1, ALP 
and OC, were observed in MG63 cells co-cultured with MSCs at day 21. At the same 
time, differences were demonstrated for MSCs co-cultured with MG63 cells 
compared to single cell type MSCs culture. Specifically, in DM and GM conditions 
the ALP mRNA expression was significantly lower in co-cultured MSCs, while  
the expression of Runx2 and COL1 showed a trend of lower expression in co-
cultured MSCs compared to single cell type culture of MSCs. The OC gene 
expression was significantly higher in MSCs co-cultured with MG63 cells compared 
to control MSCs micromass in growth medium, whereas no differences were 
reported between these groups in differentiation medium.  
To relate the differences in osteoblastic gene expression to the phenotypic stage  
of cells, the analysis of COL1/Runx2, ALP/Runx2, OC/Runx2 ratios was performed. 
We postulate that by relating the mRNA of the COL1, ALP, OC to Runx2  
the magnitude of the progression of the osteogenic differentiation can  
be demonstrated. This assumption is based on the importance of Runx2 at the early 
stages of osteoblast differentiation (Ducy, 2000;Zhou et al., 2006). It is considered 
that this transcription factor is crucial for osteogenic differentiation of progenitor 
cells by inducing the expression of osteoblast specific genes, such as ALP, OC, BSP 
(Komori, 2010). Runx2 gene expression regulation in primary osteoblasts is species 
specific. Conversely to primary rat osteoblasts in vitro culture, the Runx2 gene 
expression in human primary osteoblasts remains at the same level over time (Lian 
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and Stein, 1995;Czekanska et al., 2013). Hence, the gene expression ratios give the 
valuable information regarding the differentiation stage for ostoprogenitor cells in 
which Runx2 is decreased at the later stages of differentiation (Komori, 2010).  
The analysis of the genes' ratio indicated significant differences between MSCs co-
cultured with MG63 and single cell type cultures in cultures maintained in GM.  
The COL1/Runx2 and ALP/Runx2 were lower while OC/Runx2 ratio was higher  
in co-cultured MSCs compared to MSCs cultured alone. Similar relations were 
demonstrated for OC/Runx2 and ALP/Runx2 in co-cultured or control MSCs 
micromasses in differentiation medium, whereas the COL1/Runx2 was at the same 
level in these conditions for both groups. 
The results indicate a lower activity of ALP when MSCs were co-cultured with 
MG63 cells. Further analysis of the 
45
Ca incorporation into micromass cultures at 
day 21 revealed no effect of the co-culture on the mineralisation potential of the 
cultures.  
Altogether, the investigation of indirect cell-cell communication in the micromass 
culture system demonstrated significant effects on the osteogenic gene regulation  
in MSCs, but no such effects on MG63 cells. The obtained results could suggest 
both, suppression or stimulation of osteogenic differentiation of MSCs in co-culture 
with MG63. It has to be taken into account that the ALP activity assay was 
performed at day 14 and the analysis of osteogenic genes related to the early, mid-
term and late differentiation stage at day 21. Since ALP activity and the expression 
of early (Runx2) and mid-term (ALP, COL1) was decreased, while OC mRNA 
expression increased in co-cultured MSCs at these time points, it could be 
hypothesised that the co-culture of MSCs with MG63 cells in micromass stimulates 
the osteogenic differentiation of MSCs. At the same time, the lack of any effect  
of co-culture on MG63 cells suggest that in micromass culture system, the more 
differentiated cell type stimulates the differentiation of more phenotypically 
primitive cell population. These results are especially interesting in relation to bone 
healing where coordinated communication between cells is highly important for  
the regeneration process.  
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A more detailed investigation focusing on the analysis at the molecular level  
at earlier time points, and histological analysis of protein expression would bring 
more clear insight and verification of the postulated beneficial effects of micromass 
co-culture on MSC differentiation. It would be interesting to analyse the one-way 
paracrine communication by culturing MSCs with medium conditioned by MG63 
cells to assess whether the stimulation paracrine activity of osteoblasts is strictly 
related to the 3D or whether the is any feedback loop in MSCs-MG63. Additionally, 
the analysis of cell-cell communication in direct co-culture could be determined. 
Employing the MGreen63 cell line as an osteoblast cell model would allow  
for the separation of cell in co-culture and detailed analysis. Currently, more 
attention has been directed towards indirect cross-talk. From the reports focusing  
on analysis of the effects of the direct cell-cell communication, it is surprising that 
only a few looked at the interactions of osteoblasts with progenitor cells (Tsai et al., 
2012;Csaki et al., 2009;Wang et al., 2007;Kim et al., 2003). In addition, these reports 
present conflicting results. In has been reported that in direct co-culture  
the differentiation of MSCs, marked by ALP activity and calcium deposition, 
depends on the proportion of cells in the co-culture. The ALP activity  
and mineralisation of nodules was found to be higher in co-cultures with increased 
proportion of osteoblast cells to 50% in co-cultures compared to controls (Tsai et al., 
2012;Csaki et al., 2009). Concurrently, the calcium deposition was shown at lower 
level in co-cultures compared to single cell type cultures (Kim et al., 2003), which  
is opposed to the results presented here. Yet, it has to be kept in mind that all these 
studies as cell models included murine MSCs and osteoblasts or rabbit MSCs and rat 
osteoblast cells. This may explain the differences in the results, and raises questions 
regarding the relevance of these results in relation to human cells interactions (Tsai et 
al., 2012;Csaki et al., 2009;Kim et al., 2003).  
The results regarding the cell crosstalk suggested that 1) the secretion  
of osteopermisive factors or/and 2) the sensitivity of cells to these factors can be 
modulated by in vitro culture environment. To verify the first hypothesis,  
we analysed whether the stimulation of the secretion profile of MSCs with IL1β  
or SCF would exert a pronounced effect on osteogenic differentiation  
of unstimulated cells in monolayer culture (Chapter 5). The functional analysis  
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of the secrotome from stimulated MSCs with IL1β and SCF revealed no significant 
effect on unstimulated MSCs’ proliferation or differentiation. Specifically,  
we reported similar ECM calcification in MSCs cultured with medium from 
stimulated or unstimulated cells. It is known that chronic supplementation of human 
MSCs cultures with IL1β induces the osteogenic differentiation (Loebel et al., 
2014b;Ferreira et al., 2012). Even shorter, 48 hours stimulation of rat MSC in vitro 
cultures with IL1β, increased nodule formation and the calcium content within (Lin 
et al., 2010). However, there are no previous reports regarding the indirect effects of 
both, IL1β and SCF on osteogenesis. Nevertheless, it was surprising that only small 
differences in the expression of osteogenic genes were reported only at day 7 
suggesting the possible paracrine effects on MSCs at early, proliferative stage  
of cells. Nevertheless, recently it was reported that much shorter treatment of cells 
induces long term response of MSCs. Recently, it has been shown that only  
15 minutes stimulation of MSCs with BMP2 induces the stimulation of osteogenic 
differentiation over the nonstimulated cells (Overman et al., 2013a;Overman et al., 
2013b). Even though, these results become from directly stimulated cells, it was very 
interesting that in this study the effect of stimulation was reported only when cells 
were cultured on a calcium phosphate scaffold, while in monolayer there was no 
significant effect of BMP2 stimulation on differentiation (Overman et al., 2013a). 
The osteogenic differentiation and response to the stimulation is regulated in a 
different manner in monolayer and in 3D culture. As presented in the co-culture of 
MSCs and MG63 (chapter 4) the regulation of MSC osteogenic differentiation was 
stimulated in a 3D culture (micromass), but it was inhibited in monolayer. It seems 
that in monolayer cells became unresponsive to the action of certain factors. Hence, 
the application of the proper in vitro culture model is critical for the analysis of the 
effects of bioactive molecules in relation to the directing of cell differentiation. 
In summary, based on our results from monolayer and micromass co-culture, and the 
aforementioned report by Overmann and co-workers (Overman et al., 
2013a;Overman et al., 2013b), it appears that the sensitivity of progenitor cells  
to paracrine factors is modulated by in vitro culture environment.  
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7.3. In vitro culture environment and osteogenic differentiation 
The evaluation of the in vitro cell environment focused on the analysis  
and comparison of osteoblast phenotype development of MSCs in micromass or type 
I collagen-hydroxyapatite gel, to the differentiation of cells in monolayer (chapter 6). 
Micromass was chosen for these investigations since the positive influence of co-
culture with MG63 on MSCs osteogenic differentiation in micromass was observed 
(chapter 4). The motivation to develop a type I collagen-hydroxyapatite gel as second 
3D culture model was based on the physiological relevance of both components  
of this model.  
Conventionally, in the monolayer culture system the osteogenic differentiation  
of cells progress through 3 phases, proliferation, matrix synthesis, and mineralisation 
(Lian and Stein, 1992). Each stage can be characterised by the expression of specific 
genes and proteins (Owen et al., 1990;Lian and Stein, 1992). In our study,  
the analysis of early (Sox9, Runx2), mid-term (ALP, COL1) and late (OC, E11) 
osteogenic markers was analysed at protein and/or gene expression level.  
Our results demonstrated that in monolayer MSC culture, in the presence  
of osteogenic supplements, osteogenic differentiation is induced, as demonstrated  
by the increase of Runx2 gene expression and Runx2/Sox9 ratio. Based on the ALP 
protein data, the maturation of ECM could be expected after day 14 of monolayer 
culture. This is not unusual with primary human MSCs. The analysed expression  
of OC and E11 gene demonstrated no changes in mRNA expression by day 14  
in both DM and GM conditions. These results support the conclusion that  
the differentiation of human MSCs into a mature osteoblastic phenotype  
in monolayer occurs at a later time point than that included in this study, which  
is in line with previous reports (Lian and Stein, 1992;Guillot et al., 2008). 
In micromass, the induction and progression of MSCs differentiation was more 
strongly induced compared to monolayer. The ALP protein activity, relative  
to the DNA amount, was the highest for micromass maintained in differentiation 
medium compared to the other groups. Although, the OC gene expression  
was similar in micromass as in monolayer, the expression of other late osteogenic 
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marker, E11, was strongly up-regulated in micromass cultures. E11 expression  
is considered as reflecting an advanced stage of osteogenic differentiation  
and formation of cell processes associated with osteoblast-osteocyte transformation 
(Zhang et al., 2006;Franz-Odendaal et al., 2006). Based on these results, we could 
speculate that the potential of high density micromass culture of MSCs to promote 
enhanced osteogenic differentiation compared to monolayer within the 14 day time 
frame.  
In fact, high density cell culture models have attracted a lot of attention within  
the last few years as potential culture models for recapitulating events occurring 
during in vivo endochondral ossification. The formation of chondro-osseus structures 
within pellet culture of MSCs or human femur foetal-derived cells was demonstrated 
(Muraglia et al., 2003;Scotti et al., 2010;Tortelli et al., 2010;El-Serafi et al., 2011). 
Interestingly, the morphological structure of pellets is highly dependent on cell type, 
density and culture media. Human femur foetal-derived cells in pellet cultures 
maintained in osteogenic medium only were able to form the osseous shell around 
the cartilage-like pellet core, while in the case of MSCs from bone marrow pellet 
culture, the stimulation of both, chondrogenic followed by osteogenic differentiation, 
is required to obtain similar results (El-Serafi et al., 2011;Muraglia et al., 2003).  
The development of an even more mature phenotype is facilitated in a high density 
pellet culture system as demonstrated previously in our group (Jahn et al., 2010).   
In a pellet culture system of  primary human osteoblast cells, where proliferation  
of cells is restricted to the population at the outer part of a pellet, a rapid 
differentiation of towards osteocyte-like phenotype was achieved (Jahn et al., 2010). 
Here, we demonstrated temporal changes in osteogenic differentiation of MSCs  
at the gene expression level, and faster stimulation of osteogenic differentiation  
of MSCs in micromass compared to monolayer culture. The results are in agreement 
with the aforementioned studies which supports the potential of this simple culture 
model for in vitro research of endochondral bone formation. Nevertheless, it would 
be of interest to perform more detailed analysis of the influence of micromass culture 
on osteogenic differentiation of MSCs on both gene expression and protein level 
over the long term, to establish a defined serum-free culture medium formulation. 
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This would provide a culture model in which the differentiation would be strictly 
directed by cells without any influence of the factors present in serum.  
Based on the fact that type I collagen is the main protein of bone  
and its accumulation is fundamental for osteoblast differentiation (Lynch et al., 
1995), the third culture model included in this chapter for the analysis of directing 
MSCs osteogenic differentiation was type I collagen-hydroxyapatite gel.  
Type I collagen gel influences the osteogenic differentiation interacting with α2β1 
integrin on cell surface which activates mitogen-activated protein kinase (MAPK) 
signalling pathway, leading to phosphorylation of Runx2 and osteocalcin expression 
promoter (Wenstrup et al., 1996;Xiao et al., 1998;Uchihashi et al., 2012).  
The approach of utilising type I collagen gel for osteoblast cell culture has been 
addressed (Lynch et al., 1995;Buxton et al., 2008). However, instead of maintaining 
cells on pre-coated surface as previously described, attention was directed  
to establish a type I collagen gel culture system with the approach of formulating  
in this thesis a culture system with an even distribution of cells within the gel, while 
not compromising cell viability. 
Since the previous reports indicated a negative influence of the collagen cross-
linking agents on cell viability (Brinkman et al., 2003;Wollensak et al., 2004), we 
focused on the formulation of gel without the cross-linking of collagen fibres. 
Hydroxyapatite was added as it possesses osteoconductive properties and in addition 
improves the mechanical stability of the gel. The results from preliminary 
experiments showed retained stability of the gel and cell viability up to 37 days. 
Further analysis indicated that the type I collagen-hydroxyapatite culture system 
supported MSC differentiation towards osteoblasts, which was marked by the high 
levels of Runx2/Sox9 ratio, COL1, ALP, OC and E11 gene expression. In addition, 
ALP activity was demonstrated by immunolabelling in type I collagen-
hydroxyapatite cultured cells in both differentiation and control medium.  
The immunostaining of OC did not reveal clear correlation with gene expression 
results. Instead, comparable detection intensity was reported in MSCs maintained 
 in both types of medium. These results are not surprising, taking into the account  
the regulatory processes occurring after mRNA is transcribed, including post-
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transcriptional, translational and protein degradation regulation, which control 
steady-state protein abundances (Vogel and Marcotte, 2012). It seems that  
the OC protein expressions undergo specific regulatory processes and further 
parallel/simultaneous analysis of OC mRNA and protein expression over time would 
reveal the significance of this discrepancy.  
Similarly to our results, the positive stimulation of OC gene expression  
and ALP activity was demonstrated for rat osteoblast cultures on type I collagen 
tissue polystyrene surface (Lynch et al., 1995). Further investigations revealed  
the promotion of mineral deposition of osteogenic cells in culture system based  
on type I collagen gel (Pedraza et al., 2010;Thibault et al., 2010). In our study,  
we did not analyse the mineralisation process directly. However, based on presented 
results, including the expression of E11 gene, we could speculate that  
the differentiation of MSCs towards the osteocytic phenotype is promoted in type  
I collagen-hydroxyapatite gel. Uchihashi and co-workers demonstrated the potential 
of type I collagen culture of osteoblasts to support differentiation of osteoblast cells 
into osteocyte phenotype (Uchihashi et al., 2012). In more detail, the expression  
of sclerostin (SOST), phosphate-regulating neutral endopeptidase X-linked (PHEX), 
dentin matrix acidic phosphoprotein 1 (DMP1), which are associated with  
the osteocytic phenotype, was reported after 21 days of culture (Uchihashi et al., 
2012). We believe that type I collagen-hydroxyapatite gel could serve as model  
for the investigation of full osteocytic differentiation process of MSCs. However, 
further evaluation is needed, including the analysis the expression of osteocyte-
specific markers, to make strong conclusions regarding the potential of osteocyte 
phenotype development in the type I collagen-hydroxyapatite gel. With the positive 
results, type I collagen-hydroxyapatite gel could serve, for instance, as a model  
for the research of indirect effects of stimulation with different cytokines. 
7.4. Enhancing the secretion profile of MSCs  
It has been recognised that in addition to their direct support of tissue regeneration 
through lineage specific differentiation, stem cells secrete bioactive factors acting  
in auto- and paracrine manner and regulating the immune response (Hsiao et al., 
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2012;Tsiridis et al., 2007;Zhukareva et al., 2010). This recent identification regarding 
the potential of paracrine MSCs signalling within the damaged tissue contributed  
to naming MSCs as an “injury drugstore” (Caplan and Correa, 2011).  
Bone TE, combined with stem cell therapy, emerged as an alternative to the gold 
standard autologous bone graft for bone reconstruction. Currently, the focus  
is directed towards a one-step procedure as it overcomes the disadvantages of two-
step procedures, including the requirement for two surgical procedures, increased 
risk of contamination and extensive in vitro cell expansion (Coelho et al., 2012).  
The intra-operative enrichment and application of autologous bone marrow 
aspiration concentrate for the treatment of diseases of the musculoskeletal system  
has been evaluated as a safe and effective procedure (Hendrich et al., 2009).  
Yet, the limited amount of the osteoprogenitor cells is critical for the successful 
outcome (Hernigou et al., 2008).  Together with the decreasing number  
of osteoprogenitor cells with age (Caplan, 1994;Maijenburg et al., 2011), concern 
arises regarding the engraftment yield and further performance of cells, including  
the production of bioactive molecules and paracrine activity of cells. 
In chapter 5 of this thesis, the modulation of paracrine activity of MSCs  
was performed by preconditioning of cells. Its principle is to prepare cells  
by mimicking the hostile microenvironment, in which the cells will be engrafted,  
by pre-exposure to growth factors, cytokines or chemical agents. It is surprising that 
the application of pre-conditioned stem cells has been widely explored in relation  
to soft tissues and to a lesser extent in relation to bone (reviewed by (Baraniak and 
McDevitt, 2010;Haque et al., 2013;Hsiao et al., 2013)). This motivated us to 
investigate the influence of pre-conditioning of cells with cytokines normally present 
at the site of bone injury, including Stem Cell Factor (SCF), interleukin 1β (IL1β), 
stromal cell-derived factor 1 (SDF1) and granulocyte colony-stimulating factor 
(GCSF). Having in mind a one-step clinical concept for bone regeneration,  
we limited the stimulation time to 2 hours, which is clinically applicable.  
To our knowledge, this is the first study undertaking this aim in relation to bone 
tissue.  
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By stimulating MSCs with different cytokines for 2 hours, we reported sustained 
effects of the treatment after 48 and 72 hours on gene and protein expression level  
of various cytokines. At first, the influence of the pre-conditioning with cytokines 
was evaluated at the gene expression level for four different factors, IL1β, GCSF, 
SCF and SDF1. The obtained results confirmed our hypothesis that the short-term 
stimulation of MSCs in vitro has a long term effect on the regulation of the gene 
expression profile of the cells.  
Following these results, we were interested whether the pre-conditioning has more 
functional effects, i.e. is the regulation of cytokine genes coupled with the regulation 
of protein expression? To answer this question, the following experiments focused 
on the closer examination of gene and protein expression profile of MSCs stimulated 
with IL1β or SCF. The analysis of the obtained results, of the regulated cytokine 
genes and proteins, revealed that 2 hours stimulation has a strong influence on both, 
cytokine gene and protein expression. The secrotome analysis demonstrated that 
forty eight hours after the stimulation 20 cytokine proteins of 174 were regulated  
in a similar manner in MSCs from 5 donors in response to IL1β and 12 in response 
 to SCF treatment. The functional analysis of the protein data indicated that these 
cytokines induce the secretion mainly different classes of cytokines (chapter 5, 
tab.5.2). Specifically, IL1β induced the secretion of proteins acting during cell 
mobilisation, proinflammatory response, angiogenic and osteogenic differentiation, 
while SCF regulated mitogenic, chondrogenic and ECM regulation proteins.  
In addition, we reported interesting associations of Wnt signalling pathway 
components with the expression of genes and proteins regulating osteoclastogenesis. 
Based on these results we speculated that short term stimulation with IL1β and SCF 
could have an indirect inhibitory effect on osteoclastogenesis. Currently, IL1β  
is considered as a potent inducer of osteoclasts differentiation, nucleation  
and survival (Nakamura and Jimi, 2006;Konig et al., 1988), which in chronic 
inflammatory conditions, such as rheumatoid arthritis, leads to bone resorption 
(Abramson and Amin, 2002;Teitelbaum, 2006). On the other hand, IL1β  
is inadequate to induce osteoclast differentiation from precursors (Kim et al, 2009). 
Our study indicated the possible mechanisms of osteoclastogenesis inhibition  
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as a secondary effect of MSCs stimulation with IL1β (through down-regulation  
of RANKL and up-regulation of TNFRSF11 genes in stimulated cells) which could 
have an effect on the promotion of osteoclast differentiation. Conversely,  
the secretion of RANTES and GM-CSF, factors stimulating osteoclasts 
differentiation, after IL1β treatment was previously demonstrated (Zhukareva et al., 
2010). However, the secretion of these proteins was reported after 24 hours treatment 
(Zhukareva et al., 2010). These results together with the proteins secretion data show 
a strong influence of IL1β on stimulation of early events occurring during bone 
regeneration and the potential in its support. Hence, it emerges as an attractive factor 
for aiding the regeneration of bone in complicated injuries or severe conditions 
where the concerns regarding a successful outcome of the treatment are high.   
Similar results regarding the regulation mechanism of osteoclastic differentiation  
as for IL1β were reported for SCF treatment. In addition, other secondary 
mechanisms potentially involved in the regulation of osteoclastogenesis were 
modulated by SCF, including the up-regulation of IL18 stimulating the production  
of granulocyte macrophage colony-stimulating factor (GM-CSF), known  
as osteoclasts inhibitor, by T-cells (Harwood, 1998; Gracie, 2003). Stem cell factor 
(SCF) plays important role during development in haematopoiesis, melanogenesis 
and spermatogenesis, as well as during the regeneration of damaged tissues.  
It has been suggested that SCF strongly stimulates survival, mobilization  
and differentiation of hematopoietic stem cells. Indeed, upon activation SCF induces 
mobilization, recruitment and neovascularization activity of endothelial progenitor 
cells (EPCs) (Kim et al., 2011). In vivo studies demonstrated that intravenous 
administration of SCF promoted heart regeneration after myocardial infarction  
and recovered haematopoiesis after irradiation. SCF activates cells through binding 
to tyrosine kinase proto-oncogene receptor, c-kit, which is expressed on primitive 
and mature progenitor cells within bone marrow, megakaryocytes and platelets 
(McNiece and Briddell, 1995). Very recently, SCF has been described as fast acting 
chemokine due to its immediate effect on ERK and AKT phosphorylation observed 
after only 3-5 min stimulation of dental pulp cells (Pan et al., 2013). SCF-containing 
collagen sponges implanted subcutaneously in mice contained more cells, capillaries 
and had increased remodelling comparing to constructs without SCF (Pan et al., 
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2013). The results presented in this thesis show, for the first time, that SCF activity  
is not limited to the direct stimulation of chemotaxis and differentiation  
of hematopoietic cells, but could exert a powerful effects during bone repair.  
With the 2 hours stimulation of MSCs, the processes of endochondral bone 
regeneration, including chondrogenesis, ECM regulation and osteoclastogenesis, can 
be regulated by SCF in indirect way. Further in vitro experiments with stimulation  
of freshly isolated MSCs in suspension are essential for the closer insight  
of the stimulation effects in clinical application setting of stem cell therapy. 
Following this, in vivo analysis is essential to evaluate the functional effects  
of preconditioned cells at the injury site. It has to be considered that the potential  
of implanted cells may change in response to the microenvironment.  
The results we reported here were obtained from MSCs isolated from bone marrow 
of different donors. The effect of donor-variability was clearly seen in the magnitude 
of response to the treatment. Similarly to recent report by Zhukareva and co-workers, 
we demonstrated that similar patterns of expression can be reported for cells from 
responsive donors (Zhukareva et al., 2010). In addition to the donor variability,  
the variation of secretion profile from MSCs is associated with the site of isolation. 
Comparing the basic level of secreted proteins significant differences were 
demonstrated between MSCs derived from adipose tissue, bone marrow, dermal 
tissues (dermal sheath cells and dermal papilla cells) and umbilical cord blood 
regarding the angiogenic paracrine activity of MSCs (Hsiao, 2010; Jin, 2013).  
The superiority of cells derived from adipose tissue over the other sources has been 
demonstrated (Hsiao, 2010), which also suggest the possible differential response  
of MSCs from different isolation origin to stimulation with cytokines.  
7.5. Influence of the culture model and dexamethasone on osteo-
calcin expression 
It cannot remain unnoticed that in our experimental settings of co-cultures  
and 3D cultures osteocalcin gene expression was up-regulated in control conditions, 
i.e. in medium without any osteogenic supplements. Specifically, regarding co-
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culture experiments (chapter 4), at day 14 the OC gene expression was higher  
in MG63 co-cultured with MSCs in monolayer and in MSCs co-cultured with MG63 
in micromass. Similarly, primary human bone derived cells stimulated the expression 
of Runx2, COL1, ALP, OC, BSP and mineralisation of human embryonic stem cells 
(CHA-hES3) in the absence of any exogenous factors (Ahn et al., 2006). A more 
detailed analysis of gene expression over time would reveal whether this could  
be observed for earlier osteoblastic markers, such as Runx2, COL1 and ALP.  
In co-culture with conditioned medium of MSCs, OC mRNA was at higher level  
at day 7 and 14 in cells from cultures without any exogenous differentiation factors 
supplementation (chapter 5). Although, it is likely that these effects are related  
to the indirect co-culture, it is also possible that the regulation of OC gene expression 
is associated with the presence of osteogenic supplements. In fact, when MSCs were 
cultured alone in monolayer and 3D cultures (chapter 6), the expression of OC gene 
expression was strongly up-regulated in cells cultured in type I collagen-
hydroxyapatite gel in growth medium. Based, on our results we could speculate that 
the regulation of OC gene expression in MSCs is stimulated by both, paracrine 
factors secreted by other cells and by the interaction of cells with type I collagen gel 
which is inhibited by the presence of osteogenic supplements. The most probably  
this is caused by dexamethasone. 
Dexamethasone is a synthetic member of the glucocorticoid class of steroid drugs 
which imitates the action of many glucocorticoids located in the body, including 
cortisol, estradiol, testosterone, vitamin D3, thyroxine and retinoic acid (Kamran et 
al., 2011). Since it was demonstrated that dexamethasone up-regulation of ALP gene 
and protein expression and therefore, promotes the osteogenic differentiation of cells 
in in vitro culture (Wong et al., 1990), it has been included as the constituent  
of osteogenic differentiation medium. In fact, dexamethasone acts at multiple stages 
of the differentiation process to stimulate osteoblastic maturation in vitro (Porter, 
2003). With time it became evident that the effect of dexamethasone on osteogenic 
differentiation of bone cells depends on the cell origin, donor age, glucocorticoid 
concentration and the duration of administration (Dietrich et al., 1979;Wong et al., 
1990;Sutherland et al., 1995;Fernandes et al., 1997;Coelho and Fernandes, 
2000;Porter et al., 2003;Jorgensen et al., 2004). In relation to rat bone marrow 
Chapter 7: General discussion 
 
234 
 
stromal derived cells, dexamethasone is a necessity for in vitro bone nodule 
formation and mineralisation (Maniatopoulos et al., 1988). Similarly, it was 
concluded that the optimal in vitro osteogenic differentiation of human cells can  
be achieved upon stimulation of cell cultures with supplementation, including 
dexamethasone (Jaiswal et al., 1997). Importantly, a strong relation  
of dexamethasone treatment of osteoblastic cells on decreased proliferation and type 
I collagen synthesis and increased ALP activity and mineralization have been 
demonstrated (Wong et al., 1990;Kim et al., 1999;Jorgensen et al., 2004;Cheng et al., 
1994). At the same time of stimulation of mineralization, a negative influence  
of dexamethasone has been widely reported. Specifically, dexamethasone  
is a powerful inhibitor of OC mRNA expression which was demonstrated by the 
sustained down-regulation of OC gene over 28 day culture period after the 
stimulation of human bone marrow stromal cells for only 24 hours (Cheng et al., 
1996). Moreover, in human osteoblastic cells the vitamin D3-induced osteocalcin 
expression is strongly inhibited upon the exposure of cells to dexamethasone (Wong 
et al., 1990;Jaiswal et al., 1997;Jorgensen et al., 2004).  
All of the presented evidences regarding the action of dexamethasone  
on the regulation of osteogenic differentiation are based on the results from single 
cell type culture of osteoblast lineage cells in monolayer. In fact, in some cases  
the expression of osteocalcin was absent without the stimulation with vitamin D3  
of monolayer osteoblast cell cultures (Jaiswal et al., 1997;Jorgensen et al., 2004). 
Interestingly, the accelerated expression of osteocalcin was reported in 3D cultures 
compared to monolayer or in 3D co-cultures of progenitor cells co-cultured with 
osteoblasts in monolayer (Lynch et al., 1995;Ahn et al., 2006;Uchihashi et al., 2012). 
The results of OC gene expression in different culture settings and conditions 
collected in this thesis are in the agreement with these studies. In addition they 
indicate only little influence of dexamethasone supplementation in single cell type 
monolayer culture of cells on OC gene expression. Hence, we speculate  
that osteocalcin could be successfully induced upon 3D cell-ECM or paracrine 
interaction of cells in 3D in vitro culture. In support of the second part of this 
statement, it should be noted that the inhibition of IL1β-induced paracrine mediators 
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in human MSCs, osteoblasts and retinal microvascular pericytes by dexamethasone 
was demonstrated (Chaudhary and Avioli, 1994;Nehme and Edelman, 2008).  
7.6. Summary 
The results presented in this thesis demonstrated that significant differences exist 
between in vitro osteoblast lineage cells and culture models. The use of cell lines  
as an osteoblast cell model should be carefully considered and limited to appropriate 
and specific research questions due to the phenotypic variances compared to primary 
human osteoblast cells. In addition, the type cell culture model is critical  
for investigating the osteogenic differentiation and cell-cell communication in vitro. 
An active signalling pathway between MSCs and osteoblasts exist which is altered  
in monolayer and 3D (micromass) culture model. While the paracrine activity  
of cells can be modulated by cytokines in monolayer, the secondary effects  
of cytokine treatment do not exert any profound response on cells in monolayer 
culture. A 3D in vitro culture model emerges as being more physiologically relevant 
for the analysis of cell-cell communication and osteoblastic differentiation.  
The progression in osteogenesis depends on the applied 3D culture model. While  
in both, micromass and type I collagen-hydroxyapatite gel, the differentiation  
is enhanced compared to monolayer, the regulation of this process is triggered 
different manner. Further investigations are advised to elucidate in more details  
to what extent the osteogenic differentiation can be recapitulated in these 3D in vitro 
models. Ultimately, our data provide substantial evidence that the osteoblastic 
differentiation of cells in vitro is differentially modulated in 2D and 3D culture 
models. With the proper application of in vitro model a more in vivo-related 
osteogenic differentiation and its regulation can be achieved and investigated. This  
is fundamental for the development of new cell-therapeutic strategies and 
regenerative medicine. 
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APPENDIX 1: CELL TITER-BLUE
®
 PROTOCOL 
OPTIMISATION 
For the optimisation of incubation time cells were seeded at various densities per 
well in 24-well plates. After 4 hours medium was aspirated and cells were incubated 
for certain time with medium containing a 10% solution of Cell Titer-Blue
®
. Two no 
cell control wells were included for every time point. After incubation a 150l 
aliquot of each sample and media with dye alone, were transferred to a 96-well plate 
in duplicate and fluorescence values of samples were measured (excitation/emission: 
560/590 nm) using a Multilabel Counter Wallac 1420 (Perkin Elmer). The results 
were calculated by averaging fluorescent values of the samples and subtracting 
average value of samples without cells. Subsequently, the obtained values were 
plotted and R
2
 value was calculated for each cell type (Tab.A1.). From this 
experiment, the 2 hours incubation time was chosen for assessing the cell growth 
kinetics in primary human osteoblast cells and 4 hours for other cell types used in 
this study.   
 
 
 
Table A1. Incubation time and R-squared value for primary human osteoblasts (HOb), 
MC3T3E1, MG63 and SaOs2 cells with Cell Titer-Blue
®
. 
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Figure A3.A-B. Diagrams show the fluorescence intensity of Cell Titer-Blue
® 
against  
HOb (A) and MC3T3E1 (B) cell number after different time of incubation. 
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Figure A3.C-D. Diagrams show the fluorescence intensity of Cell Titer-Blue
® 
against HOb 
(A) and MC3T3E1 (B) cell number after different time of incubation. 
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APPENDIX 2: PRIMER EFFICIENCY OPTIMISATION 
Real time PCR is a sensitive method to detect the expression of mRNA in the cells.  
For the accuracy of the method it is critical to optimise the reaction conditions 
including the primer efficiency. The amplification efficiency of both, the target  
and reference gene, should be close to 100% and not different than ±10%.  
For the optimisation of the amplification efficiency of human and murine genes  
a diluted template from a positive control of osteoblast cells cultured  
in differentiation medium was used. The efficiency was calculated from the linear 
regression curve of concentrations against the logarithm of dilution 
(Fig.A1.A,B&Fig.A2.A,B). Additionally, to ensure the specificity of the primers  
a melting curve was generated after the reactions to analyse the dissociation-
characteristics of double-stranded DNA during heating (Fig.A1.C&Fig.A2.C).  
This step is important for evaluation of the assay specificity. At the temperature 
about 80°C the whole amplified product is expected to dissociate. If primer dimers 
were amplified an additional peak is observed at lower temperature (about 70°C). 
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Figure A1. Human primers efficiency optimisation. A: Diagram shows the Ct values for 18S 
rRNA, Alkaline phosphatase (ALP), core-binding factor subunit alpha-1 (Cbfa1)/Runt-
related transcription factor 2 (Runx2), type I collagen (COLI) and osteocalcin (OC) against 
the logarithm of the cDNA amount used for the reactions, B: The efficiency calculated  
for each primers set from the linear regression curve, C: Melting curve results obtained after 
the real-time PCR results.  
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Figure A2. Murine primers efficiency optimisation. A: Diagram shows the Ct values  
for 18S rRNA, Alkaline phosphatase (ALP), Runt-related transcription factor 2 (Runx2), 
type I collagen (COLI) and osteocalcin (OC) against the logarithm of the cDNA amount 
used for the reactions, B: The efficiency calculated for each primers set from the linear 
regression curve, C: Melting curve results obtained after the real-time PCR results.  
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APPENDIX 3: RAYBIO
®
 PROTEIN ARRAY MAP 
The analysis of proteomic profile of cytokines secreted by cells was performed using 
RayBio
®
 Human Cytokine Antibody Array G-series 2000. Antibodies  
for 174 cytokines are divided within 3 glass slides:  RayBio
®
 Human Cytokine 
Antibody Array G6, G7 and G8 (Fig.A4.A-C). After binding of the proteins results 
were obtained by scanning the glass slides using GenePix 4000B Microarray Scanner 
(Axon Instruments; Molecular Devices, CA, US). 
 
Figure A4.A-B. RayBio
®
 Human Cytokine Antibody G-Series map. A: Array G6, B: G7. 
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Figure A4.C. RayBio
®
 Human Cytokine Antibody G-Series map. C: Array G8. 
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APPENDIX 4: PROTEIN RESULTS 
Cytokine protein levels secreted by unstimulated MSCs analysed using RayBio 
Cytokine Array G-Series. Cells in monolayer were cultured for 48 hours in serum-
free medium. After that time, medium was collected, centrifuged and stored at -20°C 
until analysis. The analysis was performed using GenePix 4000B Microarray 
Scanner (Axon Instruments; Molecular Devices, CA, US). Protein presence was 
determined by the fluorescence signal intensity: n.d. (= not detected) - for the signal 
intensity up to 10; low – signal intensity of 10-1000; medium – signal intensity  
of 1001-10000; high – signal intensity above 10000 (Fig.A5.A-D). 
 
 
Figure A5. Protein level secreted by unstimulated MSCs (control) determined  
by the fluorescence signal intensity: n.d. (= not detected) - for the signal intensity  
up to 10; low – signal intensity of 10-1000; medium – signal intensity of 1001-10000; high – 
signal intensity above 10000. 
Protein donor 5 donor 6 doonor 7 donor 8 donor 9
Angiogenin medium high high high high
BDNF low low low low low
BLC low low low low n.d.
BMP-4 low n.d. n.d. n.d. n.d.
BMP-6 n.d. n.d. n.d. n.d. low
CK beta 8-1 low low low low n.d.
CNTF low low low low low
EGF n.d. n.d. n.d. n.d. low
Eotaxin low n.d. n.d. low n.d.
Eotaxin-2 n.d. n.d. n.d. n.d. n.d.
Eotaxin-3 low low low low low
FGF-6 low low low low low
FGF-7 low low low low low
Flt-3 Ligand low low low low low
Fractalkine low n.d. n.d. n.d. n.d.
GCP-2 low low n.d. low n.d.
GDNF low low low low n.d.
GM-CSF low low low low low
I-309 low n.d. n.d. low n.d.
IFN-gamma low low low low low
IGFBP-1 low low low low n.d.
IGFBP-2 low low low low low
IGFBP-4 low low low low n.d.
IGF-I n.d. n.d. n.d. n.d. n.d.
IL-10 low low low low low
IL-13 low low low low low
IL-15 low low low low low
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Figure A5. Protein level secreted by unstimulated MSCs (control) determined  
by the fluorescence signal intensity: n.d. (= not detected) - for the signal intensity  
up to 10; low – signal intensity of 10-1000; medium – signal intensity of 1001-10000; high – 
signal intensity above 10000. 
Protein donor 5 donor 6 doonor 7 donor 8 donor 9
IL-16 n.d. n.d. n.d. n.d. n.d.
IL-1alpha low low low low low
IL-1beta low low low low low
IL-1ra low low low low low
IL-2 low low low low low
IL-3 low low low low low
IL-4 n.d. n.d. n.d. n.d. n.d.
IL-5 low low low low low
IL-6 high medium medium high high
IL-7 low low low low low
Leptin low low low low low
LIGHT low n.d. n.d. low n.d.
MCP-1 high high high high high
MCP-2 low low low low low
MCP-3 low low low low low
MCP-4 low low low low low
M-CSF low low low low low
MDC low n.d. n.d. n.d. n.d.
MIG low low low low low
MIP-1-delta n.d. n.d. n.d. n.d. n.d.
MIP-3-alpha low n.d. n.d. n.d. n.d.
NAP-2 low low low low n.d.
NT-3 low low low low n.d.
PARC low low low low low
PDGF-BB low low low low low
RANTES low low low low low
SCF low low low low low
SDF-1 low low low low low
TARC low low low low n.d.
TGF-beta 1 low low low low low
TGF-beta 3 n.d. n.d. n.d. n.d. n.d.
TNF-alpha low low low low low
TNF-beta low low low low low
Acrp30 low low low low low
AgRP low low low low low
Angiopoietin-2 medium low low low low
Amphiregulin n.d. low low low low
Axl n.d. low low low low
bFGF n.d. low low low low
b-NGF n.d. low low low low
BTC low low low low low
CCL-28 low low low low low
CTACK low low low low low
Dtk n.d. low low low low
EGF-R low low low low low
ENA-78 n.d. low low low low
Fas/TNFRSF6 low low low low low
FGF-4 n.d. low low low low
FGF-9 n.d. low low low low
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Figure A5. Protein level secreted by unstimulated MSCs (control) determined  
by the fluorescence signal intensity: n.d. (= not detected) - for the signal intensity  
up to 10; low – signal intensity of 10-1000; medium – signal intensity of 1001-10000; high – 
signal intensity above 10000. 
Protein donor 5 donor 6 doonor 7 donor 8 donor 9
GCSF low low low low low
GITR-Ligand low low low low low
GITR n.d. low low low low
GRO medium medium medium medium medium
GRO-alpha low low low low low
HCC-4 low low low low low
HGF medium medium n.d. medium high
ICAM-1 n.d. low low low low
ICAM-3 n.d. low n.d. low low
IGFBP-3 n.d. low low low low
IGFBP-6 low low medium medium medium
IGF-I SR medium low low low low
IL-1 R4/ST2 low low low low low
IL-1 RI low low low low low
IL-11 low low low low low
IL-12 p40 n.d. low low low low
IL-12 p70 n.d. low low low low
IL-17 low low low low low
IL-2 Rapha low low low low low
IL-6 R n.d. low low low low
IL-8 low low low low low
I-TAC low n.d. low low low
Lymphotactin n.d. low low low low
MIF medium low medium low low
MIP-1alpha n.d. n.d. low low low
MIP-1beta n.d. low low low low
MIP-3beta n.d. low low low low
MSP-alpha low n.d. low low low
NT-4 low low low low low
Osteoprotegerin high high high high high
Oncostatin M low low low low low
PIGF low low low low low
sgp130 low low low low low
sTNF RII n.d. low low n.d. low
sTNF-RI low low medium medium medium
TECK n.d. low low low low
TIMP-1 medium medium medium medium medium
TIMP-2 high high high high high
Thrombopoietin low low low low low
TRAIL R3 n.d. low low low low
TRAIL R4 low low low low low
uPAR low medium low low low
VEGF low low low low low
VEGF-D n.d. low low low low
Activin A low low low low low
ALCAM low low low n.d. low
B7-1(CD80) n.d. low low n.d. low
BMP-5 low low low low low
BMP-7 low low low low low
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Figure A5. Protein level secreted by unstimulated MSCs (control) determined  
by the fluorescence signal intensity: n.d. (= not detected) - for the signal intensity  
up to 10; low – signal intensity of 10-1000; medium – signal intensity of 1001-10000; high – 
signal intensity above 10000. 
Protein donor 5 donor 6 doonor 7 donor 8 donor 9
Cardiotrophin-1 low low low low low
CD14 low n.d. low n.d. low
CXCL- 16 low low low low low
DR6 (TNFRSF21) low low low low low
Endoglin low low low low low
ErbB3 low low low low low
E-Selectin low low low low low
Fas Ligand low low low low low
ICAM-2 low low low low low
IGF-II medium medium medium medium medium
IL-1 R II low low low low low
IL-10 Rbeta low low low low low
IL-13 Ralpha2 low low low low low
IL-18 BPalpha low low low low low
IL-18 Rbeta low low low low low
IL-2 Ralpha low low low low low
IL-2 Rbeta low low low low low
IL-2 Rgamma low low low low low
IL-21R low low low low low
IL-5 Ralpha low low low low low
IL-9 low low low low low
IP-10 low low low low low
LAP medium medium medium medium medium
Leptin R low low low low low
LIF low low low low low
L-Selectin low low low low low
M-CSF R low low low low low
MMP-1 low low low low low
MMP-13 low low low n.d. low
MMP-9 n.d. low low n.d. low
MPIF-1 low low low low low
NGF R low low low low low
PDGF AA low low low low low
PDGF-AB low low low low low
PDGF Ralpha low low low low low
PDGF Rbeta low low low low low
PECAM-1 n.d. n.d. n.d. n.d. low
Prolactin low low low low low
SCF R low low low low low
SDF-1beta low low low low low
Siglec-5 low low low low low
TGF-alpha n.d. n.d. n.d. n.d. low
TGF beta2 low low low low low
Tie-1 low low low low low
Tie-2 low low low low low
TIMP-4 low n.d. low n.d. low
VE-Cadherin low low low low low
VEGF R2 low low low low low
VEGF R3 low low low low low
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APPENDIX 5: GENE EXPRESSION RESULTS  
Human bone marrow mesenchymal stem cells (MSCs) were cultured in monolayer 
(ML), micromass (MM) or in type I collagen-hydroxyapatie gel (CHAP). The gene 
expression of Sox9, Runx2, COL1, ALP, OC and E11 was analysed at day 2, 7 and 
14. During culturing time cells were maintained in growth medium (GM) or 
differentiation medium (DM). 
 
Figure A6. Diagrams show the mean of relative gene expression of Sox9 and Runt-related 
transcription factor 2 (Runx2) with the standard deviation of the mean in cells from 3 
different donors (3 females at age 40, 21 and 19).  
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Figure A7. Diagrams show the mean of relative gene expression of type I collagen (COL1) 
and alkaline phosphatase activity (ALP) with the standard deviation of the mean in cells 
from 3 different donors.  
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Figure A8. Diagrams show the mean of relative gene expression of osteocalcin (OC)  
and E11 with the standard deviation of the mean in cells from 3 different donors.  
 
 
 
